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ABSTRACT 
 
 
 
Cryptosporidium is a leading cause of diarrhoeal disease worldwide. 26 species and more 
than 70 genotypes have been characterised to date, but only two species, 
Cryptosporidium hominis and Cryptosporidium parvum, account for a majority of human 
infections. Despite a close genomic relationship between these species (>96.0% 
nucleotide identities) the former propagates in a predominantly anthroponotic 
transmission cycle, while the latter exhibits a broad zoonotic host range and appears well-
adapted to both humans and cattle. Intra-C. parvum host range differences have also 
been demonstrated through the existence of an anthroponotic subtype commonly 
referred to as ‘IIc’. Using a novel dataset of diverse C. hominis and C. parvum whole 
genome sequences to perform comparative genomics analyses between zoonotic and 
anthroponotic subtypes, a number of divergent loci are herein identified that are subject 
to heightened polymorphism and selective pressure in both C. hominis and C. parvum 
subtype IIc. Glycoproteins, multi-copy gene families and secreted proteins are 
predominant, and the subtelomeres houses a significant majority of these highly-variable 
putative virulence factors. A concatenated phylogeny of novel WGS reveals the existence 
of an anthroponotic subspecies within the C. parvum species clade, warranting re-
classification of zoonotic versus anthroponotic strains as C. parvum parvum and C. 
parvum anthroponosum, respectively. The concatenated phylogeny also demonstrates a 
hybrid-type IIcA5G3j isolate, which contains a IIc-type GP60 locus but an otherwise 
predominantly C. parvum parvum-type genome. Recombination analyses between this 
hybrid strain and two common zoonotic (IIa-type) and anthroponotic (IIc-type) C. parvum 
WGS and a C. hominis (Ib-type) WGS shows extensive genome-wide recombination 
between all of these strains, and divergence dating using recombination data reveals a 
relatively recent estimated time of divergence (<1,000 years ago) between these species 
and subspecies. Population genetics analyses of C. hominis GP60 sequences reveals inter-
family disparities in allelic divergence and selective pressure, with subtype famailies Ia 
and Id exhibiting significantly higher rates of diversification. Evidence of a recent 
population expansion event is also identified for these two subtypes in C. hominis 
populations from Central Asia and Sub-Saharan Africa. An updated look at whole genome 
divergence between a ‘virulent’ Ib-type and ‘avirulent’ Ia-type C. hominis WGS reveals 
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structural changes at the subtelomeres resulting in subtype-specific coding sequences, 
and identifies the location, type and degree of polymorphism and selective pressure that 
accompanies lineage-specific strain emergence and evolution. Finally, the development of 
a novel In Situ PCR/Fluorescence In Situ Hybridization technique for sensitive and specific 
detection of C. p. parvum oocysts is hereby presented. This demonstrates how in silico 
findings from preceding chapters identified a suitable subspecies-specific target, and 
were subsequently translated into an applied molecular method for discrimination of 
lineages at a subspecific level. Taken together, the results from this thesis have 
contributed significantly towards increasing our understanding of the genomic factors 
driving evolution and adaptation in human-infective Cryptosporidium spp.  
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ABBREVIATIONS 
 
A  Adenine 
AA  Amino Acid 
ABS  Absorbance 
AD  Allelic Diversity 
AIDS  Acquired Immune Deficiency Syndrome 
Ala  Alanine 
Arg  Arginine 
ART  Antiretroviral Therapy  
Asn  Asparagine 
Asp  Aspartic Acid 
AU  Australasia 
BioEdit  Biological Sequence Alignment Editor  
BLAST  Basic Local Alignment Search Tool  
C  Cytosine 
CA  Central Asia 
CD  Coding Sequence 
CDC  Centers for Disease Control and Prevention  
COWP  Cryptosporidium Oocyst Wall Protein 
CP47  47 kDa Glycoprotein  
CRU  Cryptosporidium Reference Unit 
Cys  Cysteine 
DAPI  4',6-diamidino-2-phenylindole fluorescent stain 
DN  Rate of non-synonymous substitutions 
DNA  Deoxyribonucleic Acid 
DnaSP  DNA Sequence Polymorphism software package 
DS  Rate of synonymous substitutions 
Dxy  Absolute genetic divergence 
EA  Eastern Asia 
EMBOSS European Molecular Biology Open Software Suite 
EU  Europe 
6-FAM   6-Carboxyfluorescein 
FAO  Food and Agriculture Organization of the United Nations 
FISH  Fluorescence In Situ Hybridization 
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FITC  Fluorescein isothiocyanate  
Fst  Fixation index  
G  Glycine 
GBD  Global Burden of Disease  
GenBank National Institutes of Health Genetic Sequence Database 
Gln  Glutamine 
Glu  Glutamic Acid 
Gly  Glycine 
GP21  21 kDa Glycoprotein  
GP60  60 kDa Glycoprotein  
GP63  63 kDa Glycoprotein  
GPI  Glycosylphosphatidylinositol  
HAART  Highly Active Antiretroviral Therapy 
HE  Haematoxylin and Eosin 
His  Histidine 
HIV  Human Immunodeficiency Virus 
HKY85  Hasegawa-Kishono-Yano nucleotide substitution model 
HSP  Heat Shock Protein 
HTLV  Human T-cell Lymphotropic Virus  
Ile  Isoleucine 
INDEL  Insertion/Deletion 
IS-PCR  In Situ Polymerase Chain Reaction 
ITS  Internal Transcribed Spacer 
KA  Rate of non-synonymous substitutions 
KCl  Potassium chloride 
KH2PO4 Monopotassium phosphate 
KS  Rate of synonymous substitutions 
Leu  Leucine 
LOC  Lab-on-a-chip 
LOD  Limit of Detection 
Lys  Lysine 
MCL  Maximum Composite Likelihood  
MEDLE  Telomerically-encoded secreted Cryptosporidium protein family 
MEGA  Molecular Evolutionary Genetics Analysis  
Met  Methionine 
ML  Maximum Likelihood  
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MLFT  Multilocus Fragment Typing  
MLG  Multilocus Genotypes 
MLST  Multilocus Sequence Typing  
MSC6-7  Serine repeat antigen 
Mu (μ)  Per base mutation rate per generation 
N  No. non-synonymous sites 
Na2HPO4 Disodium phosphate 
NaCl  Sodium chloride 
NAF  North Africa/Middle East 
NAM  North America 
NCBI  National Center for Biotechnology Information  
NNI  Nearest-Neighbour-Interchange 
ORF  Open Reading Frame 
PAS  Periodic Acid Schiff  
PBS  Phosphate Buffered Saline 
PCR  Polymerase Chain Reaction 
Phe  Phenylalanine 
Pi(π)  Nucleotide diversity  
Pi(π)i  InDel diversity 
Pro  Proline 
PubMed National Institutes of Health Public MEDLINE Database 
RCF  Relative Centrifugal Force 
RDP  Recombination Detection Program  
RPM  Revolutions Per Minute  
Rrna  Ribosomal ribonucleic acid  
S  No. sysnonymous sites 
SAAG  Single Amino Acid Gap 
SAAP  Single Amino Acid Polymorphism  
SAM  South America 
Ser  Serine 
SNP  Single Nucleotide Polymorphism 
SPSS  Statistical Package for the Social Sciences 
SSA  Sub-Saharan Africa 
SSU  Small Subunit 
SVSP  Subtelomere-encoded Variable Secreted Proteins  
T  Thymine 
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TGA  Thousands of Generations Ago 
Thr  Threonine 
Trp  Tryptophan 
Tyr  Tyrosine 
UNAIDS  Joint United Nations Programme on HIV/AIDS 
Val  Valine 
WGA  Whole Genome Alignment 
WGS  Whole Genome Sequence 
WHO  World Health Organization 
ZN  Ziehl Neelsen 
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OPENING REMARKS 
 
 
Establishing the genetic basis of host specificity has been one of the leading aims for 
Cryptosporidiologists since the first complete reference genomes became available just 
over a decade ago (Abrahamsen et al. 2004; Xu et al. 2004).  Since their release, there has 
been strong concordance within the scientific community regarding a ~95.0-97.0% 
consensus between the genomes of the primary human-infective species, 
Cryptosporidium parvum and Cryptosporidium hominis, in terms of global genetic 
composition (Mazurie et al. 2013). Initial comparative analyses also pointed towards 
complete synteny of chromosome size and arrangement between these two closely-
related, yet phenotypically-diverse, species. Despite the interesting phylogenetic 
inferences that can be drawn from currently-available data regarding genetic distance 
and evolutionary relatedness between and within C. hominis and C. parvum, they do not 
sufficiently explain the phenotypic discrepancies that exist between them, most notably 
the narrow anthroponotic host range in the former, and expansive zoonotic host range in 
the latter. The available studies also do not disclose any genotypic explanation for the 
existence of a presumptively anthroponotic C. parvum subtype IIc, with the single strain-
by-strain analysis performed to date only identifying limited genome-wide variation 
between this strain and its zoonotic IIa C. parvum counterpart (Widmer et al. 2012). 
Although the initial release of the reference genomes will forever be hailed for its 
revolutionary impact within the Cryptosporidium community, recent access to new and 
improved genomes have proven that current suppositions are outdated and erroneous, in 
part due to the poor sequence coverage and quality of the original reference TU502 C. 
hominis genome, but also as a result of the superficial and nucleotide-biased view with 
which the first genome-wide analyses were performed. A transition to proteomics-based 
comparisons, in conjunction with accurate synteny evaluation through improved end-to-
end chromosome alignments, and in-depth views into the nature and degree of variation 
at recombination hotspots like the subtelomeres, will help project Cryptosporidium 
genomics into a new era of understanding. Whole-genome comparisons in this context 
are specifically aimed at characterizing genetic affinities and disparities between and 
within distinct phenotype groups (i.e. anthroponotic versus zoonotic), unlocking the 
genetic basis of divergent features such as host range and virulence, and providing a new 
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stockpile of supervirulence candidates for potential translation of molecular targets into 
novel diagnostics and prevention. From a species classification standpoint, the objective is 
to achieve a validated method for classifying strains that builds upon and improves 
currently-employed phylogenetic inferences, paving the way for novel genotyping 
alternatives to be implemented throughout academic and public health spheres. 
Population genetics of the hypervariable host-parasite interactor GP60 will complement 
this by evaluating the allelic divergences and evolutionary pressures accompanying strain 
emergence and evolution worldwide, providing insight into both the geographic spread 
and chronology of GP60 subtype emergence and describing novel epidemiological trends 
across subtype families. This thesis thereby aims to contribute significantly towards 
determining the impactful yet subtle genetic mechanisms underlying phenotypic 
differences between closely related strains and species, identifying the key players in 
host-parasite interactions, and providing new insight into a parasitic disease which has 
largely been neglected and underestimated by the global research and public health 
community. The following opening section aims at providing a brief introduction to three 
important themes interlaced throughout the main chapters: classification, virulence, and 
incentive. Understanding both the history and present situation of Cryptosporidium 
isolate classification highlights the inaccuracy and inefficiency of common phylogenetic 
typing tools that this thesis aims to describe and correct, and explains why previous 
studies may have missed the extent of genomic recombination that is herein illustrated 
and discussed. Virulence and divergence are presented within the context of host-
parasite interactions and pathogenic impact, in an attempt to highlight the importance of 
these key features in differentiating phenotypically-diverse C. hominis and C. parvum 
subtypes, and to pre-emptively justify a methodological approach that focuses on 
subtelomeres, hypervariability and selective pressure. Brief introductions to the current 
understanding of genomic differences and recombination in human-infective 
Cryptosporidium spp. further highlight what we know versus what knowledge might be 
missing, creating a platform upon which all four in silico chapters will build. The final 
introductory section presents the all-important public health incentive for conducting 
Cryptosporidium research, through systemative review of published human prevalence 
studies. This review presents and discusses global prevalence data in the general public, 
as well as at-risk groups such as immunocompromised individuals, and illustrates the 
relative proportion of human infections worldwide due to C. hominis versus C. parvum. 
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Systematic review of GP60 subtype data further illustrates our current understanding of 
intra- and inter-species differences in host range and global distribution of GP60 subtype 
families, which inspired the idea for a GP60 population genetics study and intra-C. 
hominis comparative genomics piece. Introductory themes throughout chapter 0 are left 
intentionally vague and generalist, as tailored introductions have been prepared for each 
chapter individually. This has been done with the intension of presenting the results of 
this thesis within a more contextual and comprehensive ‘publication-style’ sphere. 
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                CHAPTER 0 
 
             
0.1 Cryptosporidium classification – Past and Present 
 
In 1907, an American scientist by the name of Ernest 
Edward Tyzzer peered down his oil emersion lens at 
the gastric mucosa of a common mouse and 
discovered for the first time a new sporozoan type 
coccidian he named Cryptosporidium muris. For most 
of the twentieth century that followed, 
Cryptosporidiosis was thought of as a disease of 
primarily zoonotic and benign importance, and its 
potentially devastating impact on humans was only 
revealed when a new global population of 
immunocompromised individuals emerged as a result 
of the AIDS epidemic in the 1980s (Ma & Soave, 1983; 
Current, et al. 1983; Cohen, et al. 1984; Casemore, et 
al. 1985; Tzipori, 1988).  The approach for species 
classification in this pre-molecular era was frequently 
based on the host type from which a strain was 
isolated, with individual isolates being designated as 
C. parvum “human” genotype, C. parvum “dog” 
genotype, C. parvum “bovine” genotype, and so on 
(Morgan et al. 2000; Xiao et al. 2001), in addition to the C. muris mouse strain originally 
characterized by Tyzzer almost a century earlier. The absence of a detailed 
epidemiological or biological understanding of this parasite in the decades that followed 
meant that until recently, the primary human-infective forms of Cryptosporidium were 
merely classed as genotypes belonging to a single species, C. parvum Type I 
(anthroponotic) and Type II (zoonotic) (Feng et al. 2000; Widmer et al. 2000).  
 
 
(A) E. E. Tyzzer, 1875-1965 
(https://web.stanford.edu/group/parasites/
ParaSites2001/crypto/)                                  
(B) Stomach section of a mouse infected 
with C. muris (Tyzzer, 1910) 
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Since then, extended morphological characterization and later genomic verification have 
indicated that C. parvum Type I and Type II are in fact two genetically distinct species 
(Morgan-Ryan et al. 2002), C. hominis and C. parvum respectively, and that the reported 
human-infective strains can be further grouped into a range of strains based on subtle 
genetic differences within each species. The Cryptosporidium genotyping and subtyping 
approaches have subsequently expanded, in an attempt to identify strain discriminatory 
markers exhibiting a degree and nature of variability that is considered sufficient and 
reliable enough to represent genome-wide differences between and within infective 
Cryptosporidium spp. 26 Cryptosporidium species and 70 genotypes have been 
characterized to date (Qi et al. 2015), and access to a wider range of whole-genome 
sequences is beginning to increase. This creates a platform for the advancement of 
molecular tools to better understand the way in which strains and species emerge and 
evolve in this diverse genus, while simultaneously opening the door for in depth studies 
of the structural and compositional genomic changes accounting for differential patterns 
of behaviour and infectivity.   
 
In the early days of molecular diagnostics, identification was confined to a limited 
genotypic classification of Cryptosporidium spp. and an absence of associated genomic 
data. As a result, molecular diagnostics were largely dependent on mainstream scientific 
targets such as the SSU rRNA (Awad-el-Kariem et al. 1994; Johnson et al. 1995), heat 
shock protein (HSP; Stinear et al. 1996), and internal transcribed spacer 1 (1TS1) genes 
(Cai et al. 1992). Unknown targets produced by random amplification of polymorphic DNA 
(Morgan et al. 1996; Benigno et al. 1996) and plasmid-based genomic library construction 
also started to emerge, attempting to enhance the sensitivity of typing techniques as well 
as broaden the specificity to discriminate between phenotypically-diverse targets (Laxer 
et al. 1991).  The PCR toolbox soon expanded to contain a number of oocyst protein 
(Wagner-Wiening & Kimmig 1995; Laberge et al. 1996) and oocyst wall protein (Ranucci 
et al. 1993; Meyer & Palmer 1996) targets, but these were still overwhelmingly catered 
towards C. parvum specificity and non-specific to less frequent causes of human disease 
such as C. meleagridis, C. felis, C. canis, and C. muris.   
 
One of the first improved Cryptosporidium-specific discriminatory markers to be 
implemented as a typing tool was based on a 70-kDa heat shock protein (HSP70) gene 
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(Gobet & Toze, 2001). Although successful at differentiating between C. hominis and C. 
parvum based on a simple PCR banding size approach, a number of non-human 
genotypes could not be targeted, and the marker had too great sequence conservation to 
be of any use for detailed subtype analyses.  The 18S small-subunit ribosomal ribonucleic 
acid (18SSU rRNA) locus, which is the most commonly used diagnostic marker across 
eukaryotic and prokaryotic pathogens (Wang et al. 2014), similarly proved to have 
insufficient discriminatory power between subtypes and failed to even identify the 
presence of separate species in mixed infections (Chalmers et al. 2005). The search for an 
improved substitute that contained a suitable balance between intra-strain conservation 
and inter-strain variability led to the identification of a highly-polymorphic 60 kDa 
glycoprotein commonly referred to as GP60 (Strong et al. 2000). The primary diagnostic 
benefit of this locus derives from the presence of several tandem repeats, one based on 
trinucleotides encoding a stretch of serines and another comprised of a repetitive KTVVR-
type motif (Xiao, 2010), whose amplicon size initially appeared to correspond to genome-
wide genetic changes between phenotypically-diverse isolates. This feature gave GP60 
instantaneous popularity for its ability to produce interesting and expansive phylogenetic 
characterizations for a wide range of human- and animal-isolated parasites (Jex et al. 
2007; Stensvold et al. 2014).  These highly-repetitive regions of DNA, often referred to as 
microsatellites, are hypothesized to frequently contract and expand at a constant rate 
when one strain evolves into another (Ellegren, 2004), providing a cheap and reliable 
target for studying population genetics. Although GP60 has been used in more than 150 
studies for the purpose of molecular characterization of Cryptosporidium spp. to date, the 
high mutation accumulation rate that characterizes the regions upstream and 
downstream of the repeats, as well as the recombinatory nature of this locus (Li et al. 
2013), have started to bring into question whether this gene is reliable enough to provide 
phylogenies that accurately represent the genome-wide variability between strains. There 
is also the constant uncertainty regarding whether any true associations can be drawn 
between the nature of repeat divergence at a single genetic locus and the phenotypic 
manifestations of an infecting strain. In light of the potential drawbacks of GP60, a wave 
of alternative markers has since been introduced, and the current approach most western 
diagnostic laboratories rely on is a multilocus fragment size-based typing (MLFT) 
method that employs a combination of these markers to obtain the most reliable 
subtyping of infective species. However, these markers display varying discriminatory 
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powers between C. hominis and C. parvum (Robinson & Chalmers, 2012), and there is an 
absence of MLST validation at reference laboratories located outside of the European 
geographic area.  A lack of access to diverse WGS also means that the phenotypic 
correlation between single marker targets and whole genome divergence remains poorly 
validated. Current data does not endorse or reject any combination of these markers 
wholly, and the absence of a consensus approach to Cryptosporidium genotyping, or a 
single marker for confident subtype discrimination, highlights the need to perform large-
scale genomic comparisons to fill the current gap in Cryptosporidium molecular 
diagnostics and phylogenetic characterization.  
 
0.2 The road to virulence in cryptosporidiosis – Divergence, selective 
pressure, and the telomeres 
 
Aside from the development of improved phylogenetic typing tools, whole-genome 
comparisons in parasitic species are primarily aimed at identifying virulence factors which 
are essential for parasite survival and host pathogenesis, and through this understanding 
the genetic basis of host specificity. The genetic changes that accompany host-driven 
adaptation most significantly impact the protein repertoire of first line defences which a 
parasite utilizes upon encountering novel host immune cells and response mechanisms.  
As such, it is often possible locate virulence factors by identifying loci that are subject to a 
particularly high degree of divergence or selective pressure between species. Although 
the exact genetic changes resulting in specific virulence features are driven by individual 
host and parasite combinations, there are certain genetic changes that are ubiquitous in 
evolutionary adaptation across most parasitic species. Understanding the way in which 
these generalized genetic changes manifest themselves in genome data, and identifying 
the shortcomings of currently-available software tools for detecting them, provides a way 
to develop a customized approach to obtaining a thorough, accurate, and reliable 
understanding of genome-wide divergence between closely-related strains and species. 
One of these changes is the increased occurrence of indels, or single nucleotide insertion 
and deletion events, which result in frameshifts that have the potential to drastically alter 
or altogether eradicate coding sequences, and thereby impact the activity and function of 
encoded proteins (Williams & Wernegreen, 2013). The implications of indels in host-
driven divergence is compounded by the increased mutation accumulation rate observed 
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in proximal genetic regions, seemingly a form of knock-on effect as a consequence of 
their occurrence (Jovelin & Cutter, 2013). What complicates the identification of genome-
wide indel inflictions is that automated software tools are often customized to search for 
specific changes in SNP rates, rather than the protein-level impact of single nucleotide 
changes, and as a result these are often overlooked. Despite these shortcomings, an 
increase in indel mutations as a result of host species switching has been well-established 
in a number of pathogenic microorganisms, such as Campylobacter jejuni (Thomas et al. 
2014), Streptococcus agalactiae (Rosinski-Chupin et al. 2013), parasitic nematodes (Wang 
et al. 2009), and Mycobacterium spp. (Streenu et al. 2006). Monitoring the occurrence of 
frameshift-causing indels at the genomic level can hence be used as evidence for a 
presumed case of host-driven adaptation, and is an important component towards 
understanding the genetic basis of host specificity and virulence in Cryptosporidium.  
 
Another mechanistic consequence of speciation is the overrepresentation of sequence 
divergence, loss, and gain at subtelomeric regions (Monerawela et al. 2015). The 
enhanced gene turnover rates at these regions is facilitated by a high frequency of 
recombination (Jiang et al. 2011), often resulting in extensive expansion or contraction of 
subtelomeric gene copy number and an elevated rate of divergence (Anderson et al. 
2015). Subtelomeres are thus often observed as the source of virulence and pathogenicity 
factors in microbial parasites, and frequently feature at the core of genome-wide 
divergence studies. In Plasmodium, the rapid rate of divergence at the subtelomeres has 
resulted in the evolution of an expansive and highly-effective virulence gene family 
collectively known as var genes, whose hypervariability and variegated expression 
enables the parasite to evade the host’s antibody-driven immune response (Witmer et al. 
2012). A number of other subtelomeric gene families also promote virulence in this 
protozoan parasite, including a repetitive interspersed DNA element family (Weber 1988), 
a variable open reading frame family (Niang et al. 2014), an interspersed helical domain 
gene family (Oberli et al. 2014), and a Maurer’s cleft membrane gene family (Sam-Yellowe 
et al. 2004).  In Trypanosoma, a vast network of subtelomerically-encoded variable 
surface glycoproteins allows this parasite to employ antigenic variation (Jehi et al. 2014). 
This fascinating feature of continuously shifting recognition molecules on the parasite’s 
cell surface almost uniformly accounts for the success with which trypanosomes evade 
host immune responses during the bloodstream form, and the high rates of morbidity and 
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lethality it can inflict as a result. Theileria similarly contains a range of subtelomere-
encoded variable secreted proteins (SVSP) whose rapid inter-strain divergence, variable 
gene copy number and significant representation in the macroschizont secretome makes 
them likely virulence factor candidates (Hayashida et al. 2012).  Despite this wealth of 
knowledge in other protozoan parasites, very little is known about the significance of 
subtelomeric regions in Cryptosporidium host specificity and virulence; in fact, only few 
studies are currently published that even mention subtelomeres in conjunction with 
Cryptosporidial genetics (Bouzid et al. 2013a; Li, et al. 2013; Bouzid et al. 2013b; Guo et 
al. 2015; Liu et al. 2009; Liu & Abrahamsen, 1999). Novel whole genome comparisons 
using improved WGS assemblages have begun to expose physical evidence of genome-
wide incongruence, with significant subtelomeric sequence insertion and deletion (indels) 
events identified between C. hominis and C. parvum (Guo et al. 2015). Identifying 
significant changes in subtelomeric consistency between phenotypically-diverse strains 
and species is thus a key component to understanding how and why certain human-
infective Cryptosporidium subtypes and species exhibit differential patterns of behaviour, 
host specificity, and virulence.   
 
Although the subtelomeres require special focus in discerning virulence factors in 
protozoan parasites, proteins involved in host-parasite interactions and pathogenesis are 
by no means limited to this region of the genome. A number of internally-encoded 
proteins have been implicated as equally contributing to the success and severity with 
which protozoa cause disease. This includes the metalloprotease GP63 of Leishmania, 
involved in cell signal modulation and evasion of complement-driven lysis (Shio et al. 
2015); a family of rhoptry kinases in Toxoplasma that facilitate invasion and host-cell gene 
expression in supervirulent strains (Sibley et al. 2009); a family of cathepsin L-like 
peptidases in Eimeria (Liu et al. 2014); and GP60, a GPI-anchored secreted sporozoite 
antigen that displays hypervariability between Cryptosporidium strains and species 
(Strong et al. 2000). In addition, protozoan parasites as a group seem to contain an 
impressive repertoire of glycoconjugates encoded at numerous loci spanning the genome, 
whose sugar-saturated outer coating and frequently-secreted nature implicates them as 
key host-parasite interactors at various stages of parasite development (Ivens et al. 2005; 
Ramly et al. 2013; Tomita et al. 2013; Bhalchandra et al. 2013). Putative virulence factors 
have a very diverse infrastructure in terms of localization, function, and activity across the 
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tree of Apicomplexan life, and exhibit a highly taxon-specific nature at many of the 
encoding loci (Kissinger & DeBarry, 2011). This makes it difficult to develop a generalized 
pipeline for deducing virulence-associated protein function based on sequence similarity 
between putative virulence factors in one Apicomplexan genus and established virulence 
factors in another. Whole-genome comparisons between phenotypically-diverse strains 
are consequently one approach to overcome this, generating a list of tentative candidates 
based on all areas of the genome displaying higher-than-average divergence rates, as well 
as those that are under a positive versus negative degree of selective pressure. This 
provides a solid virulence platform upon which molecular studies can build.     
 
0.3 Justification and rationale – the global significance of exploring 
human-infective Cryptosporidium spp. genomics  
 
The importance of performing this genome-wide comparative analysis and population 
genetics study has to be explained in the context of the known epidemiological features 
that classify C. hominis and C. parvum as distinct species types, as well as the big picture 
of global disease burden imposed by these on human populations. The primary 
pathogenic distinction between C. hominis and C. parvum is an almost entirely 
anthroponotic host range in the former, and an extensive zoonotic host range in the 
latter, characterizations which have repeatedly been reported and were independently 
validated in this systematic review (Figure 0.3.1). Despite this widely-accepted 
characterization, the genomes of these two species have perpetually been described as 
largely homogeneous (Mazurie et al. 2013), with current data providing only limited 
genotypic insight into their unique patterns of host specificity through SNP-based 
divergences, missing subtelomeric sequence data and occasional recombination at the 
GP60 locus. What adds to the mystery of the genetic basis of host specificity is the 
existence of a presumptively anthroponotic C. parvum strain, described as GP60 subtype 
family IIc (Widmer et al. 2012), which complicates the generalizability of the association 
between host range and species as it currently stands. The IIc isolates are closely related 
to other C. parvum subtype families genetically, but they appear to predominantly 
propagate in an overwhelmingly anthroponotic transmission cycle, similar to the C. 
hominis host range phenotype. This alludes to the potential existence of more complex 
differences at the genomic level which previous analytical approaches may have missed, 
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and which the lack of access to diverse WGS have historically hampered. Re-visiting the 
phenotypic differences of human-infective Cryptosporidium spp., and illustrating global 
prevalence rates and disease burden in high risk populations, provides a core justification 
for studying genomic differences in human disease.   
 
 
 
 
Figure 0.3.1. Flow diagram of inclusion/exclusion procedure during systematic review of GenBank GP60 entries, to define host range 
for the GP60 subtype families used in this study: C. hominis subtypes Ia and Ib, and C. parvum subtypes IIa, IIc, and IId 
The process of data extraction, exclusion, and inclusion during systematic review of GP60 sequences is outlined, describing the 
approach by which host range was characterised for GP60 subtype families Ia, Ib, IIa, IIc, and IId. The initial GenBank 
(https://www.ncbi.nlm.nih.gov/genbank/) search was based on the terms “GP60”, “GP40”, and “GP15” (GP60 has previously been 
referred to as GP15, GP40, and GP40/15), and hits were subsequently filtered to remove all non-C. parvum/C. hominis related entries.  
These hits were further cleaned to remove all GP60 sequences not belonging to families Ia, Ib, IIa, IIc or IId, as were all entries of non-
human (e.g. environmental) or unspecified origin. The last phase involved removing all study duplicates, which resulted in a final 
dataset of 353 GenBank entries for inclusion in this study. Data extracted from each GenBank entry included nucleotide sequences (to 
confirm subtype family), date of submission, geographic origin of isolates, any associated publications and host species. 
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The systematic review of GP60 sequences submitted to GenBank revealed 1,203 
submissions for the subtypes used in this comparative genomics study (Ia, Ib, IIa, IIc, IId).  
After the dataset was cleaned to remove environmental samples, entries with unspecified 
host and study duplicates, a total of 353 remained and were included in the host range 
analysis.  Submission quantities were not evenly distributed across the subtypes, with a 
significant proportion belonging to C. parvum subtype IIa (N=143), followed by C. parvum 
subtype IId (N=74), C. hominis subtype Ib (N=67), C. hominis subtype Ia (N=42), and C. 
parvum subtype IIc (N=27) (Figure 0.3.1). GenBank submissions included GP60 sequences 
from 48 countries, but the geographic origin of samples was equally unbalanced across 
the world. More than one-fourth (26.9%) of entries referring to samples from the United 
Kingdom and Australia, and when the dataset was further stratified into geographic 
regions it became evident that a vast majority of samples originated in the European 
region (40.5%), followed by Australasia (14.7%), Eastern Asia (10.7%), North Africa 
(10.7%), South America (9.2%), Central Asia (5.5%), Sub-Saharan Africa (4.9%) and North 
America (3.7%) (Figure 0.3.2).    
 
 
Figure 0.3.2. Geographic origin (country and region) of GP60 GenBank submissions included in systematic review of host range for C. 
hominis (GP60 subtypes Ia and Ib) and C. parvum (subtypes IIa, IIc, and IId) 
The country and region of origin of each GP60 sequence retrieved for this systematic review is here summarised. Regions are defined 
as Australasia/Oceania (AU), Central Asia (CA), Eastern Asia (EA), Europe (EU), North Africa/The Middle East (NAF), North America 
(NAM), South America (SAM), and Sub-Saharan Africa (SSA). 326 of the 353 (92.4%) GenBank submissions included in this host range 
characterisation reported a country of origin, or referred to an associated publication which provided isolate origin information, while 
the remaining 27 (7.6%) did not and so were excluded from this figure. 
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The systematic review of the Cryptosporidium spp. subtypes for which WGS were 
available in this study (Ia, Ib, IIa, IIc, and IId) provided an overview of host specificity that 
accurately reflects and confirms host range associations as they currently stand (Figure 
0.3.3). Collated data from a range of epidemiological and clinical studies clearly separate 
certain subtypes into zoonotic versus anthroponotic categories. C. hominis subtypes Ia 
and Ib, and C. parvum subtype IIc, were isolated from humans in more than three-fourths 
(>75.0%) of published studies reviewed, corroborating previous reports of predominantly 
anthroponotic transmission cycles. C. parvum subtypes IIa and IId, on the other hand, 
were reported in approximately equal proportions from human, cattle, and ‘other’ host 
types (~30% each). This demonstrates the true breadth of zoonotic host range in these 
subtypes, together identified in more than twenty separate host species, which appear 
well-adapted to both human and cattle hosts. These trends describe C. hominis and C. 
parvum as specialist and generalist respectively in terms of their ability to thrive in 
various host environments. Their close overall genomic relationship implies that a subset 
of targeted divergences and rearrangements from a recent common ancestor could have 
driven this evolutionary adaptation and speciation event, supporting the rationale for a 
multi-faceted and extensive study to describe the underlying genetic features. 
Interestingly, C. hominis subtype Ib exhibited a slight zoonotic tendency, having been 
isolated from 8 non-human host types on at least fourteen separate occasions. This 
observation places this subtype’s host range phenotype closer to that of C. parvum 
subtypes IIa and IId than indeed C. parvum subtype IIc is situated. This provides some 
evidentiary support for the claim that certain subtypes may be more virulent and 
infectious than others (Cama et al. 2008), based on a direct association between broader 
host range and greater pathogenicity as observed in other pathogens (Sree & Varma, 
2015; Stephenson & Foley, 2016). This adds another layer of complexity to what this 
comparative genomics and population genetics study aims to achieve, as similar to the IIc-
phenomenon it shows a tendency of certain subtypes to contradict intra-species 
phenotypic expectations. Correlating genetic differences with these types of phenotypic 
characteristics therefore requires expansive and detailed genomic and population 
genetics analyses, and provides a strong scientific rationale for expanding the scope of 
this study to elucidate genetic differences not simply on a species-by-species basis, but 
between individual subspecies and subtype families for which WGS are available. 
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Figure 0.3.3.  Host range patterns of Cryptosporidium GP60 subtype families Ia, Ib, IIa, IIc, and IId  
Host range patterns were determined through a systematic review of peer-reviewed studies describing molecularly-discriminated 
Cryptosporidium subtypes Ia, Ib, IIa, IIc, and IId isolated from animal species on NCBI’s PubMed database 
(http://www.ncbi.nlm.nih.gov/pubmed). The presence of a subtype through host faecal examination and molecular screening was 
given a value of 1.0 per study, and comparative figures are hence not representative of overall or relative prevalence of infection or 
subtype in any given host population. Frequency of subtype distribution was estimated from 48, 29, 114, 54, and 28 peer-reviewed 
articles for subtype families Ib, Ia, IIa, IId, and IIc, respectively.  
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A further important justification and rationale for this comparative genomics study lies in 
the global burden of disease that can be attributed to C. hominis and C. parvum, in 
humans generally and in at-risk groups such as immunocompromised individuals. For this 
purpose, a systematic review of all human prevalence studies published in the new 
millennium (2000-2017) was undertaken. The objective was to capture the relative 
burden of human cryptosporidiosis between different geographic regions and study 
groups (e.g. children, immunocompromised, etc.), and to illustrate differential 
distribution patterns of C. parvum and C. hominis as well as their respective GP60 
subtypes. A total of 754 peer-reviewed journal articles were extracted and included in this 
systematic review, representing 128 countries worldwide (Figure 0.3.4). Most studies 
originated in Sub-Saharan Africa (19.9%), with similar proportions stemming from Central 
Asia (15.9%), Europe (15.7%), North Africa/The Middle East (16.9%) and South America 
(14.5%), and slightly fewer originating in Eastern Asia (11.3%) (Figure 0.3.5). A notable 
fewer proportion of prevalence studies took place in Australasia (3.3%) and North 
America (2.4%). Country-based differences were also observed, with a significant number 
of studies originating from India (N=63) and Iran (N=40), and half of the studies reviewed 
overall originated from only 14 countries (Australia, Brazil, China, Egypt, Ethiopia, India, 
Iran, Malaysia, Nigeria, Saudi Arabia, Spain, Thailand, Turkey, United Kingdom). It is also 
important to note that no human prevalence data could be identified for more than one-
third of countries worldwide (66 of 194; 34.0%), with islands in Oceania and the 
Caribbean accounting for >30.0% of the missing data (Figure 0.3.4). This highlights a 
significant knowledge gap for human cryptosporidiosis that is more pronounced in 
remote, resource-poor areas. As a consequence, the current description of human 
Cryptosporidium spp. distribution and burden worldwide remains incomplete and 
skewed. A substantial margin of uncertainty remains to be corrected and filled in order to 
improve our understanding of the burden cryptosporidiosis poses on human populations 
worldwide, and to better understand the epidemiogical features that define and separate 
human-infective species and subtypes.     
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Figure 0.3.4. Flow diagram of study selection procedure and criteria for systematic review of human cryptosporidiosis prevalence 
studies, 2000-2017. 
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Figure 0.3.4. Flow diagram of study selection procedure and criteria for systematic review of human cryptosporidiosis prevalence 
studies, 2000-2017. 
The human cryptospodiosis database was constructed using data from all peer-reviewed journal publications describing non-outbreak 
associated prevalence studies in humans, published between 2000-2017. A total of 7,977 PubMed 
(https://www.ncbi.nlm.nih.gov/pubmed) hits for the search term “Cryptosporidium” were obtained, and initially filtered to remove all 
pre-2000 publications (N = 2,555). Abstracts for the 5,422 hits that remained were individually reviewed to extract all human 
cryptosporidiosis prevalence studies (N = 1,010), and subsequently cleaned to remove all outbreak and seroprevalence studies, as well 
as studies where a full version of the publication could not be accessed. This resulted in a dataset of 704 peer-reviewed studies 
spanning 115 countries worldwide. In order to enhance global coverage, pre-2000 published human prevalence studies were included 
for countries where post-2000 data was not available, which added another 50 hits from 13 countries (Austria, Azerbaijan, Belarus, 
Bolivia, Burma, Burundi, Congo, Costa Rica, El Salvador, Honduras, Liberia, Trinidad and Tobego, and Turkmenistan). The final dataset 
consisted of 754 peer-reviewed journal publications, and spanned a total of 128 (66.3%) of the 194 countries worldwide. The database 
was subsequently constructed using manually-extracted data from each of these studies, and included: date of publication, date(s) of 
study, study group(s) (including all descriptive characteristics pertaining to age, pre-existing chronic conditions, disease manifestations, 
and high-risk exposures such as animal contact), location (including where possible country, city, and rural versus urban environment), 
overall prevalence, prevalence for individual study groups (e.g. HIV-positive versus HIV-negative study participants), proportion of 
prevalence attributable to known species/genotypes, and the proportion of C. hominis and C. parvum cases caused by individual 
subtype families.   
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A stratification of the study groups in which cryptosporidiosis rates are frequently 
investigated generates further information about populations at a higher risk of infection 
or severe pathogenesis (Figure 0.3.6). Children made up the largest proportion of study 
groups targeted in prevalence studies between 2000-2017 (35.9%), of which ~65% 
involved symptomatic patients. This heightened focus reflects the high burden of 
cryptosporidiosis and the associated morbidity and mortality in children that has 
previously been reported (Sow et al. 2016). Another high-risk group that featured 
predominantly was HIV-positive individuals, making up 26.0% (196 of 754) of the human 
prevalence studies reviewed. This targeted focus similarly reflects the significant burden 
that cryptosporidiosis is known to inflict on persons infected with HIV and other 
immunocompromising conditions. Symptomatic populations (including adults only or 
cases of all age groups) was the final major study group targeted by the prevalence 
studies reviewed, making up 24.7% (186 of 754). The remainder were made up of 
immunodeficient individuals suffering from non-HIV related conditions (9.0%), 
asymptomatic cases (7.0%), and humans reporting close contact to animals or farming 
facilities (2.1%).   
 
 
 
 
 
 
 
 
 
 
 
 
   
34 | P a g e  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 0.3.6. Types of study groups included in prevalence database of human cryptosporidiosis, 2000-2017 
The types of study populations included in human cryptosporidiosis prevalence studies (2000-2017) are here illustrated. These 
characterisations are based on all pre-existing conditions/exposures/criteria present in the study population and used by the reporting 
authors to define their study groups, and include: asymptomatic individuals (A), children <18 years (C), individuals with exposure to 
agricultural settings/animals (F), HIV-positive (H), other immune-compromising conditions (e.g. organ transplant recipients) (I), and 
symptomatic sporadic cases/patients (S). Studies with multiple pre-existing criteria/conditions were included in multiple groups where 
applicable (e.g. studies focused on HIV-positive children were included in both “C” and “H”).   
 
Global prevalence rates in affected human communities and populations highlight the 
persistence of C. hominis and C. parvum across a wide range of geographically- and 
socioeconomically-diverse localities (Figure 0.3.7). In the new millennium (2000 – 
present), cryptosporidiosis was diagnosed in symptomatic (broadly referring here to 
groups exhibiting some form of gastrointestinal manifestations) individuals in more than 
93% (699 of 754) of prevalence investigations reviewed. Prevalence rates for 
cryptosporidiosis ranged from <0.1 to 100.0% of study participants, varying significantly 
across geographic regions and between immunocompromised versus competent 
patients. In immunocompetent patients with gastrointestinal symptoms, countries of 
North America, Europe, North and East Asia and Australasia showed relatively low 
frequencies of cryptosporidiosis (<1.0-5.0%), while large parts of South America, Sub-
Saharan Africa, the Middle East and Central/South Asia had higher average prevalence 
rates ranging from 5.0 to >30.0%. These more heavily affected regions are simultaneously 
areas with disproportionately higher rates of malnutrition, particularly in children <5 
years (FAO 2013), which re-emphasizes the significant impact of cryptosporidiosis on 
populations suffering from compromised nutritional states (Sallon et al. 1988; Costa et al. 
2011).  
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Figure 0.3.7. Global prevalence maps of human cryptosporidiosis in immunocompetent versus immunocompromised groups, and 
the relative compositions of primary human-infective Cryptosporidium spp. in human populations, 2000-2017 
   
36 | P a g e  
 
Figure 0.3.7. Global prevalence maps of human cryptosporidiosis in immunocompetent versus immunocompromised groups, and 
the relative compositions of primary human-infective Cryptosporidium spp. in human populations, 2000-2017 
The prevalence and geographic distribution of cryptosporidiosis cases in immunocompetent and immunocompromised human study 
groups (non-outbreak related investigations), and relative proportion of infections attributable to C. hominis versus C. parvum, were 
assessed through systematic review of all relevant prevalence studies published between 2000-2017 on NCBI’s PubMed Database 
(http://www.ncbi.nlm.nih.gov/pubmed). A total of 754 peer-reviewed publications providing data from 128 countries (66.3% global 
coverage) were selected, having fulfilled the pre-determined inclusion criteria as specified for this extensive systematic review 
(detailed methodology outlined in Figure 0.3.4.) 
 
The global picture of burden changes instantaneously when immunodeficiency is taken 
into focus, with the heat-mapped figures demonstrating a more than five-fold increase in 
prevalence in all but five of the countries investigated (Australia, Denmark, Nepal, 
Taiwan, and The Netherlands). The association between immune-compromising 
conditions, most notable HIV positivity, and substantial rates of cryptosporidiosis has 
repeatedly been reported (O’connor et al. 2011), and this systematic review reveals 
exactly how pervasive this association is across the world. More than 60% of studies 
across all geographic regions exhibited greater than 10.0% prevalence rates in 
immunocompromised symptomatic patients, and in almost half of the countries in Sub-
Saharan Africa (47.8%; 11 of 23 countries) at least one-fifth of immunocompromised 
patients had cryptosporidiosis. This is largely linked to the high rates of HIV infection 
found in this region, with Sub-Saharan Africa accounting for more than 70.0% of 
individuals infected with HIV worldwide (GBD HIV Collaborators, 2015). The increased 
availability of highly active antiretroviral therapy (HAART) to treat HIV, particularly in the 
last six years (UNAIDS 2013), means a number of Cryptosporidiosis studies focused on 
HIV-positive groups have begun to report decreases in prevalence rates in HAART naïve 
versus HAART experienced patients (Figure 0.3.8).  
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Figure 0.3.8. Prevalence rates for Cryptosporidium infection in ART-experienced versus ART-naïve patients 
Human cryptosporidiosis studies comparing prevalence rates between ART-experienced and ART-naïve patients are here described. 
The figure illustrates data for both the overall prevalence of cryptosporidiosis in the study population, as well as the relative 
proportion of cases found in ART-experienced versus ART-naïve individuals. References: Bachur et al. 2008; (B) Mengist et al. 2015; 
(C) Ukwah et al. 2017; (D) Missaye et al. 2013; (E) Adamu et al. 2013; (F) Teklemariam et al. 2013; (G) Taye et al. 2014; (H) 
Hiros et al. 2015; (I) Nsagha et al. 2016; (J) Shimelis et al. 2016 
 
Despite this initial success towards lowering disease burden, HAART coverage in many of 
the most resource poor groups remains low, and studies as recent as 2016 continue to 
report rates well above 30.0% in patients with HIV (Abdel-Hafeez et al. 2012; Masarat et 
al. 2012; Noor et al. 2012; Wanyiri et al. 2014; Nsagha et al. 2016). In addition, a few of 
the HAART-experienced versus HAART-naïve prevalence studies were unable to 
demonstrate a direct benefit of antiretroviral therapy on cryptosporidiosis, with negligible 
differences in prevalence rates between HAART naïve and experienced groups (Nsagha et 
al. 2016; Shimelis et al. 2016; Ukwah et al. 2017), and some studies even identifying 
higher rates in the HAART experienced than naïve individuals (Taye et al. 2014). However, 
the higher incidence rates in HAART experienced individuals could reflect selective 
administration of these drugs to those patients suffering most severely from AIDS-related 
conditions, and that immune functioning is already so compromised in these patients that 
HAART is ineffective at protecting against infections such as cryptosporidiosis. These 
consistently high prevalence rates and potential inefficiency of HAART at resolving 
cryptosporidiosis in the most at-risk group of HIV individuals are worrying, as are reports 
of the only available treatment option Nitazoxanide repeatedly failing to reach optimal 
levels of symptomatic and infection relief in both immunocompromised and 
immunocompetent individuals (Doumbo et al. 1997; Rossignol et al. 2001; Elaine & 
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Sanford, 2008). This means the search for an effective approach towards treatment and 
prevention continues. As new studies continue to appear that highlight the true morbidity 
and mortality attributed to cryptosporidiosis worldwide (Sow et al. 2016), the need to 
prevent and cure this neglected disease continues to rise up the international public 
health agenda. The identification of new diagnostic and treatment targets through 
genomic comparisons of phenotypically-diverse Cryptosporidium spp. is therefore an 
important step significant towards improving diarrhoeal health and thereby productivity 
worldwide. 
 
The global distributions and relative proportions of C. hominis and C. parvum GP60 
subtypes identified in human populations provided a further summary of the intra-
species genetic heterogeneity known to date. GP60 subtype families were sub-
categorised based on the defined region of isolate origin, to analyse potential associations 
between certain subtypes and/or phenotypes and global distribution. This was specifically 
aimed at demonstrating geographic disparities in the diversity and relative proportions of 
subtype families, and correlating these with described differences in host range (i.e. 
zoonotic versus anthroponotic sources of infection). Intra-C. parvum distribution patterns 
revealed one such association, with the anthroponotic C. parvum subtype IIc exhibiting 
regional dominance over zoonotic subtypes such as IIa and IId in certain locations, and 
vice versa. In the more economically-prosperous regions of Australasia, Europe, North 
America, and The Middle East, the anthroponotic:zoonotic subtype ratios strongly 
favoured zoonotic C. parvum subtypes, at rates of 0.033, 0.034, 0.071, and 0.068, 
respectively. In the more resource-poor areas of Central Asia, South America, and Sub-
Saharan Africa, on the other hand, this trend was entirely reversed, with 
anthroponotic:zoonotic subtype ratios strongly favouring anthroponotic C. parvum 
subtype IIc, at rates of 5.5, 6.125, and 5.429. What this seems to imply is that zoonotic 
sources of infection, such as farm animals and household pets, may account for a 
significant majority of C. parvum-related cryptosporidiosis in more developed countries, 
while C. parvum isolates in less developed areas predominantly propagate within an 
anthroponotic transmission cycle. The potential of zoonotic sources being more 
responsible for human cases in developed regions is further supported by the frequent 
reports of Cryptosporidium outbreaks linked to petting zoos and agricultural practices in 
developed countries such as the United States (Reif et al. 1989; Preiser et al. 2003; Smith 
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et al. 2004; Kiang et al. 2006; Starkey et al. 2007; CDC 2011; Webb et al. 2014; Drinkard et 
al. 2015; Suler et al. 2016; Hancock-Allen et al. 2017), the United Kingdom (Evans & 
Gardner, 1996; McGuigan 2005; Gait et al. 2008; Hoek et al. 2008; McGuigan et al. 2010; 
Gormley et al. 2011; Utsi et al. 2016), Sweden (Kinross et al. 2015), Norway (Robertson et 
al. 2006; Rimšelienė et al. 2011; Lange et al. 2014), Ireland (Sayers et al. 1996; Zintl et al. 
2006), and Italy (Cacciò et al. 2013). Results from this systematic review thereby confirms 
and enhances the frequent reports of variable phenotypes and epidemiological 
specifications separating zoonotic from anthroponotic C. parvum GP60 subtype families, 
and motivates the comprehensive whole genome comparison and subsequent 
recombination analysis described in chapters 1 and 2. Access to a dataset of novel 
Cryptosporidium spp. WGS provides a unique opportunity to further investigate the 
extent to which genetic variation drives species and subspecies development in this 
species, and will assess the degree to which current GP60-based subtyping approaches 
accurately correlate with genomic divergence. 
 
The intra-regional diversity of GP60 subtypes was also variable, with Sub-Saharan Africa 
reporting the broadest range of GP60 subtypes (14 families total) followed by Central Asia 
(11 families), compared to 9 or fewer subtype families reported in the remaining 
geographic regions. This indicates a trend that associates particularly high regional rates 
of cryptosporidiosis with a greater GP60 subtype diversity, as both Sub-Saharan and 
Central Asian countries exhibited some of the highest prevalence rates in both 
immunocompetent and immunocompromised individuals (Figure 0.3.7). Inter-species 
differences between C. hominis subtypes were similarly striking across regions, and this 
systematic review provides the first accumulation of comprehensive prevalence data to 
illustrate a global overview of regional subtype composition. As C. hominis predominated 
as the cause of cryptosporidiosis in the highest prevalence regions (Figure 0.3.7), and a 
greater subtype family diversity was determined across a majority of geographic regions 
(Figure 0.3.9A and B), this species was selected for the focus of population genetics 
analyses at the GP60 locus in chapter 3. The tentative differences in host range patterns 
and distributions between subtypes Ia and Ib also explains their focus in the intra-C. 
hominis whole genome comparison in chapter 4. Understanding the dynamics of 
population genetics at this hypervariable locus, particularly within the context of 
evolutionary selection and genetic differentiation, aims to evaluate how these features 
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may link to host environments and behaviours, or help explain epidemiological 
differences in subtype distribution and pathogenicity. A detailed examination of the 
complex genetic features that separate phenotypically-diverse Cryptosporidium isolates 
at both the allelic and genomic level is fundamental to our understanding of how this 
parasite infects, evolves, and evades. This study therefore hopes to provide some of the 
vital in silico information about virulence that is required in order to translate and apply 
scientific findings into public health practice, and start to make significant strides towards 
lowering the disease burden and impact of this still neglected tropical disease.
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                                             CHAPTER 1 
 
 
Characterizing evolutionary histories and protein sequence divergence in 
Cryptosporidium spp. WGS: the genetic basis of host range and virulence in 
human-infective strains 
 
1.1  INTRODUCTION 
 
(i) Limitations of the single marker Cryptosporidium spp. phylogenetics 
 
Phylogenetic analyses and trees have long been the primary approach towards visualizing 
and evaluating genetic distances between species. Although traditionally based on 
morphological characteristics (Wheeler, 1917; Chamberlain, 1915; Van Cleave, 1949; 
Sinclair & Dunn, 1961), the development of genetic sequencing and computer 
programming have enabled detailed insight into the genetic distances, and chronological 
spacing, that separate organisms between and within all existing taxonomic 
classifications. The classical approaches to designing phylogenies can be categorized as 
either phenetic (distance matrix) or cladistic (maximum parsimony versus maximum 
likelihood) in nature, with the former drawing from overall similarities between 
compared organisms, and the latter basing predictions on shared characteristics to the 
most recent common ancestor. The introduction of nucleotide sequencing in the 1970s 
facilitated a massive improvement to phylogenetic interpretations (Salser et al. 1972, Fry, 
et al. 1973; Maizels, 1973), through statistical evaluation of the rate of evolutionary 
divergence, and thereby the development of mathematical models which evaluate and 
weight patterns of genetic changes. These models, which are based on pre-calculated 
assumptions and predictions of rate heterogeneity, DNA substitution, and amino acid 
replacement, have expanded the functionality of phylogenetics beyond a simple 
understanding of how certain traits have evolved over time (Liò & Goldman, 1998). It is 
now possible to identify unique genetic components of non-ancestral origin (Peng et al. 
2012), designate a timescale for the emergence of closely related phenotypically-diverse 
strains (Schuh et al. 2015), and trace the path of infectious diseases back to the original 
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source of infection, a vital component for battling outbreaks and understanding the rate 
at which an infectious agent is capable of mutating and spreading geographically (Emmett 
et al. 2015; Weisberg et al. 2015). The construction of extensive, detailed, and most 
notably accurate phylogenies is thus a vital component towards understanding the 
evolutionary relationships between pathogenic species, along with inferences about the 
environmental changes that historically drove phenotypic diversification. 
 
The phylogenetic relationships between Cryptosporidium spp. have been explored in 
more than 57 peer-reviewed publications (NCBI PubMed; 
https://www.ncbi.nlm.nih.gov/pubmed). A common feature of a majority of these studies 
is the application of only a handful of markers (18S rRNA, HSP70, Actin, COWP, and 
GP60), with the exception of a few studies which employed alternative markers such as 
ITS1, ITS2, and 5.8S rRNA (Morgan et al. 1999), CP47 and MSC6-7 (Ramo et al. 2015), 
HSP90 (Feng et al. 2009) and a concatenated sequence of 10 arbitrarily selected loci 
(Bouzid et al. 2010). What this means is that there is a significant bias in terms of the 
genetic targets used to explore phylogenetic relationships between Cryptosporidium 
strains and species, and questions surrounding how well these associations actually 
represent genome-wide divergence have not sufficiently been addressed. Studies using a 
common marker have frequently used different tree-building algorithms and nucleotide 
substitution rates, which can make it difficult to interpret the true phylogenetic distances 
between strains and species, and there has been a historical irregularity in the specific 
nomenclature used to define isolates included in phylogenetic analyses, with studies 
repeatedly referring to the host from which parasites were extracted rather than the 
species or subtype group to which each strain is likely to belong based on genetic 
similarities. The lack of a reliable typing method that consistently correlates marker 
variation with whole genome divergence makes it difficult to classify and understand the 
genomic diversity of Cryptosporidium. The development of new phylogeny-based 
approaches is therefore key to understanding how phenotypically-diverse strains and 
species have emerged and evolved over time.   
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(ii) A brief history of divergence between C. hominis and C. parvum 
 
The ~9.14Mbp Cryptosporidium parvum genome is comprised of 8 chromosomes ranging 
in size from 0.88 to 1.34Mbp, and has a highly compact coding sequence composition 
(73.2-77.6%). Genomic comparisons between the original C. parvum IIaA15G2R1 
(Abrahamsen et al. 2004) and C. hominis IaA25R3 (Xu et al. 2004) reference genomes 
currently provide an overview of chromosome-wide hotspots for single nucleotide 
polymorphism (SNP) elevation and increased levels of divergence and selective pressure 
between orthologous coding sequences, and have established a number of species-
specific genes and duplication events (Mazurie et al. 2013; Bouzid et al. 2013). This has 
highlighted telomeric clustering of hyperpolymorphism (Bouzid et al. 2013), and 
identified a number of mucin-like and GPI-linked putative virulence mediators (Priest et 
al. 2001; O’Connor et al. 2009; Chatterjee et al. 2010; Jenkins et al. 2014). The 
assessment of protein-level consequences of genomic diversity has been limited, 
however, as has the largescale assessment of intra-species divergence for key host-
parasite interactors. In addition, the only available study providing a genomic comparison 
between zoonotic and anthroponotic C. parvum subtype WGS (IIa and IIc, respectively) 
identified only a limited number of shared SNPs between the anthroponotic C. parvum 
and C. hominis subtype WGS (Widmer et al. 2012), and the genetic mechanisms or rates 
of intra-C. parvum suspeciation events were not explored. Novel whole genome 
comparisons using improved WGS assemblies have begun to explore physical evidence of 
genome-wide incongruence, with significant sequence insertion and deletion (indels) 
events identified between C. hominis and C. parvum (Guo et al. 2015), and a well-
established case for interallelic recombination at the site of the hypervariable 60-kDa 
GP60 subtyping locus (Li et al. 2013). Expanding cross-comparisons to include multiple 
WGS across a range of anthroponotic and zoonotic C. parvum and C. hominis strains will 
help to explore these phenotype-associated features, and is an essential component to 
understanding the genetic basis of divergence between human-infective strains.  
 
The first complete reference genomes for C. hominis and C. parvum were both published 
in 2004 (Xu et al. 2004; Abrahamsen et al. 2004). The former, named TU502, was 
developed from oocysts isolated from an infected Ugandan child, while the latter, Iowa II, 
was so named because the utilised oocysts were obtained during a largescale outbreak in 
   
46 | P a g e  
 
the US state earlier that year.  Although these genomes are still considered one of the 
most significant advancements within the field of Cryptosporidium genetics, providing the 
very first insights into the genomic basis of host specificity, the sequence coverage and 
quality between the two genomes differs significantly. This has limited the extent to 
which genomic comparisons between these two WGS could be used to explore genome-
wide drivers and consequences of speciation, particularly at highly-repetitive and 
hypervariable regions like the subtelomeres.  The first publicly-available releases of these 
genomes contained 69 non-specific nucleotides (N’s) and 18 contigs for C. parvum Iowa II, 
and 2,449 N’s and 1,422 contigs for C. hominis TU502 (GenBank Accession: C. parvum 
AAEE01000000; C. hominis AAEL000000).  Equally problematic is the complete lack of 
synteny between the assemblies (NCBI Map Viewer; Wheeler et al. 2003), which is most 
severe at subtelomeric regions, and has complicated the process of whole genome 
comparisons through automated analyses (Figure 1.1.1).  
 
 
Figure 1.1.1. Degree of inconsistent synteny between C. parvum Iowa II and C. hominis TU502 reference WGS 
The lack of coding sequence synteny between reference C. parvum Iowa II and C. hominis TU502 whole genome 
sequences is demonstrated based on the annotated order of the first 25 genes extending from the 3’-end telomeric 
repeat on chromosome 8. A novel PacBio-produced C. parvum WGS is included for synteny verification purposes 
(source: Dr. James Cotton, The Wellcome Trust Sanger Institute). Gene order was extracted from NCBI’s Map Viewer 
Tool (http://www.ncbi.nlm.nih.gov/mapview/; Wheeler et al. 2003). 
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First insights from comparative genomics studies using these reference WGS focused 
largely on global summary figures (Widmer & Sullivan 2012) such as nucleotide sequence 
identities (~95-97%), GC content (~30%), genome size (9.1-9.2Mb) and protein coding 
gene content (~4,000). Shortly thereafter an attempt was made to correlate host range 
differences with genomic divergence, in a study that cross-compared an anthroponotic C. 
parvum WGS (TU114) against the two reference genomes (Widmer et al. 2012). The 
results of this study highlighted genomic areas of elevated SNP frequency and re-
emphasized the notion of polymorphic clustering around the telomeres, simultaneously 
describing patterns of mutations between chromosomes and reporting basic functional 
properties (molecular weight, localization signals, and putative protein function) of 
highly-diverged proteins. However, very few correlations between host range phenotype 
and genetic divergence were identified.  
 
In the second study that followed, a significant improvement to comparative genomics 
was achieved by utilising a re-assembled version of C. hominis TU502 (Mazurie et al. 
2013). The primary benefit of this study was inclusion of protein level comparisons to 
delineate divergence, facilitating an assessment of selective pressure through dN/dS 
characterization of gene orthologs. This study confirmed the previously-reported global 
average gene identities of ~97%, but additionally identified highly diverged amino acid 
sequences (<90.0% AA IDs) in conjunction with those under positive selective pressure 
(dN/dS > 1.1). However, this study erroneously reported the absence of any significant 
insertion, deletion, or rearrangements, and did not consider the impact of frameshift-
causing indels. Despite this, the authors provided the first tentative link between site-
specific divergence and host range, and the realization that speciation likely occurs 
rapidly, and as a result of direct interactions with novel environmental conditions and 
most importantly host immune systems. A review of the available data has highlighted a 
number of gaps in Cryptosporidium genomics analyses and interpretations, but 
simultaneously provides a good theoretical basis of reference C. hominis/C. parvum 
subtype WGS divergence upon which novel and more expansive comparisons can build. 
This chapter will present phylogenetic and comparative genomics results for a novel 
collection of more diverse subtype WGS, in a way that expands on our understanding of 
the way intra- and inter-species evolution is structured. It also aims to provide greater 
depth of knowledge on the common features driving anthroponosis in human-infective 
   
48 | P a g e  
 
species, and thereby enhance our understanding of the mechanisms underlying 
phenotypic divergence within and between Cryptosporidium hominis and 
Cryptosporidium parvum.  
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1.2 METHODS 
 
(i) Whole genome sequences for phylogenetic analyses – empirical data 
 
16 novel Cryptosporidium spp. whole genome sequences were generously provided by 
the Cryptosporidium Reference Unit (Rachel Chalmers; Singleton Hospital, Wales, United 
Kingdom) for use in this comparative genomics study (Table 1.2.1). These included one C. 
cuniculus (GP60 subtype VbA37), one C. hominis (IaA14R3), two C. meleagridis 
(IIIgA23G3), ten C. parvum (IIaA15G2R1, IIaA17G1R1, IIaA18G2R1, IIaA19G1R2, IIdA22G1, 
IIcA5G3a, IIcA5G3j, and IIcA5G3k), and two C. ubiquitum (XIIb) whole genome sequences.  
A detailed methodology describing the generation of these novel WGS can be found in 
the associated publication (Hadfield et al. 2015). As a supplement these previously-
available genomes were additionally included: RN66 C. muris WGS (Lorenzi, H., 
unpublished; BioProject Accession: PRJNA29965), TAMU-09Q1 C. baileyi WGS (Da Silva, 
JC., unpublished; BioProject Accession: PRJNA222835), UKMEL1 C. meleagridis 
(IIIbA22G1R1) WGS (Widmer, G., unpublished; BioProject Accession: PRJNA222838), and 
UKH1 C. hominis (IbA10G2) WGS (Widmer, G., unpublished; BioProject Accession: 
PRJNA222837). FASTA files containing whole genome sequence data for these isolates 
were retrieved from The Cryptosporidium Genomics Resource CryptoDB 
(http://cryptodb.org/cryptodb/). Assembly statistics (including scaffold number, mean 
scaffold length, and N50) are additionally outlined for each of the twenty included WGS in 
Appendix I. 
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Table 1.2.1. Summary of 20 Cryptosporidium spp. and GP60 subtypes of whole genome sequences 
included for phylogenetic analyses and comparative genomics 
SPECIES GP60 SUBTYPE STANDARD ID SOURCE   ACCESSION   WGS SIZE (bp) T (%) A (%) C (%) G (%)   N (%) 
C. baileyi N/A TAMU-09Q1 Da Silva, J. C. 1    CryptoDB.org     8,502,994 38.0 37.7 12.2 12.1  0 
C. cuniculus VbA37 UKCU2 This study               7,853,082 34.0 34.1 15.9 16.0          0
C. hominis IaA14R3 UKH4* Hadfield, S.2  PRJNA253838       9,502,496 34.4 34.3 15.6 15.5 0.2 
C. hominis IbA10G2 UKH1‡ Widmer, G.3   CryptoDB.org     9,141,398 34.8 35.0 15.0 15.2 0 
C. meleagridis IIIbA22G1R1 UKMEL1 Widmer, G.3    CryptoDB.org     8,973,224 34.5 34.6 15.4 15.5  0 
C. meleagridis IIIgA23G3 UKMEL3 This study      12,181,424 30.6 30.6 18.4 18.3 2.1 
C. meleagridis Novel GP60  UKMEL4 This study         9,663,721 33.9 33.9 15.9 15.7 0.6 
C. muris N/A RN66 Lorenzi, H.4 AAZY02000000    9,245,251 35.7 35.8 14.2 14.2  0.07 
C. parvum IIaA15G2R1 UKP6*‡ Hadfield, S.2  PRJNA253846     9,112,937 34.4 34.4 15.5 15.4 0 
C. parvum IIaA17G1R1 UKP7 Hadfield, S.2  PRJNA253847     9,035,974 34.8 34.8 15.2 15.0 0.2 
C. parvum IIaA18G2R1 UKP3 Hadfield, S 2  PRJNA253840     9,172,817 34.8 34.7 15.2 15.1 0.2 
C. parvum IIaA19G1R2 UKP2 Hadfield, S.2  PRJNA253836     9,759,982 34.2 34.1 15.9 15.8 0.07 
C. parvum IIdA22G1 UKP8* Hadfield, S.2  PRJNA253848       9,377,202 34.4 34.5 15.4 15.5 0.2 
C. parvum IIcA5G3a UKP13*‡ This study       8,416,777 33.5 33.4 16.5 16.5 0 
C. parvum IIcA5G3a UKP14 This study         8,594,935 32.9 32.9 17.2 17.1 0 
C. parvum IIcA5G3a UKP15 This study       10,134,261 34.4 34.5 15.4 15.6 0 
C. parvum IIcA5G3j UKP16‡ This study                 9,496,690 34.4 34.3 15.8 15.6 0 
C. parvum IIcA5G3k UKP12 This study         8,038,639 34.2 34.2 15.8 15.8 0 
C. ubiquitum XIIb UKUB1 This study         9,060,260 34.5 34.5 15.4 15.4 0.2 
C. ubiquitum XIIb UKUB2 This study         9,069,162 34.5 34.5 15.4 15.5 0.1 
            
* Included in whole genome comparative genomics  
‡ Included in whole genome recombination analysis (chapter 2) 
1 University of Maryland Institute for Genome Sciences, Baltimore, Maryland, United States (Unpublished genome, CryptoDB.org) 
2 Hadfield et al. 2015 
3 Tufts University School of Veterinary Medicine, Medford, Massachusetts (Unpublished genome, CryptoDB.org) 
4 Craig Venter Institute, Rockville, Maryland, United States (Unpublished genome, CryptoDB.org) 
Regarding methods used for oocyst sourcing, purification and preparation; DNA extraction and characterization; and next 
generation sequencing and analyses, a detailed description can be found in the relevant publication (Hadfield, et al. 2015). 
 
 
The rationale behind strain inclusion for the novel whole genome sequences was 
determined by the lead investigators running the Hadfield et al. study. The overarching 
aim was to build a comprehensive genomic resource of the primary human-infective 
species (C. hominis, C. parvum, and C. meleagridis), specifically subtypes for which 
phenotypic data has previously been described, as well as infrequent human pathogens 
for which little to no data is currently available (C. ubiquitum, C. cuniculus and C. 
viatorum). C. parvum in particular has exhibited well-established phenotypic and 
epidemiological differences between many of this species’ GP60 subtype families (Figure 
0.3.3). There is a significant degree of GP60 divergence between the C. parvum subtype 
families used in this study (Figure 1.2.1), reaching nucleotide divergences as high as 18.5-
   
51 | P a g e  
 
26.4% between subtypes IIa, IId, and IIc. Intra-C. hominis GP60 divergence between the 
two subtypes (Ia and Ib) used in this study is equally significant, exhibiting 25.0% 
nucleotide divergence. Descibing intra-species GP60 divergence provides an important 
justification for this study, as it highlights the importance of investigating the degree to 
which GP60 variability correlates with whole genome divergence, and evaluating whether 
hypervariability between WGS is limited to this locus. The specific C. hominis and C. 
parvum GP60 subtype sequence data used in this study also display broad geographic 
distributions and host range patterns, providing an important “phenotypic incentive” for 
comparing the included WGS, with the exception of IIaA19G1R2 which has only recently 
been discovered in the United Kingdom (Figure 1.2.2).  
 
 
 
Figure 1.2.1. GP60 nucleotide divergence between whole genome C. parvum subtypes used in this study 
GP60 sequence divergence was assessed between C. parvum strains belonging to varying GP60 subtype families IIa, IId, 
and IIc. Nucleotide sequences comprising the standard GP60 typing sequence (5′-TCCGCTGTATTCTCAGCCCCA-3′ to 5′-
AGCAGAGGAACCAGCATCCTT-3) were compared between strains using the EMBOSS Needle pairwise sequence 
alignment tool (The European Molecular Biology Open Software Suite; Rice et al. 2000). Values representing nucleotide 
divergence between strains in terms of % non-identities are shown.
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(ii) Concatenated Cryptosporidium phylogeny  
 
The methodology for the phylogeny relied on concatenation and alignment of 61 
neutrally-evolving, genome-wide protein coding sequences, followed by construction of a 
maximum likelihood tree using the Tamura-Nei distance model, Nearest-Neighbour-
Interchange (NNI) maximum likelihood (ML) heuristic method, and 2,000 bootstrap 
replicates, all courtesy of MEGA version 5.2 (Molecular Evolutionary Genetics Analysis 
version 5.2; Tamura et al. 2011). But the theory behind this approach requires a bit more 
explanation. The use of concatenated gene sequences to infer species phylogenies has 
become a preferred alternative to the single-gene approach, producing phylogenies that 
consistently result in a greater degree of accuracy and resolving power (Gadagkar et al. 
2005; Devulder et al. 2005; Zhao et al. 2005). The thought behind this is that the use of a 
greater number of loci increases the probability of achieving a genome-wide genetic 
representation, thereby maximising the phylogenetic signal. But what compromises this 
approach is that different combinations of targets often result in completely different 
phylogenies (Kubatko & Dregnan, 2007; Roch & Steel, 2015; Warnow, 2015), largely due 
to the varying degrees of selective pressure (i.e. negative versus neutral versus positive) 
and divergence (% nucleotide identities) acting throughout the genome. Loci under 
negative (or purifying) selective pressure often classify isolates as more closely related 
than they actually are, while loci under positive selective pressure are often subject to 
such a high mutation accumulation rate that they place strains in completely the wrong 
proximity and orientation to their true “nearest neighbour”. There is also often 
disagreement between phylogenies resulting from nucleotide- versus protein-based 
sequence concatenations. A thorough review of these previous concatenation 
approaches led to a new, experimental methodological technique for selection and 
inclusion of concatenated loci in this study; one that aimed to correct for previous 
shortcomings.  
 
The inclusion process for protein coding sequences was based on fulfilment of three 
criteria: a neutral selective pressure between C. parvum (IIaA15) and C. hominis (IaA14R3) 
orthologous coding sequences, a magnitude of nucleotide consensus between 93.0% and 
96.0% identities, and an even spread of targets across the genome. Selective pressure in 
this context was determined by dN/dS, a ratio which evaluates the average rate of 
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nucleotide substitutions at every non-synonymous versus synonymous site (Yang & 
Bielawski, 2000). The formal way to interpret dN/dS values is to view anything less than 1 
as subject to negative selective pressure, anything greater than 1 as positive selective 
pressure, and anything equalling 1 as being under neutral selective pressure. However, 
the use of dN/dS to describe selective pressure does its limitations. The first complication 
is that certain nucleotide exchanges occur more frequently in some lineages than in 
others. This can introduce a strong bias that sways the nature of substitution in one 
direction or another, conveying an incorrect degree of selective pressure for a locus 
between closely-related strains. Another issue is that dN/dS values can vary significantly 
across coding sequence data, a phenomenon which often affects virulence proteins that 
contain active sites and domains whose function is involved in host-parasite interactions 
(Figure 1.2.3). dN/dS values also cannot distinguish between substitutions that result in 
amino acids that are biochemically similar versus different to one another, resulting in 
many proteins appearing to be under selective pressure when in reality their biological 
purpose and function may not have significantly changed. In light of these limitations, it 
seems more reasonable to assume that neutrally-evolving loci would have a dN/dS value 
somewhere in the range of 0.5, with values nearing 0.0 and 1.0 indicating negative and 
positive selective pressure respectively. The specific dN/dS values required for inclusion in 
this study were hence set at 0.3 to 0.6. In order to additionally ensure that coding 
sequences did not contain hidden pockets of positive selective pressure, often the case 
when specific protein domains become subject to a high degree of divergence, a 
minimum nucleotide percent identities of 93.0% was enforced. The upper cap of 96.0% 
was implemented to ensure that sequence variability was sufficient to provide for 
comprehensive phylogenetic discrimination between strains.  
 
 
 
 
   
55 | P a g e  
 
 
 
Figure 1.2.3. dN/dS limitations exemplified for a hypervariable C. hominis/C. parvum coding sequence 
The limitations of using dN/dS to describe positive versus negative selective pressure for a single coding sequence is shown. Telomeric 
C. parvum gene cgd8_20 and its C. hominis ortholog Chro.80011 were selected due to a low overall dN/dS value (0.440) and 
simultaneously high degree of protein sequence divergence (<87.0% amino acid identities). Nucleotide and protein coding sequences 
were aligned using Clustal Omega multiple sequence alignment tool (http://www.ebi.ac.uk/Tools/msa/clustalo/), and dN/dS was 
consequently calculated using the web-application for Pal2Nal (Suyama et al. 2006). Sections displaying positive versus negative 
selective pressure are highlighted in red versus grey respectively. Predicted protein domains were identified by running nucleotide 
sequences through NCBI’s conserved domain finder tool (http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi), with a majority of 
predicted domains overlapping with the central segment exhibiting positive selective pressure. 
 
 
An even distribution of genomic loci was also implemented, so that the concatenated 
sequence would be an reliable representation of the entire Cryptosporidium genome. This 
meant that genes were specifically chosen to represent equal genomic distribution 
between and across (both telomeric and internal) the eight annotated chromosomes 
(Figure 1.2.4). The process for achieving this was significantly simplified by a pre-existing 
database containing global dN/dS values and percent nucleotide identities for all 
annotated C. hominis (subtype IaA14R3) versus C. parvum (subtype IIaA15G2R1) genes 
(Mazurie et al. 2013; supplementary table 3). Genes exhibiting the correct range of dN/dS 
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(0.3-0.6) and percent identities (93.0-96.0) were extracted from the data set, and then 
sorted according to the unique C. hominis numeric identifier (Chro.XXXXX). As the five-
digit number associated with each identifier indicates the relative position of each gene, it 
was possible to semi-randomly select genes with a decently widespread genomic 
distribution across the genome. This approach made it possible to select eight loci from 
each of the eight chromosomes, three of which would eventually come to be excluded 
due to an unexpectedly high degree of divergence between closely related 
Cryptosporidium parvum strains (Chro.50435; Chro.60602; Chro.80266).       
 
Figure 1.2.4. Genomic chromosome location of neutrally-evolving loci used for concatenated Cryptosporidium spp. phylogeny 
The genome-wide localization of neutrally-evolving coding sequences (CDs) chosen for concatenation is shown. Horizontal markings 
indicate the location of CDs relative to the 5’- end and 3’- end telomeric repeats (5’-AAACCT-3’) of chromosomes 1 to 8, but are not in 
any way representative of the size or orientation of individual coding sequences. Chromosome size was ascertained through manual 
reassembly of contigs from novel C. parvum IIaA15G2R1 (UKP6) genome sequence data, and by simple counting of nucleotide number 
from 5’ telomere repeat to 3’ telomere repeat. Specific location was similary determined through manual searches, which generated 
the exact nucleotide position along whole chromosome contiguous telomere-to-telomere sequence data.  
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(iii) Superaligning Supersequences and Building Trees 
 
The primary and most time-consuming component of the concatenation approach was to 
seek and extract the 61 selected loci from the 21 Cryptosporidium whole genome 
sequences. Sequence data for the C. parvum IIaA15G2R1 reference strain was initially 
obtained by searching through the CryptoDB online Cryptosporidium genome database 
(Puiu, et al. 2004; http://www.cryptoDB.org). In order to confirm sequence integrity, the 
extracted genes were compared against the novel C. parvum IIaA15G2R1 genome (UKP6). 
Orthologous coding sequences in all included Cryptosporidium spp. were identified in 
whole genome datasets by setting up local nucleotide databases (FASTA format) in the 
BioEdit Sequence Alignment Editor, and running gene sequences against these using the 
local BLAST search tool (BioEdit v7.2.5; Hall, 1999).  Individual gene sequences were 
subsequently extracted manually from each WGS. Distantly related and highly diverged 
sequences in C. baileyi and C. muris were additionally confirmed by backwards BLASTing 
hits through the BLASTn nucleotide database (NCBI Basic Local Alignment Search Tool; 
Altschul et al. 1990).  
 
Nucleotide coding sequences were accumulated in the alignment editor of MEGA v 5.2 
(Molecular Evolutionary Genetics Analysis version 5.2; Tamura et al. 2011) and 
automatically translated into amino acid sequences. Stop codons were removed to 
achieve the contiguous, concatenated amino acid sequences, which were aligned using 
the ClustalW alignment algorithm for codons (default parameters).  The alignment was 
extracted as a MEGA format file, which was used to construct the maximum likelihood 
phylogenetic tree (Dayhoff substitution model, Nearest-Neighbour-Interchange (NNI) 
heuristic method). Phylogenetic confidence was inferred with the bootstrap method, 
using 2,000 bootstrapping replicates. A bootstrap cut-off of >95% was interpreted as 
indicating accurate and reliable branch topology.  
 
Summary statistics for genome-by-genome comparisons were obtained by calculating 
sequence consensus and dN/dS values between the individual concatenated sequences. 
This was particularly important for the C. hominis IaA14R3 and C. parvum IIaA15G2R1 
reference strains, as it would validate whether the designated approach had achieved the 
desired amino acid divergence and dN/dS rates at a concatenate-wide level (93.0-96.0% 
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and 0.3-0.6 respectively). Sequence identities and the relative proportions of SAAPs 
(single amino acid polymorphisms) and SAAGs (single amino acid gaps) were calculated 
using the EMBOSS Stretcher pairwise sequence alignment tool (The European Molecular 
Biology Open Software Suite; Rice et al. 2000). dN/dS values were manually ascertained 
by comparing nonsynonymous to synonymous substitution rates between orthologous 
coding sequences (PAL2NAL; Suyama et al. 2006).  
 
(iv) Whole Genome Protein Comparisons - Included species and subtypes 
 
Strains were selected for WGS protein divergence characterization based on GP60 
similarity to the original zoonotic C. parvum and anthroponotic C. hominis reference 
genomes (IIaA15G2R1 and IaA25R3 respectively), namely UKP6 (IIaA15G2R1) and UKH4 
(IaA14R3). To explore the association between protein-level genome changes and host 
range specification, two further closely-related but phenotypically-diverse whole genome 
C. parvum strains were included; zoonotic strain UKP8 (IIdA22G1) and the most common 
anthroponotic strain UKP13 (IIcA5G3a). These were specifically chosen based on 
equidistant GP60 nucleotide variability from C. parvum IIaA15G2R1 (Figure 1.2.1), but 
non-correlated phylogenetic distances based on the concatenated phylogeny. Parallel 
comparisons of UKP13 and UKH4 against UKP6 was specifically aimed at determining 
whether anthroponotic host range is associated with site-specific shared protein 
sequence divergence. The tertiary comparison between UKP8 and UKP6, both zoonotic, 
served as a positive control.  
 
(v) Whole Genome Protein Comparisons - Analytical approach 
 
Whole genome datasets were annotated into protein coding sequences (EMBOSS 
GetOrf), uploaded as standalone protein databases (BioEdit v.7.2.5) and sequences were 
compared locally using the BLOSUM62 substitution matrix and a cut-off expectation value 
of 1.0E-10. Tabulated results were visually scrutinized and all putatively divergent protein 
sequences (<90.0% amino acid identities) were manually extracted. Amino acid coding 
sequences were re-checked (ORF Finder), underwent functional characterization 
(UniPROT BLASTp; E-threshold < 10-5; http://www.uniprot.org/blast/), and protein 
localization (Wolf PSORT; Horton et al. 2007), and were backwards blasted (BioEdit) to 
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identify putative paralogs and classify intra-species protein families.  Significant stretches 
of sequence inconsistencies (indels > 3,000bp) between whole genomes were identified 
by global nucleotide alignment (EMBOSS Stretcher) of individual contigs from de novo 
assemblies. Telomeres were additionally re-assembled (30,000bp extending from the 5’-
AAACCT-3’ telomeric repeats) manually by identifying overlapping contig sequence data, 
with the exception of the 5’ end of chromosomes 1 and 7, and the 3’ end of chromosome 
8, as these lack sequence evidence of telomeric repeats. The purpose of targeted 
telomere reassembly was to obtain detailed insight into gaps, insertions, and 
rearrangements in these highly recombinant regions, through graphical visualization of 
alignments (Artemis Comparison Tool; Carver et al. 2005). 
 
The mechanistic drivers of divergence between orthologous protein sequences were also 
characterized. Single nucleotide insertions/deletions (indels) resulting in frameshift 
mutations were determined through alignment of highly-diverged (<90.0% AA IDs) 
orthologous proteins, which revealed instances where nucleotide changes had shifted the 
start/stop codon upstream or downstream, or altogether eradicated the open reading 
frame (EMBOSS Stretcher). The proportion of divergence due to amino acid gaps (SAAGs) 
versus polymorphisms (SAAPs) was similarly obtained. The direction of selective pressure 
between conserved orthologous coding sequences was evaluated through dN/dS 
calculation, using the CodeML analysis component of PAML (PAL2NAL; Suyama et al. 
2006), and categorised as either negative (<1.0) or positive (>1.0). A student’s T-test 
(significance cut-off P<0.05), assuming heteroscedasticity of recorded values, was used to 
assign any statistical significance to dN/dS trends across comparisons. 
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1.3  RESULTS 
 
(i) Concatenated phylogeny of Cryptosporidium spp. WGS reveals intra-species genomic 
divergence and classification of a new C. parvum subspecies 
 
A novel approach to phylogenetic evaluation of Cryptosporidium spp. was achieved 
through gene-to-gene concatenation of 61 neutrally-evolving loci across 21 whole 
genome isolates (Figure 1.3.1 A). Genome-wide representation of the evolutionary 
relationships was ensured through an even genomic distribution of targets (Figure 1.3.1 
B), as well as a well-balanced neutrality of selection pressure (dN/dS 0.3-0.6) and 
divergence (0.4-0.7%) between orthologs of the reference C. hominis TU502 and C. 
parvum Iowa II subtypes (Figure 1.3.1 C). The proposed branching patterns and genetic 
distances of the concatenated phylogeny are confidently supported (bootstrap values > 
99.0), lending statistical credibility to this maximum likelihood tree as a new phylogenetic 
gold standard for evolutionary interpretation of Cryptosporidium spp.      
 
Figure 1.3.1. Concatenated phylogeny of neutrally-evolving loci reveals true evolutionary relationship between zoonotic and 
anthroponotic Cryptosporidium spp. 
Concatenated phylogeny of Cryptosporidium spp. was constructed using 61 neutrally-evolving loci from 20 whole genome sequences. 
Loci were included for concatenation based on genome-wide distribution (B), dN/dS values of 0.3-0.6 and amino acid consensus of 
93.0-96.0% identities between orthologous C. parvum (IIaA15G2R1) and C. hominis (IaA14R3) genes. Chromosome-wide averages 
between concatenated loci confirm consistency of the prescribed parameters (C), ascertained through EMBOSS Stretcher pairwise 
sequence alignment of concatenated sequences (The European Molecular Biology Open Software Suite; Rice et al. 2000) and dN/dS 
calculation (PAL2NAL; Suyama et al. 2006). ClustalW alignment and maximum-likelihood tree construction was performed using the 
Molecular Evolutionary Genetics Analysis tool (MEGA version 5.2; Tamura et al. 2011). Phylogeny was calculated using the Dayhoff 
substitution model and Nearest-Neighbour-Interchange (NNI) heuristic method, and 2,000 bootstrap replications were implemented 
to infer confidence values on the phylogenetic tree. 
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The phylogenetic reconstruction of whole genome sequences provides an improved 
understanding of the evolutionary basis of phenotypic intra- and inter-species differences 
of Cryptosporidium spp. Primary human-infective isolates form a distinct C. 
hominis/cuniculus/C. parvum superclade, indicative of their shared global nucleotide 
consensus (π<0.04) and genetic distinction from less common human-infectious species 
such as C. meleagridis, C. viatorum, and C. ubiquitum (0.9<π<0.27). The limited genetic 
distance between these two species (<0.02 nucleotide substitutions per site) illustrates 
the recent and rapid nature of the genetic change that distinguishes anthroponotic C. 
hominis from zoonotic C. parvum. The concatenated phylogeny further provides a 
preliminary genotypic association between phenotypically-diverse C. parvum strains. 
Classically zoonotic subtypes IIa and IId form a separate subclade from the presumptively 
anthroponotic IIc subtypes within the C. parvum clade.  The taxonomic inference that can 
be drawn from this phylogenetic trait is the existence of two C. parvum subspecies, 
proposed to be renamed C. parvum parvum and C. parvum anthroponosum to allow for 
phenotypic distinction between zoonotic and anthroponotic strains respectively. 
The concatenated phylogeny further provides insight into rates and mechanisms of 
divergence at neutrally-evolving sites between distantly related species. The single-host 
WGS species C. muris and C. baileyi reveal a 1.75 and 2.0-fold increase in divergence 
respectively compared to the next closest C. ubiquitum branch of the concatenated tree 
(Figure 1.3.2 B), corresponding to an overall divergence of 0.63 and 0.73 compared to the 
C. parvum IIaA15G2R1 reference concatenation. This highlights the degree with which 
adaptive evolution to non-human, narrow host range has influenced changes to amino 
acid coding sequences in these species over time, even at loci showing little evidence of 
selective pressure between human strains. Evaluation of selective pressure across strains 
demonstrates a steady decrease associated with increasing divergence, although this is 
likely an artefact of the inability of dN/dS to accurately assess positive versus negative 
selection between distantly related orthologous sequences (Hurst 2002). In addition, the 
analysis of gaps versus amino acid polymorphisms (SAAPs) featured here revealed an 
interesting trend, indicating that gaps play a more prominent role than SAAPs in driving 
initial variability between closely related, phenotypically-similar strains. This observation 
corresponds with previous reports of significant microsatellite variation between closely-
related human-infective strains in Cryptosporidium (Widmer et al. 2004). 
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(ii) Amino acid composition of neutrally-evolving concatenations reveals potential protein 
consequence of host adaptation between human and non-human infective strains  
 
The adaptive changes to protein coding sequences are further highlighted by the relative 
amino acid composition of the concatenated sequences globally (Figure 1.3.3). Of note in 
this context are the two predominantly-zoonotic species included in the concatenated 
phylogeny, C. muris (murine host type) and C. baileyi (fowl host type), which only 
infrequently are isolated from human hosts (Palmer et al. 2003; Ditrich et al. 1991). Based 
on 5-95% confidence intervals around the mean amino acid composition (2 SD) of the 
concatenated sequences, a significant decrease in aspartic acid (D), glutamic acid (E), 
glycine (G), asparagine (N), proline (P), and serine (S) was identified for C. muris, and 
glycine (G) and arginine (R) for C. baileyi. Alternatively, a significant increase was 
observed in histidine (H), isoleucine (I), leucine (L), methionine (M), glutamine (Q), valine 
(V), and tyrosine (Y) composition in C. muris, and lysine (K) and asparagine (N) in C. 
baileyi. The prominent decrease in acidic amino acids (D, E) coupled with the sharp 
increase in aliphatic (I, L) and basic (H) amino acids in C. muris, could be attributed to a 
differing propensity for infection localization. C. muris preferentially infects the stomach, 
while C. baileyi and the human-infective species largely infect the small intestine (Xiao et 
al. 1999). Adaptation to a more acidic environment for the former, or a more basic 
environment for the latter, could in part resolve the observed shifts in C. muris’ amino 
acid composition, and simultaneously explain why C. baileyi has largely retained a similar 
protein coding profile to the distantly related human-infective strains (Appendix II). 
However, the exact evolutionary origin of changes in amino acid composition is poorly 
understood (Hormoz, 2013), and the focus on neutrally-evolving Cryptosporidium spp. 
genes in this context makes it difficult to infer whether these trends represent genome-
wide changes that could have resulted from host range or environmental changes. It is 
also possible that a number of the observed changes in amino acid frequencies are 
merely the result of expansions or contractions in repeat-rich sequences, or the 
consequence of a progressive loss or gain in protein sequence complexity that resulted 
from zoonotic to anthroponotic speciation events. This was investigated further by 
analysing the putative protein functions and predicted localizations for each of the genes 
included in the concatenated phylogeny (Appendix III). Only a small fraction (13.1%; 8 of 
61) of the neutrally-evolving genes were predicted as having an extracellular localization, 
   
64 | P a g e  
 
with the majority localizing to the cytoplasm (34.4%; 21 of 61), plasma membrane (27.9%; 
17 of 61) and the nucleus (24.6%; 15 of 61). This implies that the list of concatenated 
genes includes only few predicted host-parasite interactors, and decreases the possibility 
that environmental factors might have driven the observed changes in amino acid 
frequencies. The composition of amino acids also appears relatively stable across the 
protein sequences analysed, which further points towards subtle progressive changes in 
the make up of certain over- and under-represented amino acid types during the 
evolution of these species, and may have resulted in the observed pattern described in 
figure 1.3.3.     
 
 
Figure 1.3.3. 5-95% Confidence Intervals for mean amino acid composition of concatenations (2 SD), combined with specific amino 
acid composition values for C. baileyi and C. muris 
The degree of amino acid composition divergence between zoonotic Cryptosporidium spp. (C. baileyi and C. muris) and human-
infective species is here illustrated. Mean amino acid composition across all Cryptosporidium spp. concatenations, along with amino 
acid compositions for C. muris and C. baileyi only, were calculated using MEGA (v 7.0; Kumar et al. 2016) and plotted graphically using 
SigmaPlot v 13.0 (Systat Software, San Jose, CA). 5-95% confidence intervals were calculated for mean amino acid composition data 
points, and are indicated by error bars on the figure. 
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(iii) Novel concatenated phylogeny revisits applicability of classic phylogenetic markers for 
classification of human-infective Cryptosporidium spp. 
 
Three Cryptosporidium species-types account for more than 90.0% of all human 
infections: C. parvum, C. hominis, and to a lesser extent C. meleagridis (Qi et al. 2015). 
The concatenated phylogeny reveals that strains belonging to these species form a 
branch that is phylogenetically distinct from other strains, resulting in an apparent 
separation of clades based on a propensity to cause disease in humans. The close 
evolutionary distance between these species has made it difficult in the past to identify 
genotyping makers that accurately reflect whole-genome divergence through 
conventional means (ribosomal RNA, heat shock protein, etc.), which simultaneously 
makes it difficult to identify appropriate genetic targets for strain tracing and outbreak 
source tracking. The concatenated phylogeny specifically highlights the shortcomings of 
the five most widely-used typing markers at representing evolutionary divergence, 
demonstrating that single markers often display insufficient discriminatory power (D, E) 
or inaccurate genetic distances and relationships between strains (B, C, F).  
 
Figure 1.3.4. Comparative phylogenetics between the concatenated phylogeny and standard single-locus subtyping markers for 
human-infective Cryptosporidium genotyping and classification 
Nucleotide sequences for five common subtyping loci were extracted from C. hominis, C. parvum, and C. meleagridis WGS using 
standard primers: (B) 18S rRNA (F 5′-GGAAGGGTTGTATTTATTAGATAAAG-3′; R 5′-AAGGAGTAAGGAACAACCTCCA-3′), (C) HSP70 (F 5’- 
TCATGTGTTGGTGTATGGAGA-3’; R 5’-CAACAGTTGGACCATTAGATCC-3’),(D) Actin (F 5’- CAAGCATTGGTTGTTGAT-3’; R 5’-
TTTCTGTGTACAATTGATG-3’), (E) COWP (F 5’-ACCGCTTCTCAACAACCAT-3’; R 5’-TTGAGTGGGAACAGGTGCG-3’) and (F) GP60 (F 5’-
TCCGCTGTATTCTCAGCC-3’; R 5’- GCAGAGGAACCAGCATC-3’). Nucleotide sequences were aligned, translated into amino acids, and 
converted into Maximum Likelihood (ML) phylogenetic trees using MEGA v5.2 (Molecular Evolutionary Genetics Analysis version 5.2; 
Tamura et al. 2011). The ML phylogeny was calculated using the Dayhoff substitution model and Nearest-Neighbour-Interchange (NNI) 
heuristic method.  
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The limitations of traditional single locus targets, most notably the erroneous 
characterization of isolates based on the infamous GP60 subtyping locus (Figure 1.3.4. F), 
means there is still a vacancy for a universally-applicable typing tool that efficiently 
discriminates strains in a phenotype-associative manner.  The generation of novel WGS 
and subsequent production of the concatenated phylogeny has provided a phylogenetic 
gold standard for isolate discrimination, but replicating this approach to genetically 
characterize each instance of cryptosporidiosis is unfeasible. Based on the phylogenetic 
grouping of human-infective Cryptosporidium spp. WGS in this study, three polymorphic 
single-gene alternatives were identified that mimic the relative positioning of strains, 
most importantly separating anthroponotic versus zoonotic isolates of Cryptosporidium 
parvum (Figure 1.3.5). Further significant benefit can be derived from the use of any of 
these three markers to definitively characterise “true” C. p. anthroponosum isolates 
versus cryptic examples that contain predominantly IIa-type genomes but a IIc-type GP60 
(e.g. IIcA5G3j).  
 
 
Figure 1.3.5. Single marker alternatives for phenotype-associative phylogenetic classification of Cryptosporidium spp. WGS  
Human-infective WGS were compared using standalone BLASTn databases (BioEdit v7.2.5; Hall, 1999) to identify divergent (<90.0% 
amino acid identities) loci, and tabulated results were visually scrutinized to identify loci capable of segregating isolates in a manner 
resembling the concatenated phylogeny.  Candidate loci were subsequently extracted from C. hominis, C. parvum, and C. meleagridis 
WGS to obtain full length gene sequences for (B) cgd2_390, (C) cgd2_4370, and (D) cgd3_1780, based on annotated coding sequences 
(Puiu, et al. 2004; http://www.cryptoDB.org). Nucleotide sequences were aligned and converted into Maximum Likelihood 
phylogenetic trees using MEGA v5.2 (Molecular Evolutionary Genetics Analysis version 5.2; Tamura et al. 2011). Phylogeny was 
calculated using the Dayhoff substitution model and Nearest-Neighbour-Interchange (NNI) heuristic method.  
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(iv) Common protein sequence divergence reveals convergent evolution of anthroponotic 
Cryptosporidium spp. WGS lineages 
 
The level of genetic divergence and the rate of evolution does not appear to be uniform 
across the genome. Evaluation of genome-wide protein coding sequences identified 165 
significantly diverged orthologous loci (<90.0% amino acid IDs) between C. hominis 
IaA14R3 and C. parvum parvum IIaA15G2R1 (Figure 1.3.6.A). Forty-six (27.9%) of these 
variable protein coding sequences are localized to the first and last 20,000bp extending 
from the 5’- and 3’-end telomeric repeats (i.e. the subtelomeric regions, representing 
~3.5% of the genome). The subtelomeric regions are thus significantly more diverged than 
the rest of the genome (randomization test: p<0.0001). Evidence of host-adapted 
evolution through positive selective (dN/dS-values >1.0) was identified for 11.5% of these 
variable proteins, with 36.8% of these dN/dS-values affecting subtelomeric loci, which is a 
significant enrichment of sites under positive selection in the subtelomeric region 
(binomial test p-value 1.95 x 10-6). In addition to positive selection, species-specific 
genome expansions and contractions (>500bp) were identified at the 5’-end of 
chromosome 5, at the 3’-end of chromosomes 2, 3, and 6, and 7, and approximately 
170,000bp internally from the 5’-end of chromosome 8. Functional annotation of highly 
diverged loci indicates a predominance of mucins and other non-specific glycoproteins 
(N=34 (20.6%); Chi-sq. test: χ2=196.21; d.f.=1; p<0.0001), and an overrepresentation of 
secreted proteins (N=98 (59.4%); Chi-sq. test: χ2=322.41; d.f.=1; p<0.0001). The signature 
of selection, the contraction and expansion of subtelomeric regions, as well as the gene 
content of this region are all consistent with adaptive coevolution of a pathogen that 
employs rapidly evolving proteins located in the subtelomeric regions to enable 
cryptosporidiosis in a variety of hosts (Figure 1.3.6.B). 
 
Analysing and comparing the 165 significantly diverged orthologous loci between C. 
hominis and C. parvum anthroponosum made it possible to study parallel evolution in the 
putatively anthroponotic WGS subtypes. C. parvum anthroponosum IIcA5G3a was highly 
diverged (>10.0%) at the amino acid level from C. parvum parvum IIaA15G2 at 54 of the 
165 C. hominis divergent loci, and a further 42 showed a moderate amino acid divergence 
(3.0 – 10.0%) (Figure 1.3.6.D). These values are significantly higher than the genome-wide 
average of <1% amino acid divergence (binomial test: p<0.0079 for 96 out of 165 loci). 
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The impact of host-driven adaptation on protein level divergence is further substantiated 
by a tertiary comparison with a zoonotic C. p. parvum WGS subtype, IIdA22G1. This strain 
displays high amino acid divergence (>10.0%) at only 13 of these loci, which is significantly 
fewer than the 54 highly diverged loci in common between the two anthroponotic 
subtypes (Chi-sq. test: χ2=33.881; d.f.=1; p<0.0001) (Figure 1.3.6.G). The genomic 
similarities in hypervariability between anthroponotic Cryptosporidium subtypes and 
obvious disparity from intra-zoonotic divergence provides evidence for host-specific 
adaptations and convergent evolution at the protein level. 
 
In addition to the evidence of selective pressure being exerted on a common group of 
proteins, some genomic features are shared between C. parvum anthroponosum and C. 
hominis to the exclusion of the C. parvum parvum lineages.  For instance, they lack a 
portion of the C. p. parvum-specific sequence data on chromosomes 5 and 7 (Figure 
1.3.6.D). The absence of this sequence data has most notably resulted in two missing 
genes from the six-gene-strong C. parvum parvum-specific multi copy MEDLE gene family 
in C. parvum anthroponosum, and five missing genes in C. hominis. In addition, C. parvum 
anthroponosum uniquely lacks a 3,360bp stretch of sequence data at the 3’-end of 
chromosome 1. These vast structural chromosomal alterations, which again are not 
present in zoonotic C. parvum strain IIdA22G1 (Figure 1.3.6.G), highlight the potential 
relevance of telomeric sequence data loss as a major recombinatory process 
accompanying host species narrowing and adaptation in Cryptosporidium.
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Figure 1.3.6. Comparative genomics of protein divergence reveals whole-genome consequence of host-driven adaptation in 
anthroponotic Cryptosporidium spp. 
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Figure 1.3.6. Comparative genomics of protein divergence reveals whole-genome consequence of host-driven adaptation in 
anthroponotic Cryptosporidium spp. 
Whole-genome protein coding sequences were annotated from nucleotide sequence data (EMBOSS GetOrf, Rice et al. 2000) for C. 
hominis (IaA14R3) and three C. parvum isolates (zoonotic C. p. parvum strains IIaA15G2R1 and IIdA22G1, and anthroponotic C. p. 
anthroponosum IIcA5G3a) and cross-compared using standalone protein BLAST databases (BioEdit v7.2.5; Hall 1999). Columns display 
chromosome-wide protein divergence and structural alterations (A, D, G), putative protein function and localization (B, E, H) and 
composite representations (C, F, I). Parallel alignments and visual examination of whole chromosome sequence data revealed 
significant inconsistencies between whole genome sequence content, particularly featured adjacent to 5’-AAACCT-3’ repeats (Artemis 
Comparison Tool; Carver et al. 2005), as well as frameshift mutations resulting in species-specific generation or loss of whole coding 
sequences (ORF Finder, NCBI; http://www.ncbi.nlm.nih.gov/projects/gorf/). Putative protein localization was inferred using Wolf 
PSORT (Protein Localization Predictor; Horton et al. 2007) and predicted protein function was determined by BLASTing protein 
sequences against The Universal Protein Resource UniPROT (E-threshold <10-5; http://www.uniprot.org/blast/). 
 
 
(v)  Frameshift-causing indels and dN/dS characterization reveal micro-level genetic 
drivers of protein divergence  
 
Descriptive characterization of protein divergence reveals a striking and recurring feature 
of zoonotic versus anthroponotic orthologous comparisons – frameshift-causing indels. 
These non-triplet genetic insertions and deletions were identified as the genetic 
mechanism behind protein divergence in 60 (36.4%) and 25 (23.6%) of variable C. hominis 
IaA4R3 and C. p. anthroponosum amino acid coding sequences respectively (Figure 1.3.7). 
The ability of frameshift-causing indels to dramatically alter genome composition is a 
well-documented consequence of host-adapted speciation in microbial pathogens. The 
fact that these types of genetic inflictions are present in both of the anthroponotic strains 
examined in this study, and that 84.0% of C. p. anthroponosum indels simultaneously 
affect the protein reservoir of C. hominis, provides an indication of the genomic neo-, sub-
, and non-functionalization of proteins that accompanies narrowing of host range to a 
single, human host. Although a common subset of loci is subject to similar types of 
genetic changes between C. hominis and C. p. anthroponosum, they differ in terms of 
magnitude (size of non-triplet indel, degree of selective pressure) and location (specific  
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position within coding sequence), pointing to convergent evolution rather than 
recombination as the underlying cause of divergence. Exploration of selective pressure 
through dN/dS values indicating a positive (>1.0) versus negative (<1.0) direction 
identified evidence of positive selection in 19 (11.5%) and 26 (24.5%) of divergent C. 
hominis IaA4R3 and C. p. anthroponosum loci, respectively. The association of positive 
selective pressure with anthroponotic host-parasite adaptation is further exemplified by 
the significantly higher dN/dS levels in C. p. anthroponosum divergent proteins than in C. 
p. parvum IIdA22 (Student’s t-test p-value <0.05).
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Figure 1.3.7. Characterization of amino acid divergence for variable loci reveals significant positive selective pressure and widespread frameshift 
inflictions between anthroponotic and zoonotic Cryptosporidium spp. 
Amino acid divergence of hypervariable loci between anthroponotic C. hominis IaA14R3 and zoonotic C. p. parvum IIaA15G2R1 (<90.0% amino acid 
identities) and between anthroponotic C. p. anthroponosum IIcA5G3a and zoonotic C. p. parvum IIaA15G2R1 (<98.0% amino acid identities) is 
characterized and described. A tertiary comparison between two C. parvum zoonotic subtypes, C. p. parvum IIaA15G2R1 and C. p. parvum IIdA22G1, at 
divergent loci (<98.0% amino acid identities) is included. The proportion of non-consensus amino acid sites that can be attributed to single amino acid 
polymorphisms (SAAPs) versus amino acid gaps (AAGs) was determined through protein coding sequence alignment (The European Molecular Biology 
Open Software Suite; Rice et al. 2000). Protein sequence divergence resulting from frameshift-causing insertions or deletions (indels) was evaluated based 
on non-triplet nucleotide gaps between genetic coding sequences. dN/dS calculation was performed between true orthologous protein sequences, 
excluding those where frameshifts have resulted in an altered open reading frame (PAL2NAL; Suyama et al. 2006). Grey lozenges represent chromosomes 
1-8 in a 5’->3’ orientation, with extended grey lines representing relative chromosome location of hypervariable coding sequences and the ir respective 
divergence (% AA IDs) and selective pressure (dN/dS). Degree of selective pressure is detailed based on relative positioning above (positive) or below 
(negative) the 1.0 dN/dS cut-off value. 
 
In addition to assessing selective pressure and diversity for highly-variable loci, universal 
trends of divergence across coding sequences were examined. For this purpose, an 
aligned concatenation of all coding sequences (5’ -> 3’-end orientation) on chromosome 1 
was used as an example. The results for dN/dS and nucleotide diversity (π) largely 
mirrored trends identified for highly-polymorphic loci across the intra- and inter-species 
comparisons. Average rates of π and dN/dS were 0.00032 and 0.089, 0.0022 and 0.334, 
and 0.0236 and 0.119 for comparisons between C. p. parvum (subtype IIa) and C. p. 
parvum (subtype IId), C. p. anthroponosum (IIc) and C. hominis Ia, respectively. The 
universally-low manifestation of divergence and selective pressure for the intra-C. p. 
parvum zoonotic IIa/IId comparison indicates a high degree of conservation and excess of 
synonymous mutations, describing a relationship of purifying selection between these 
two subtype families (Figure 1.3.8). The high rate of divergence yet moderately low 
selective pressure between zoonotic C. p. parvum IIa and anthroponotic C. hominis Ia is 
characteristic of the tail-end of a speciation event, as an already perfected host-parasite 
adaptation removes the incentive for further largescale positive selective pressure. The 
relationship between zoonotic C. p. parvum IIa and anthroponotic C. p. anthroponosum 
IIc, on the other hand, has signature features of diversifying selection, exhibiting less than 
one-tenth the average nucleotide diversity yet more than double (dN/dS 0.334 versus 
dN/dS 0.119) the selective pressure observed between C. p. parvum IIa and C. hominis Ia. 
It is important to also note that the significantly lower dN/dS between C. p. parvum and C. 
hominis in combination with the high rate of frame-shift causing InDels may be a signal of 
strong purifying selection, whereby an enhanced rate of deleterious non-synonymous 
mutations could have acted to shed certain superfluous genes in the more specialized C. 
hominis. A naturally-smaller or recently-reduced population size of C. hominis could 
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further explain the potential signature of purifying selection that was observed. This rapid 
accumulation of non-synonymous mutations is a key feature of recent evolutionary 
adaptation towards a novel host. Composite patterns of nucleotide diversity and selective 
pressure therefore demonstrate not only the genotypic basis of a specialist host range in 
C. parvum anthroponosum, but simultaneously provides a timeline that places this 
subspeciation event at a more recent historical divergence date than the speciation that 
occurred between C. parvum and C. hominis.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3.8. Sliding window nucleotide diversity (π) and selective pressure (dN/dS) across chromosome 1 coding sequences, for 
human-infective anthroponotic and zoonotic Cryptosporidium spp. WGS 
5,000bp sliding window blocks were used to assess selective pressure (dN/dS) and nucleotide diversity (π) for chromosome 1 coding 
sequences between zoonotic C. p. parvum IIa and three other human-infective subtypes (zoonotic C. p. parvum IId, anthroponotic C. p. 
anthroponosum IIc, and C. hominis Ia). Coding sequences >300bp were initially extracted from chromosome 1 whole chromosome 
sequence data using Emboss GetOrf (EMBOSS GetOrf, Rice et al. 2000). These were subsequently aligned using the ClustalW alignment 
function for codons in MEGA v5.2 (Molecular Evolutionary Genetics Analysis version 5.2; Tamura et al. 2011), and species-specific 
coding sequences were manually removed. All subsequent sliding window analyses were conducted using ‘polymorphism and 
divergence’ functions embedded within the DnaSP software suite v. 5.10.1 (Librado & Rozas, 2009). 
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1.4  DISCUSSION 
 
In this chapter I have provided the first genome-wide representative phylogenetic 
evidence of two distinct subspecies within the C. parvum species-group, using a novel 
concatenated approach based on 61 neutrally-evolving loci, and described some of the 
key potential drivers of anthroponosis versus zoonosis in cryptosporidiosis. Concatenated 
alignments of neutrally-evolving loci produced a novel phylogenetic representation of 
Cryptosporidium species; one that efficiently correlates phenotypic differences with 
genetic distance for closely-related human-infective strains based on non-recombinant 
regions of WGS (Figure 1.3.1). The identifiable sub-grouping of anthroponotic versus 
zoonotic strains within the C. parvum clade confirms the existence of two phenotypically 
distinct C. parvum lineages (as proposed by Widmer et al., 2012). Further comparisons 
between the common GP60 subtyping locus and the concatenated phylogeny reveals an 
inconsistency in the genome-wide divergence representation of this marker, and 
highlights the existence of a cryptic IIcA5G3j subtype that houses a IIc-type GP60 locus in 
a IIa-type genome (Figure 1.4.1). These distinct genotypic features could be attributed to 
the unique isolation of this subtype from hedgehog species (Sangster et al. 2016), 
revealing novel insight into the recombinatory processes that drive host adaptation 
between human and animal transmission shifts. This analysis suggests that these lineages 
be nominated subspecies rather than species due to the observation of relatively recent 
hybrid formation between the lineages exemplified in the WGS for IIcA5G3J. The 
subspecies should be named C. parvum parvum and C. parvum anthroponosum to 
improve the evolutionary classification within this species. 
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Figure 1.4.1. Concatenated phylogeny of human-infective Cryptosporidium spp. confirms new C. parvum subspecies 
(Cryptosporidium parvum anthroponosum) and revisits applicability of GP60 typing marker 
The concatenated phylogeny of 61 neutrally-evolving amino acid sequences in C. parvum and C. hominis (A) and C. parvum only (B) 
WGS reveals the genetic relationship between and within the dominant human-infective Cryptosporidium spp. The C. parvum 
anthroponosum isolates form a distinct and separate clade from the neighbouring C. parvum parvum sister taxon, warranting re-
classification of this anthroponotic group as a novel C. parvum subspecies. Construction of a comparative phylogenetic tree using 
standard GP60 typing sequences (5’-TCCGCTGTATTCTCAGCC-3’ to 5’-GCAGAACCAGCATC-3’) revealed strong discordance with the 
concatenated phylogeny for C. hominis and C. parvum WGS (C), and incorrect evolutionary grouping of C. parvum isolates (D). 
Phylogenetic positioning of C. parvum isolate IIcA5G3j, which contains a IIc-type GP60 sequence but shares greater genome-wide 
genetic similarity to the zoonotic C. parvum parvum subspecies, reveals incongruence between the concatenated versus single locus 
phylogenetic approach. Confidence values on the maximum likelihood trees (MEGA 5.2; Tamura et al. 2011) were generated using 
2,000 bootstrap replications. 
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Previously-reported genotyping markers were also assessed within the context of this 
study, and revealed that there is a lack of discriminatory consensus between commonly 
used targets. An evaluation of the five most popular markers revealed that phylogenetic 
groupings and genetic distances were consistently inconsistent with one another for 
discriminating the novel WGS (Figure 1.3.4). None of the markers produced phylogenies 
that successfully mirrored the concatenated phylogeny, and the Actin gene proved 
particularly problematic when it grouped C. hominis with C. meleagridis, and further 
showed no discrimination between C. parvum anthroponosum and C. parvum parvum; 
this demonstrates the Actin marker as lacking discriminatory power at the subspecies 
level, as well as producing misleading genotypic descriptions of human-infective 
Cryptosporidium spp. GP60 produced a phylogeny that exhibited the weakest correlation 
with whole genome-divergence, creating entirely unexpected and unexplained 
phylogenetic patterns between C. hominis, C. parvum, C. meleagridis, and C. cuniculus. 
However, this is likely explained by the previously-demonstrated occurrence of 
recombination at this locus (Li et al. 2013; Guo et al. 2015). The hypervariability and 
recombinant nature of GP60 means it will likely never be effective as a genotyping marker 
aimed at describing genomic proximities, but rather continue to receive focus as a 
potential driver of host-parasite interactions in cryptosporidiosis. In this context, the 
proximity of the C. hominis GP60 subtype Ia to anthroponotic C. parvum WGS, versus the 
proximity of C. hominis GP60 subtype Ib to zoonotic C. parvum IId, and zoonotic C. 
cuniculus, could be of importance (and will be discussed in chapter 3).  
 
Although it could be argued that each marker is useful in its own targeted way, such as 
the inter-species separation achieved by 18S rRNA, there have been repeated calls from 
within the Cryptosporidium community for novel genotyping methods that accurately 
describe genome-wide patterns of divergence (Cacciò & Widmer, 2013; Sikora et al. 
2016). This study proposes three single-marker alternatives, cgd2_390, cgd2_4370, and 
cgd3_1780 (Figure 1.3.5), which produce comparable phylogenies to the concatenated 
sequence. Most importantly, they separate the C. parvum parvum strains from the C. 
parvum anthroponosum strains, consistently discriminate C. hominis from C. cuniculus 
within the C. hominis/C. cuniculus clade, and repeatedly differentiate UKMEL4 from the 
other two C. meleagridis strains. This provides a strong incentive for moving these 
markers forward to the next level of validation, by testing whether their efficiency is 
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retained on larger and more epidemiologically-diverse Cryptosporidium sequence 
datasets. An important component to this will be the improved epidemiological 
characterisation of Cryptosporidium, particularly in-depth classification of the true host 
ranges and pathogenicity associated with various GP60 subtypes, as it will highlight how 
well these new markers establish a link between phenotype and genotype. Only then will 
the Cryptosporidium community likely consider replacing outdated and inefficient 
genotyping approaches, and give these novel markers their scientific endorsement.   
 
The combined divergence and selective pressure analyses performed during this whole 
genome analysis provides one of the first comprehensive overviews of the micro- and 
macro-level changes accompanying host specialisation (or generalisation) in 
Cryptosporidium spp. It touched upon many of the important themes and results 
commonly associated with speciation and subspeciation events, and simultaneously 
identified a significant new toolset of putative virulence factors. Species-specific gene 
duplication events were one of the major findings of this study, confirming previous 
reports on the existence of a C. p. parvum-specific MEDLE gene family (Guo et al. 2015), 
but also expanding on this to include specific genomic locations and further examples of 
C. p. anthroponosum and C. hominis-specific genes throughout the genome (Figure 1.3.6). 
It is important, however, to note the variability in the quality and coverage of the whole 
genome sequences included in this comparison (Appendix I). Of particular importance 
here is the significant differences in whole genome and scaffold sizes between the various 
human-infective isolates, which highlights a number of shortcomings due to potentially 
missing sequence data and a compromised sequence quality and coverage (e.g. an excess 
of non-specific (N) nucleotides). Access to improved WGS generated from more 
sophisticated sequencing and assembly platforms will therefore help to expand the 
comparative genomics analyses between and within the subtypes included in this study, 
the importance or which is clearly highlighted by the inconsistent assembly statistics 
described. Despite this limitation, the findings of this study provide numerous examples 
of gene duplication and deletion events that could be validated across same-subtype 
family WGS. This genetic mechanism has been observed during phenotypic shifts towards 
generalisation and specialisation, respectively, in other host-parasite systems (Cole et al. 
2001; Chain et al. 2004; Cuomo et al. 2007; Hu et al. 2014), and this in silico finding 
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therefore may provide an important insight into the evolutionary processes driving host 
range in C. hominis and C. parvum.   
 
Divergence can tell us a lot about the extent, rate, and consequences of evolution 
between closely-related species. In this specific study, the functional characterisations 
and genomic locations of divergence went a step further, providing not only a 
quantitative analysis of the variability but also beginning to highlight the true nature of 
pathogenicity in human-infective Cryptosporidium. The first divergence feature worth 
noting is the limited genome-wide proportion of coding sequences which exhibited 
significantly variable nucleotide identities between C. p. parvum IIa and C. hominis Ia 
(Figure 1.4.2). This targeted elevation of divergence and selective pressure, affecting less 
than 5.0% of all coding sequences, points toward a recent, rapid, and highly effective 
speciation event that resulted from a perhaps unexpected and strong environmental 
pressure to evolve and adapt. It also indicates that the genetic factors most vital for 
successful pathogenicity and proliferation within the host, i.e. the infamous virulence 
factors, can likely be found among the 165 highly-diverged (<90.0% amino acid IDs) genes 
identified in this study (Figure 1.3.6).   
 
 
Figure 1.4.2. Genome-wide dN/dS and amino acid identities (%) between C. parvum IIa and C. hominis Ia coding sequences  
Amino acid identities (%) and dN/dS values between complete coding sequences for reference C. parvum (Iowa II) and C. hominis 
(TU502) whole genome sequences were obtained from Mazurie et al. (2013; supplementary table 3). Individual values for AA IDs (%) 
and dN/dS are presented, along with the genomic average for these values as determed from whole genome alignments analysed 
using DnaSP (v 5.10.1; Librado & Rozas, 2009).  
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The functional annotation of highly-diverged genes further adds to the big picture of 
virulence and infectivity, with two predominant themes being secretion and 
glycoproteins.  Bacterial and protozoan pathogens rely heavily on extracellular proteins to 
both defend and attack, and have evolved complex virulence secretion systems that 
efficiently interact with, modify, and manipulate host cells (China & Goffaux 1999; Souza 
2006; De Buck et al. 2007; Büttner & Bonas, 2010; Voth et al. 2012; Neves et al. 2014; 
Atayde et al. 2015). Previous studies have suggested links between secreted proteins in 
Cryptosporidium and host epithelial cell damage, and postulated that secreted 
enterotoxins may significantly impact the pathogenic manifestations of disease, but the 
molecular pathways and genetic factors remain poorly understood (Guarino et al. 1995; 
Gookin et al. 2002). The significant over-representation of secreted proteins in this study 
therefore could indicate a crucial role of these in human Cryptosporidium infection. 
Glycoproteins and specifically mucins were also significantly represented amongst the list 
of putative virulence candidates, and have been implicated as powerful virulence factors 
in a number of other pathogenic protozoa, such as the variant surface glycoproteins in 
Trypanosomes (Horn, 2014). A subset of these highly-variable cryptosporidial mucins, 
located at the 5’-subtelomere on chromosome 2, have already been investigated in a 
number of epidemiological and in vitro settings (Cervallos et al. 2000; O’connor et al. 
2009a; O’connor et al. 2009b; Paluszynski et al. 2014). The discovery that these mucins 
are not only highly variable across a range of geographic and clinical settings, but also 
likely to play an indispensable role in attachment and invasion, makes their involvement 
in virulence increasingly credible, and places them high on the candidate list of putative 
drug targets and potential markers of disease. These virulence-associated features also 
warrant further investigation of some of the currently unexplored highly-variable mucins 
and glycoproteins identified through this genomic study. 
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                             CHAPTER 2 
 
 
Genetic exchange as a driving force for phenotypic diversity in human-
infective Cryptosporidium spp. - and the historical context of divergence 
 
2.1  INTRODUCTION 
 
C. hominis and C. parvum have consistently been reported as exhibiting a high average 
global consensus of ~95.0-97.0% nucleotide identities (Widmer & Sullivan, 2010; Mazurie, 
et al. 2013), yet the former has predominantly been reported from human cases, while 
the latter permanently traverses human-livestock-wildlife transmission boundaries (Fayer 
& Xiao, 2007). The high level of genomic conservation between these species and 
subtypes indicates that phenotypic variation may reflect elevated genetic exchange at 
virulence-associated loci, rather than slow evolutionary progression of divergence; a view 
which is mirrored in other pathogenic protozoa (Freitas-Junior et al. 2000). With the 
emerging view that generalist pathogens may evolve novel virulence factors through 
recombination and genetic introgression (McMullan et al. 2015), whole genome 
comparisons between pathogenic strains, subtypes or races are particularly insightful. 
Such studies help to identify significant hybridisation events and evolutionary changes to 
protein repertoires, and hence, they are key to understanding the genetic underpinnings 
and chronological context of host-pathogen coevolution. 
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(i) Sex or no sex – the inevitable debate of Cryptosporidial sexual affairs 
Genetic exchange is one of the most important drivers of immune evasion and 
diversification in human pathogenic protozoa. Although a basic probability for 
recombination exists in all DNA-replicating eukaryotes, the occurrence of the more 
impactful meiotic recombination is dependent on an important, and less common, 
biological prerequisite: sex. The potential for sexual reproduction in the life cycle of 
Cryptosporidium has been well-documented and accepted, ever since the first macro- 
(female) and microgametes (male) were visualized and described (Figure 2.1.1) many 
decades ago (Barker & Carbonell, 1974; Bird & Smith, 1980; Sanford & Josephson, 1982). 
For a long time, however, the frequency at which this potential was actually fulfilled, as 
well as the extent to which separate strains, subtypes, and species were capable of 
interbreeding, remained elusive. In addition, the lack of effective in vitro culturing 
techniques meant that the occurrence of sexual reproduction had not previously been 
observed “real-time” in Cryptosporidium (Malik et al. 2007). Despite these gaps and 
limitations, a partially sexual reproductive nature has largely been accepted and 
demonstrated within the scientific community (Chen et al. 2002; Hijjawi et al. 2004; 
Leitch & He, 2012), and where sex occurs, the potential for meiotic recombination 
follows. This means that the minimum evidentiary support required for investigating 
genetic exchange as an operator for diversity in Cryptosporidium has, at least in theory, 
been fulfilled (Weedall & Hall, 2015).   
 
Figure 2.1.1. Electron microscope image 
of a Cryptosporidium spp. 
macrogametocyte and microgametocyte 
Image of a macrogametocyte (A) 
containing macrogametes (spherical 
bodies) and a microgametocyte (B) 
containing microgametes (oval 
bodies) at a magnification of x20,000 
and x24,000, respectively (Bird & 
Smith, 1980). 
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The first indication of sexual recombination in Cryptosporidium came with the 
introduction of molecular techniques to differentiate epidemiologically-unique strains.  
Genetic similarities between geographically-distinct C. parvum isolates through an RFLP-
based approach gave rise to the first supported claim of genetic exchange between 
human-infective strains (Widmer et al. 1998). Experimental genetic crosses in laboratory 
mice subsequently produced the first instances of recombinant progeny (Feng et al. 2002; 
Tanriverdi et al. 2007), and extended microsatellite analyses of human and cattle C. 
parvum isolates showed that genetic exchange does indeed happen in nature (Mallon et 
al. 2003), providing much-needed experimental validation for the underlying biological 
mechanisms involved. With an increasing portfolio of genomic data, and in particular the 
extended genetic characterization of the hyperpolymorphic GP60 locus (formerly known 
as Cpgp40/15), the true extent of genetic exchange within human Cryptosporidium spp. 
has started to emerge. GP60 alleles, which frequently defy genotypic exclusivity and seem 
to readily “hop” between subtypes, have since been the primary feature of 
recombination studies in this genus (Leav et al. 2002; Peng et al. 2003; Gatei et al. 2007; 
genetic exchange, however, more recent attempts to identify and enumerate 
recombination signals at the genomic level have remained largely limited to GP60 and 
less than a handful of other loci (Guo et al. 2015; Tang et al. 2016). Thus, there still 
remains a large knowledge gap regarding the role of genetic exchange in driving 
pathogenic changes in cryptosporidiosis. Delineating the presence, features, and 
consequences of genetic exchange is therefore key to understanding its role in driving 
phenotypic diversity between genetically-similar, human-infective, Cryptosporidium 
strains and species. 
 
(ii) Mechanistic Capacity for Genetic Exchange in Cryptosporidium 
 
Genetic exchange is an essential interaction between DNA molecules that promotes the 
transposition or interchange of genetic material between or within a species. While 
recombination primarily serves as a complex DNA repair mechanism and telomere 
maintenance facilitator, vital for preserving genome stability and integrity (Thompson & 
Schild, 1999; Heyer 2015; Tacconi & Tarsounas, 2015), it is also one of the most effective 
tools for promoting allelic diversity and contributing to new or altered phylogenetic 
profiles. This latter impact of recombination is often particularly pronounced in 
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pathogenic organisms, where exchange or transfer or genetic data between variably- or 
differentially-virulent strains often serves to impact the survival and/or pathogenic 
potential within a given host.   
 
In many other pathogenic protozoa, like in Cryptosporidium, reproduction was referred to 
as predominantly, if not wholly, asexual. Scientific acceptance of this fact was largely a by-
product of the comprehensive “clonal theory of parasitic protozoa” presented in the early 
1990s (Tibayrenc et al. 1990), a controversial argument of exclusive clonality made in the 
absence of modern molecular techniques and genomics analyses. As a result of this, the 
presence, nature, and molecular drivers of genetic exchange have only recently begun to 
be fully explored and understood, and with this, the contribution towards fitness-driven 
genetic diversity and immune-evasive tactics. Over the past decade, molecular 
exploration through means such as transfection and hybrid cloning studies, in compilation 
with in silico characterization of genotype diversity and distribution, have implicated 
recombinatory processes as effective drivers of virulence in some of the most infamous 
human parasites, including (but not limited to): Trypanosoma cruzi (Gaunt et al, 2003; 
Baptista Rde et al. 2014; Weatherly et al. 2016), Leishmania (Viannia and Leishmania) 
species (Kuhls et al, 2013; Genois et al. 2015), Toxoplasma Gondii (Grigg & Suzuki, 2003; 
Minot et al. 2012), Giardia duodenalis (Cooper et al. 2007; Kosuwin et al. 2010), and of 
course Plasmodium (Dias et al. 2011; Sutton et al. 2011; Jiang et al. 2011; Kirkman & 
Deltsch, 2014) and African Trypanosome spp. (Conway et al. 2002; Hartley & McCulloch, 
2008; Gibson, 2015; McCulloch et al. 2015).  
 
Genetic recombination studies in protozoa have largely been focused on Plasmodium 
falciparum and Trypanosoma brucei, the primary parasitic causes of severe malaria and 
African sleeping sickness respectively. This bias, although considerable, is defendable due 
to the lethal biological ability of these organisms to evade immune responses and rapidly 
develop resistance to antimicrobials, a characteristic that directly contributes to the 
devastatingly high mortality rates that persist across much of Sub-Saharan Africa and 
parts of Southeast Asia (Odiit et al. 1997; Stich et al. 2002; Nadjm & Behrens, 2012; 
Kumar et al. 2012). The role of recombination through genetic exchange in facilitating this 
antigenic variation and drug resistance has been well-documented, with a number of the 
associated recombination hotspots and putative breakpoints identified to date, but the 
   
- 85 - | P a g e  
 
underlying mechanisms are still largely based on in silico inferences or translated from 
well-characterised model organisms (Morrison et al. 2009; Jiang et al. 2011; Sander et al. 
2014). The physical modus operandi of recombination in these species is predominantly 
facilitated by DNA double-strand break repair (DSBR) systems (Glover et al. 2011; Lee et 
al. 2014), which subsequently lead to genetic transfer or chromosomal rearrangements 
through homologous, micro-homologous or non-homologous end joining (MMEJ and 
NHEJ, respectively; Vink et al. 2012).  
 
The underlying genetic features involved in these complex processes have been relatively 
well-defined in Plasmodium and Trypanosoma spp., initially through homology 
comparisons against known recombination proteins in model organisms such as yeast. In 
Saccharomyces cerevisiae, the enzymes involved in recombination have been described in 
much detail (Krogh & Symington, 2004), and by identifying homologous protein coding 
sequences in other species it is possible to identify whether a likely capacity for 
recombination exists. RAD51, the eukaryotic homolog of the essential recombination 
protein RecA in E. coli, proved vital for the homologous recombination process in yeast 
when mutants proved defective at the process (Bhattacharyya et al. 2004). Homologs 
have since been identified in both Plasmodium (Bhattacharyya & Kumar, 2003) and 
Trypanosoma spp., with RAD51-defective T. brucei mutants displaying an impaired VSG 
switching mechanism (McCulloch & Barry, 1999), and PfRad51(K143R) Plasmodium 
mutants associated with a significantly diminished parasite burden within the host (Roy et 
al. 2014).  MRE11, which partners with RAD50 and XRS2 to form the MRX complex, is 
another vital player in DBS repair (Tsubouchi & Ogawa, 1998), and null mutants have 
demonstrated significant hypersensitivity to DNA damaging agents in Plasmodium 
(Badugu et al. 2015) and Trypanosoma, although in the latter an associated impairment 
to VSG switching did not take effect (Robinson et al. 2002).  
 
In Cryptosporidium, the limitations of in vitro cultivation technologies have delayed 
progress in understanding the true extent, nature, and impact of genetic exchange in this 
parasite. Despite this, a solid platform of genetic diversity and putative genetic exchange 
has already been laid through in silico exploration, and with an increasing number of WGS 
becoming available there is much interest and incentive to expanding this platform, even 
in the absence of experimental validation. As a pre-requisite to this WGS genetic 
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exchange study, an extensive search of Cryptosporidial homologs to characterized 
recombination proteins in Saccharomyces cerevisiae, of which there are around forty 
(Krogh & Symington, 2004), was performed. This revealed significant hits to more than 
half of these (20 of 38; E-value < E-04), and an incredible degree of conservation in 
homologs of the important RAD51 and MRE11 mediators discussed above (Table 2.1.1). 
Although the absence of a number of these proteins (18 of 38; 47.4%) could seem 
significant, their absence was confirmed in other protozoa in which recombination has 
been experimentally confirmed, and could point to drastic divergence of homologs (E-
value hits > E-04) rather than complete genomic eradication. This demonstrates a 
potential mechanistic capacity for genetic exchange in Cryptosporidium, providing 
additional incentive for performing the extensive cross-strain and species genetic 
exchange analyses for the novel WGS unique to this study. 
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2.2  METHODS 
 
(i) Recombination Analysis  
 
Whole genome recombination analyses were performed as an adjunct to findings from 
the concatenated phylogeny. Based on the phylogenetic characterisation of neutrally-
evolving loci, one of the IIc-type C. parvum GP60 strains, IIcA5G3j, exhibited a closer 
genomic proximity to the zoonotic (IIa and IId) WGS than the anthroponotic IIc-type GP60 
strains. This warranted investigating the presence, location, and chronology of potential 
recombination events between three representative whole genome sequences, and how 
these may have contributed to or influenced the observed genetic disparities. Due to a 
superior sequence coverage and quality, the WGS lineages selected for extensive 
recombination analyses were UKP16, UKP6, and UKP13 (IIcA5G3j, IIaA15G2R1, and 
IIcA5G3a respectively).  C. hominis was included as an outgroup to enhance 
recombination signals at the intra-C. parvum level, and C. hominis strain UKH1 was again 
chosen due to its superior sequence coverage and assembly quality compared to other C. 
hominis WGS. Including a C. hominis strain also served to identify regions of uniquely 
elevated genetic similarity with UKP13 (IIcA5G3a), as they share a narrow anthroponotic 
host specificity.  
 
Whole chromosome sequences were constructed, edited, and aligned using the same 
manual approach described for genomic protein comparisons (Section 1.2). Potential 
recombination signals due to introgression, or repeated back-crossing with an ancestral 
strain, were detected and dated by cross-comparing triplet WGS, chromosome-by-
chromosome, using the HKY85 nucleotide substitution model (50 bp sliding windows) 
imbedded in the HybridCheck recombination analysis tool (Ward & Oosterhout, 2015).  
Recombination signals were verified and expanded to include potential parentage and 
recombinant fragment breakpoints using RDP4 (Martin et al. 2015). Automated detection 
algorithms RDP, GENECONV, Bootscan, Maxchi, and Chimaera were run with default 
values, with RDP p-values of <10-5 used to infer confidence of recombination signals.   
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(ii) Divergence dating 
 
Estimating the chronology surrounding major speciation and sub-speciation events is a 
useful way to understand the potential impact of historical events on driving and 
influencing host-parasite interactions. The generally high conservation and sequence 
similarity between C. hominis and C. parvum genomes, and more pronouncedly the C. 
parvum parvum versus C. parvum anthroponosum genomes, indicates that the divergence 
of these species and subtypes may have occurred relatively recently. This makes it 
possible that the phenotypic variances observed within human-infective Cryptosporidium 
spp. were affected by some of the major geographic and demographic shifts that 
accompanied the industrialization and modernization of society over the past millennium. 
The algorithm HybridCheck implements to date recombination (introgression) events 
calculates chronology in terms of generation numbers, and is based on prokaryotic 
propagation models whereby parent to offspring development occurs after a single round 
of DNA replication (i.e. one generation = one replication). Specifically, it bases divergence 
estimates on the quantitative presence of mutations in introgressed blocks between two 
sequences, taking into account a baseline mutation rate (µ) for the given species, as well 
as different substitution models with distinct base frequency and mutation rate 
assumptions (Ward & Van Oosterhout, 2015). In this study, the HKY85 substitution model 
was selected, as it assumes unequal base frequencies between sequences, a relevant 
prerequisite for the considerably AT-rich Cryptosporidium genome (Appendix II). The 
default mutation rate of 10-7 per generation (0.0000001) was retained, as it fell within the 
conservative estimated mutation accumulation rate observed between two outbreak 
WGS that were sampled seven days apart (Table 2.2.1).    
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Table 2.2.1. Whole genome comparison of two outbreak strain WGS reveals estimated mutation accumulation rates per generation 
for Cryptosporidium spp. 
Whole genome sequences for UKP4 and UKP6 WGS (excluding telomeric repeats) were constructed in MEGA version 7.0 (Kumar et al. 
2015) and aligned using the ClustalW algorithm to produce whole genome alignments (WGA). Polymorphisms were subsequently 
characterised in DnaSP v 5.10.1 (Librado & Rozas, 2009), and mutation rates per generation are estimated based on the assumption 
that infections were successive cases of the same outbreak isolate.  
 
UKP4 v UKP6 Whole Genome Comparison 
Sampling separation 7 days  
No. of sites in WGA (bp) 9086411 
No. of SNPs 10 
Nucleotide diversity 0.0000011 
No. of indel sites 78 
No. of indel events 35 
Total no. of polymorphisms (SNPs + indel Events) 45 
Per base SNP mutation rate per generation (µ) 9.50E-08 
Per base indel rate per generation (µ) 3.32E-07 
Combined mutation rate per generation (µ) 4.27E-07 
 
 
 
Applying this method to a protozoan like Cryptosporidium, where multiple rounds of 
nuclear division occur in a single life cycle, therefore meant it would be important first to 
characterise and quantify asexual versus sexual stages, and then assign tangible units 
(seconds, minutes, or hours) for the parental (oocyst) to offspring (oocyst) generation 
time. One common misconception surrounding Cryptosporidium reproduction is that one 
oocyst (or four sporozoites) into the host, equals four oocysts (or 16 sporozoites) out of 
the host, but this does not take into account that there are multiple rounds of DNA 
replication that take place within a single cycle. Breaking down the individual nuclear 
division stages, specifically outlining the input and output of sexual and asexual 
replication cycles, generated a much better idea of the numbers involved (Figure 2.2.1) 
and was crucial for calculating a reliable estimate of generation time in Cryptosporidium. 
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The method used to assign units of time to each generation of oocysts was based on a 
back-extrapolation of “oocysts out” versus “oocysts in”, taking into account challenge 
dose, duration, and total excretion from past infectivity studies, as well as the 
proportional relationship between offspring and parental oocysts. Important to 
calculating this proportion was initially an understanding of the sex ratio between 
gametocytes produced during gametogony, as an unequal rate directly influences the 
number of progeny that are produced. A single published source makes reference to this 
rate in Cryptosporidium, estimating the proportion of male gametocytes at 0.5 (West et 
al. 2000), or a 1:1 ratio between males (microgametocytes) and females 
(macrogametocytes). Similar rates have been observed in a number of other intestinal 
protozoa, including Eimeria (Chauve et al. 1994), Schellackia (Paperna & Finkelman, 
1996), and Toxoplasma (Omata et al. 1997). Another important consideration was the 
number of oocysts that are excreted (thick-walled) versus recycled (thin-walled) within 
the host. This number has previously been estimated at around 80% and 20%, 
respectively (Ridley & Olsen, 1991). As only 20% of new oocysts produced are involved in 
autoinfection, propagation rates needed to be adjusted for each subsequent cycling 
calculation accordingly. The quantitative life cycle figure highlights this, demonstrating 
how a single sporozoite can produce up to 13 thick-walled and 3 thin-walled oocysts 
(Figure 2.2.1). Hence, one ingested oocyst (4 sporozoites) can result in 52 excreted 
oocysts and 12 autoinfective ones, and these 12 autoinfective oocysts can in turn result in 
624 excreted oocysts and 144 autoinfective ones, which in turn can result in 7,488 
excreted and 1,728 autoinfective oocysts, and so on.  
 
 
Table 2.2.2. Oocyst infectivity and intensity rates in human volunteers summarized from peer-reviewed publications 
 
 
 
 
 
 
 
Study Challenge organism Challenge dose Onset of Excretion 
(days) 
Duration of 
Excretion (days) 
Total no. of 
oocysts excreted 
Estimated no. of 
oocyst generations 
Estimated no. of 
days/generation 
Okhuysen et al. 2002 C. parvum 100 7.5 3.5 1.8 x 106 3-4 2-4 
 C. parvum 300 5 3 3.5 x 106 3-4 2-3 
 C. parvum 1,000 4 11 3.1 x 108 4-5 3-4 
 C. parvum 3,000 5 6 2.1 x 107 ~3 3-4 
Chappell et al. 2011 C. meleagridis 10,000 8 3 4.5 x 108 ~3 3-4 
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In light of these biological numerical considerations, a factor of 12 autoinfective offspring 
per 1 parental oocyst was used to estimate the rate of expansion of oocyst populations in 
vivo. Using this value in correlation with excretion data from past infectivity studies 
revealed a population expansion of 3-5 new generations, and an estimated life cycle 
duration of 2-4 days, or 48-96 hours, per infection (Table 2.2.2). Although this estimate 
deviates significantly from the frequently-reported generation time of 12-14 hours for 
Cryptosporidium (Upton, 2008; Oram, 2014; Fleming 2015), not a single one of these 
resources makes reference to the source of this estimation, which makes it difficult to 
verify or investigate how these numbers were achieved. In addition, an early cell culture 
experiment of Cryptosporidium development in human and animal cell lines showed that 
the sexual forms (macro- and microgametes) did not develop until 48 hours after 
inoculation, and that oocysts only appeared after 72 hours (Current & Haynes, 1984). 
These estimates nicely complement the 48 to 96-hour generation estimate calculated in 
this study, lending support to the use of this range to generate estimated divergence 
dates for human-infective Cryptosporidium spp. 
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2.3  RESULTS 
 
(i) Recombination events are associated with host specialization in closely-related 
Cryptosporidium spp. 
 
The role of recombination in driving phenotypic diversity was investigated through whole 
genome alignments and comparisons across three C. parvum (IIaA15G2R1, IIcA5G3j, 
IIcA5G3a) and a single C. hominis (IbA10G2) GP60 subtype strain. A total of 104 unique 
recombination events were detected across the whole genomes compared through the 
RDP4 recombination analysis software (Appendix IV), confidently mirrored by the 
complementary recombination signal analysis performed using HybridCheck (Figure 
2.3.2). Based on observed outliers from the 5-95% confidence intervals encompassing the 
expected mean number of recombination events between C. p. parvum and C. p. 
anthroponosum, the distribution of recombination events across chromosomes was 
skewed, with a disproportionately higher number of individual events estimated for 
chromosome 6 (25.9% of total events), and a disproportionately lower number of events 
calculated for chromosomes 3, 5, and 7 (Figure 2.3.1). Similarly, an unequal distribution of 
recombination events across subtype strains was identified, with a greater number of 
events observed for C. parvum anthroponosum subtype IIcA5G3a than for any other 
strain (37.5%). Another prominent feature was a distinct clustering of recombination 
events within 20,000bp of putative virulence factors. The working definition of virulence 
here encompasses subtelomeric gene families, hypervariable low-complexity proteins and 
large secreted glycoprotein-type proteins, particularly those associated with significant 
dN/dS values (>1.0), or any combination of the aforementioned features. Accordingly, 
more than 90.0% of all recombination events occurred proximal to loci suspected to drive 
virulence or play a major role in host-parasite interactions in human cryptosporidiosis. 
From this, a working hypothesis can be derived that the occurrence of recombination in 
Cryptosporidium spp., although infrequent, largely results in novel gene configurations 
and chromosome arrangements that directly benefit the parasite’s ability to adapt and 
survive within a novel host environment. 
 
   
- 95 - | P a g e  
 
 
Figure 2.3.1. 5-95% Confidence Intervals for Mean no. of Expected Recombination Events per Chromosome between C. p. parvum 
and C. p. anthroponosum WGS 
Binomial distribution of expected and observed number of recombination events for each chromosome is shown, based on the 
number of recombination events identified in C. p. parvum (IIaA15G2R1 and IIcA5G3j) and C. p. anthroponosum (IIcA5G3a) WGS, with 
5-95% confidence intervals indicated by error bars around the expected mean number of events. Statistically significant outliers are 
indicated by datapoints that fall outside of the error bars. All calculations were performed using Microscoft Excel (2013), and the figure 
was created using SigmaPlot (v 13.0; Systat Software, San Jose, CA). 
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The consequential nature of recombination was further explored in this study by 
phylogenetic reconstruction of highly significant (E-value < E-40) recombination events 
(Appendix V). These were further summarized into a proportional break-down of the 
phylogeny-types represented (Figure 2.3.3). By comparing the resulting phylogenies to 
the concatenated phylogeny of neutrally-evolving loci (Figure 2.3.3. A), it was possible to 
evaluate how site-specific recombination impacted genotypic sequence integrity in these 
strains. This detailed phylogenetic analysis revealed that a large proportion of major 
recombination events in these strains result in a “C. parvum anthroponosum-outgroup” 
type topology (45.5% of highly significant events), with C. parvum parvum strains 
IIaA15G2R1 and IIcA5G3j forming a separate clade at the top and C. hominis subtype 
IbA10G2 at an intermediate position (Figure 2.3.3. C). This describes an excess of 
recombination between C. p. anthroponosum and a yet undescribed divergent 
Cryptosporidium WGS. That is to say, the resulting phylogenies of highly significant 
recombination events complement the RDP4 findings that C. parvum anthroponosum 
contains the greatest proportion of recombinant fragments amongst the strains 
compared, but that the origin of this genetic exchange cannot be traced to any of the 
three remaining WGS. Although the potential exchange of genetic material between C. p. 
anthroponosum and an unknown Cryptosporidium WGS might explain the excess of this 
phylogeny-type, it is important to also discuss the possibility that certain C. p. 
anthroponosum alleles may have failed to coalesce with their orthologous counterparts in 
other anthroponotic Cryptosporidium spp. Genetic loci are further known to be subject to 
variable evolutionary rates, and an excess or lack of gene flow between isolated 
populations may have impacted the rate and nature of allelic divergence in some 
Cryptosporidium spp. populations more so than others. Fluctuations in the effective 
population sizes of certain species and subspecies through time could have further 
introduced a bias of allelic divergence at certain loci. It is also possible that a broader 
network of anthroponotic C. parvum subspecies exists than is currently known, with 
multiple lineages that can be traced to a number of subspeciation events, and thereby 
different most recent common ancestral gene sequences (Nichols, 2001). It is therefore 
important to note that a number of external factors and processes beyond population 
genetics alone could account for the observed C. p. anthroponosum-specific divergence 
and the resulting unexpected phylogenies at certain loci.    
   
99 | P a g e  
 
 
 
Figure 2.3.3. Relative distribution of recombinant fragment phylogeny-types amongst highly significant recombination events 
Phylogenetic reconstructions of highly significant recombination events (E-value < E-40; Appendix V) were organised based on the type 
of phylogenetic grouping and ordering of strains they represented (C). Sequence data extracted from WGS for C. parvum parvum 
IIcA53j, C. parvum parvum IIaA15G2R1, C. parvum anthroponosum IIcA5G3a, and C. hominis IbA10G2 are represented by blue, green, 
purple, and orange bars respectively. Phylogeny-types were quantitatively broken down, with percentages representing the proportion 
each type comprised of the total 22 recombinant fragment phylogenies (B). The concatenated phylogeny for the four included 
Cryptosporidium strains is additionally shown for comparative purposes (A). Note: Trees do not represent accurate branching or 
nucleotide substitution rates; only a generalised pattern of strain positioning is intended. 
 
 
(ii) Species diversification is a modern phenomenon in human-infective Cryptosporidium 
spp.  
 
The estimated divergence dates calculated in this study provide the first chronological 
description for genetic introgression between human-infective Cryptosporidium spp. 
(Figure 2.3.2.C). HybridCheck divergence time analyses revealed a chromosome-wide 
consensus that places a majority of introgression events between C. parvum parvum 
(IIaA15G2R1 and IIcA5G3j) and C. parvum anthroponosum (IIcA5G3a) strains at 
approximately 10-15 thousand generations ago (TGA), while genetic recombination 
between the two more closely related C. parvum parvum appears to be more recent (~3-5 
TGA). Recombinant fragments in C. hominis that could have originated from any of the C. 
parvum strains analysed appear to be rare (~6.8% of all recombination events measured), 
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and as expected occurred more anciently (i.e. ~75-100 TGA) than the intra-C. parvum 
events (Fig. 2.3.2C). Translating generation periodicity into tangible units of time is a 
difficult task for Cryptosporidium, due to its lengthy environmental cyst stage and the lack 
of existing human transmission studies. Based on transmission rates in healthy adult 
volunteers, however, this study determined a likely range for generation time to be 
between 48 and 96 hours (Table 2.2.1). In the absence of experimental data on the 
environmental versus host transmission rates and durations for Cryptosporidium, this 
study chose to present divergence dating estimates based on the assumption that there is 
a steady rate of transmission for recombining lineages within a host population only. This 
dates divergence to circa 16-55 years ago for zoonotic C. parvum strains IIaA15G2R1 and 
IIcA5G3j, 55-164 years ago for zoonotic vs. anthroponotic C. parvum strains, and 410-
1096 years ago for the C. hominis vs. C. parvum major divergence events (Figure 2.3.4). 
This estimates that the evolutionary split between the four human-infective 
Cryptosporidium spp. included in this study all occurred quite recently, within or at the 
dawn of the past millennium.  
 
Figure 2.3.4. Divergence dating estimates for three human-infective Cryptosporidium spp. WGS comparisons 
The range of estimated divergence dates (thousands of generations ago) between the C. parvum reference genome (IIaA15G2R1) and 
three other human-infective Cryptosporidium WGS (C. parvum IIcA5G3a, IIcA5G3j, and C. hominis IbA10G2) is shown, as calculated 
according to the HKY85 substitution model (HybridCheck; Ward et al., 2015). Minimum, mean, and maximum generation numbers 
were converted into units of time (years) for both 48- and 96-hour life cycle estimates, and are represented here by box-and-whisker 
plots. Estimates are portrayed in terms of maximum (upper whisker) and minimum (lower whisker) values, with horizontal box lines 
indicating (from top to bottom) upper quartiles, medians, and lower quartiles. X-symbols represent mean values.  
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2.4  DISCUSSION 
 
The role of recombination in driving phenotypic disparities between human-infective 
Cryptosporidium strains has long been central to understanding pathogenicity in 
cryptosporidiosis, but only a limited number of legitimate examples and explanations 
have been provided to date. The current study provides the first extensive insight into the 
What, When, Where, and Why surrounding recombination in Cryptosporidium: What 
strains appear to recombine with one another, When these recombination events are 
estimated to have taken place, Where in the genome these events take their effect, and 
Why these changes appear to have had an evolutionary impact and potential benefit in 
these species. The discovery that all four of the included GP60-subtype strains appear to 
have recombined with one another at some point in history, taking into consideration 
that dozens of further GP60 human subtypes exist, indicates a potentially massive 
implication of recombination in driving genetic diversity within these species. The 
overwhelming bias towards recombination in C. parvum subtype IIcA5G3a, the most 
frequent anthroponotic C. parvum subtype identified in human cases, further provides a 
strong case for the direct role of recombination in producing a host-specialised lineage 
within an otherwise predominantly zoonotic species. The high frequency and distribution 
of these non-zoonotic type recombinant fragments in C. parvum IIcA5G3a also provides 
genetic verification for the classification of this strain as a separate C. parvum subspecies 
(Figure 2.3.3). Likewise, the presence of recombination in C. parvum subtype IIcA5G3j, 
although significantly less frequent, helps to provide a genotypic basis for the 
predominantly anthroponotic and sporadically zoonotic (hedgehogs) nature of associated 
infections.  
 
Recombination has long been viewed as one of the most effective evolutionary 
mechanisms at influencing virulence and host specificity within parasitic organisms. The 
discovery that more than 90.0% of recombination events in the analysed Cryptosporidium 
WGS appear to impact regions within close proximity to putative virulence factors is a 
strong indication of the functional significance of recombination - aimed at enhancing 
survival within the host environment and increasing the pathogenic impact. This direct 
incentive is mirrored in the pathogenically-savvy malaria and trypanosome parasites, 
where recombination has been shown to affect both host range (Rathore et al. 2003) and 
   
102 | P a g e  
 
pathogenicity (Ferreira et al. 2004; Kyes et al. 2007; Horn & McCulloch, 2010; McCulloch 
et al. 2015). The higher frequency of recombination within 25,000bp of telomere ends, 
accounting for around half (49 of 104 events, ≈ 47.1%) of the identified occurrences 
(Appendix IV), is also a common occurrence in both Plasmodium and Trypanosoma, 
primarily because this is where many of their most important virulence factors, such as 
the famous antigenic variation genes, are situated (Pays et al. 1985; Freitas-Junior et al. 
2000). As the underlying genetic factors for virulence in Cryptosporidium are largely still 
unknown and uncharacterised, the parallels that can be drawn with recombination traits 
in other protozoan parasites form a strong basis for future exploration of virulence and 
pathogenicity in this genus. This study thus provides a rationale for focusing the search on 
recombination-affected loci, particularly at the subtelomeres, and perhaps those that 
additionally exist in multi-variant forms. 
 
The result that perhaps bears the greatest novelty in this study is the unique approach 
used to estimate Cryptosporidium generation times, as well as the chronological 
characterisation of speciation events through divergence dating. No other study could be 
found that provides in detail: A.) a quantitative breakdown of the Cryptosporidium life 
cycle, or B.) an estimation of how long ago some of the main human-infective species and 
subspecies splits are likely to have occurred. If accurate, this study places divergence 
within a relatively modern context, estimating that divergence from the most recent 
common ancestor occurred sometime within the past 1,000 years between and within 
human-infective Cryptosporidium spp. This timescale is more recent but comparable to 
lineage-specific divergence estimates in Plasmodium falciparum (Figure 2.4.1), another 
apicomplexan parasite, which has a similar life cycle duration of ~48 hours within the 
host. It does, however, significantly contrast from estimates for Toxoplasma gondii and 
Babesia microti, both of which are estimated to have diverged ~10,000 years ago at the 
intra-species level. However, their complex life cycle, involving multiple host and 
environmental settings, points to a significantly longer (weeks, rather than days) life cycle 
duration. This could explain the significant disparity in divergence dating between the 
two. The putative timeframes for major recombination events in this study also revealed 
a potential link between the evolution of human-infective Cryptosporidium spp. and 
historical changes in human behaviour. This type of real life co-evolution of host and 
parasite is rarely witnessed in nature, and it demonstrates the potential impact that 
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demographic and socioeconomic change can have on restructuring pathogenic 
phenotypic diversity. The chronological assessment of recombination events indicates 
that the main subspeciation event between C. parvum IIaA15G2R1 (zoonotic) and C. 
parvum IIcA5G3a (anthroponotic) took place around the 1800s, a time during which 
developed societies were constantly evolving and adapting in order to keep up with rapid 
changes in industrialization and modernization. The massive influx from agricultural and 
rural communities to the overcrowded and less sanitary urban cities could conceivably 
have forced Cryptosporidium into a new anthroponotic lifestyle, and a single historical 
switch from broad to narrow-host-range could explain why divergence is primarily limited 
to a subset of loci in these species, and why the remaining global nucleotide consensus 
has remained so high. Although preliminary, these results provide the first time-linked 
theory for how C. hominis and C. parvum once came to be. Expanded investigation of 
recombination in more diverse Cryptosporidium WGS will help to further characterise the 
type, rate, and biological impact of recombination and divergence within human-infective 
species, and thereby continue to increase our understanding of the way strains and 
species evolve and adapt within this neglected protozoan genus.  
 
Figure 2.4.1. Estimated 
dates of divergence 
for the most recent 
common ancestor in 
human protozoan 
parasites 
Divergence dates relating 
to the most recent 
common ancestor for 
closely-related lineages 
within three other human 
protozoa (Plasmodium 
falciparum, Babesia 
microti, and Toxoplasma 
gondii) were extracted 
through PubMed literature searches (https://www.ncbi.nlm.nih.gov/pubmed), and correlated with reported life cycle durations (i.e. 
generation time between infectious life forms). These were reported at 3,000-7,000 years ago for extant forms of Plasmodium 
falciparum, and a life cycle duration of 48 hours (Volkman et al. 2001; de Koning-Ward et al. 2015), respectively. In Babesia microti, a 
divergence time of ~10,000 years has been estimated for two geographically-diverse strains of a limited <2% genomic diversity 
(Lemieux et al. 2015). The life cycle for Babesia has not been assigned time units, but is estimated at a minimum of one to several 
weeks, as it is complex and involves two different hosts (Homer et al. 2000).  Toxoplasma gondii was also estimated at exhibiting an 
estimated divergence time of around 10,000 years between three common clonal lineages (Su et al. 2003), and like Babesia has 
complex multi-host and multi-environment requirements for life cycle completion; hence the life cycle was likewise given a minimum 
but not maximum estimated duration (Weiss & Kim, 2007).  
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                                     CHAPTER 3 
 
 
Strain evolution and diversification of the GP60 locus during the 
global expansion of Cryptosporidium hominis 
 
3.1  INTRODUCTION  
Cryptosporidium hominis is the leading cause of human cryptosporidiosis in many parts of 
the world. Although ten unique GP60 subtype families have been classified to date (Ia, Ib, 
Id, Ie, If, Ig, Ih, Ii, Ij and Ik), very little is known about the genetic diversity that defines and 
differentiates these subtypes, and comprehensive data on associated distribution and 
host range patterns remain limited. This chapter has attempted to tackle this gap from a 
combined epidemiological and population genetics perspective, utilizing systematic 
review of global GP60 sequence submissions to describe diversity between and within 
subtype families. Segregating sequences into subtypes and geographic regions provided a 
unique opportunity to understand how selective pressure and diversity define divergence 
across subtype families and regions, and genetic differentiation analyses aimed to 
illustrate whether any evidence of recent population expansion or contraction events 
exists. Allele frequencies and diversities worked to define how well GP60 allele 
populations are structured across C. hominis subtypes, and assess whether certain allele 
types significantly dominate human infections. The potential overlap between alleles and 
regions (i.e. phylogeography) was used to further examine the potential role of genetic 
migration/interbreeding, and the potential impact of host behaviour on the 
diversification of certain subtype families was discussed. By exploring and analysing 
population genetics across/between geographic regions and subtype families, and 
correlating genetic data with epidemiological features, this chapter provides a new 
understanding of the processes that have accompanied strain evolution and 
diversification of GP60 within C. hominis.  
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 (i)  Cryptosporidium hominis – The origin of a new species 
Cryptosporidium parvum as a universal descriptor of the human Cryptosporidium 
pathogen first came into use in the mid-1980s (Upton & Current, 1985), when it was 
characterised morphologically as being significantly smaller than the original mouse 
species discovered in 1907, Cryptosporidium muris. The derivation of the genus name is 
based on a combination of descriptive Latin terms: ‘kruptos’, the Latin word for hidden, 
and ‘spora’, meaning spore. The species name ‘parvus’ refers to its small size, although C. 
parvum has since been absolved of its miniature reputation, ranking as the 11th largest 
out of 18 oocyst species in a recent review (Australian Society for Parasitology, 2010). As 
molecular advancements towards genotyping began to emerge throughout the 90’s, 
distinct polymorphisms within common targets such as the 18S ribosomal RNA gene 
(Kilani & Wenman, 1994) and non-telomeric repetitive sequences (Bonnin et al. 1996) 
were being identified, leading to the re-classification of C. parvum into two genotypes: 
type I (human), and type II (animal), correlating with their respective transmission cycles 
(Peng et al. 1997). Extended multilocus analyses and in vitro growth differences 
eventually added to their divergent phenotypic profiles, widening the evolutionary and 
biological gap of these two genotypes, and by 2002 C. hominis the species was finally 
recognised (Morgan-Ryan et al. 2002).  
Historically, the first attempts at characterising differential epidemiological features of 
human Cryptosporidium spp. were predominantly focused on C. hominis versus C. 
parvum, largely because the early genetic markers only provided limited discriminatory 
power between subtypes. After the introduction of GP60-based subtyping, however, the 
absence of clonality within these species quickly became evident, and in recent years the 
available information on subtype distribution and virulence has rapidly advanced 
(Putignani & Menichella, 2010). To date, C. hominis has been identified as comprising ten 
unique GP60 subtype families, Ia, Ib, Id, Ie, If, Ig, Ih, Ii, Ij, and Ik, and has been reported as 
being the more frequently isolated human pathogen in the Americas, Australia in Africa 
(Caccio et al. 2005). Recently, an expansive study of more than 10,000 children under 24 
months of age across Sub-Saharan Africa and South Asia, where the clinical consequences 
of diarrhoeal disease are often most severe, found that more than three-quarters (>75%) 
of Cryptosporidiosis associated with mild-to-severe diarrhoea was caused by 
Cryptosporidium hominis (Sow et al. 2016). A distribution pattern of the constituent 
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subtypes themselves has also begun to emerge – although these studies are still too 
sporadic to draw actual geographic boundaries or measure predominance of subtypes on 
a global level. No exhaustive review currently exists that attempts to present globally-
reported C. hominis data in a combined fashion. The most recent and most 
comprehensive summary put forth to date provides a useful overview of C. hominis 
burden and distribution from a public health perspective (Caccio & Chalmers, 2016). 
However, this study included data from only 14 European countries (less than one-third 
of the 51 European countries in existence), did not include subtype data for non-human 
sources of C. hominis infection, and refrained from elaborating on the sequence 
variability between the reported and submitted GP60 sequences to date, nor the 
potential genetic factors responsibility for this variability. Compiling all of the available 
data into a summarised format is thus an important first step towards better 
understanding global distributions and host ranges associated with variable C. hominis 
GP60 subtype families. Through this, we get closer to being able to establishing if, how, 
and why certain C. hominis GP60 subtype families inflect a greater degree and severity of 
cryptosporidiosis on human populations worldwide. 
 
 (ii) Population genetics at the GP60 locus - what we already know 
A number of studies are currently available that describe and discuss GP60 allelic diversity 
between and within human-infective Cryptosporidium spp. populations.  One of the 
earliest reports on GP60 population genetics focused on C. parvum isolates from an area 
of Scotland, and used GP60 in combination with a number of other markers to determine 
the most common multilocus genotypes (MLGs) infecting humans, sheep, and cattle 
(Morrison et al. 2008). Analysis of Nei’s genetic distance and Fst found that geographic 
sub-structuring was largely absent, but genetic sub-structuring indicated that a limited 
number of MLGs were genetically-isolated from the predominant genotypes, and thereby 
illustrated the potential for genetically-distinct populations across the areas compared. 
Another early UK-based study found that less common GP60 subtypes were associated 
with foreign travel, and that limited heterogeneity could be found for regional 
(originating in the UK or Europe) isolates, with a vast majority (>91.0%) of these samples 
belonging to GP60 subtype IbA10G2 (Chalmers et al. 2008).  The existence of specific 
subpopulations that are associated with host types and geographic regions was also 
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reported in an Italian study focused on C. parvum in livestock (Drumo et al. 2012). A 
different multilocus study on C. parvum isolates from Irish calves reported significantly 
higher allelic diversity for GP60 compared to a number of other genotyping loci, with 
regional differences in diversity observed, but found an overall panmictic population 
structure rather than distinct subpopulations within Cryptosporidium parvum (De Waele 
et al. 2013). This lack of genetic sub-structuring appears to reflect random mating within 
the population, and differs from the distinct and isolated sub-populations described for 
Scottish and Italian C. parvum populations. A similar observation of panmictic population 
structure within C. parvum was identified for human and bovine isolates in the Upper 
Midwest of the United States, where an MSLT approach including GP60 found little 
evidence to support sub-structuring due to host or geographical associations (Herges et 
al. 2012). The nature and degree of selective pressure at the GP60 locus was further 
evaluated for human samples originating in Santiago, Spain, revealing that balancing 
selection and an excess of synonymous mutations likely drive allelic divergence, and that 
similar degrees of genetic differentiation separate GP60 subtypes within C. hominis and C. 
parvum populations (Abal-Fabeiro et al. 2013). Balancing selection at GP60 was also more 
recently identified for human samples collected from New Zealand between 2010 and 
2015 (Garcia-R & Hayman, 2017). This study also found evidence of a recent population 
expansion in certain sample groups, an observation which was complemented by 
increased cryptosporidiosis notification rates in the same areas and timeframes. This 
demonstrates how GP60 could be used to monitor and predict demographic or 
geographic shifts in human infection rates, or to evaluate how sudden changes in 
selective pressure may indicate modifications to host-parasite immune interactions and 
infectivity. Despite this progress, access to studies that have attempted to extensively 
describe the nature of selection and divergence at the GP60 locus in the context of 
Cryptosporidium population diversity and expansion remains limited, and the data that 
does exist can at times seem inconsistent and contradictory. A majority of studies tend to 
be somewhat geographically limited, so as to prevent estimation of the global spread of 
certain allele-types or compare population genetics between geographically-isolated 
regions. Divergence is also often analysed between sequences samples within a finite 
timeframe rather than monitored long-term, making it difficult to identify traits of 
divergence that may correlate with changes in transmission patterns or pathogenicity. 
This means population genetics studies need to undergo an expansion, comparing and 
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contrasting isolates across a wider range of geographic locations. This should generate a 
better picture of the genetic mechanisms driving divergence at the GP60 locus on a more 
global scale, thereby identifying certain populations that may be defined by distinctive or 
unique signals of selection or differentiation in a way that better explains the spread or 
physical manifestations of disease in human cryptosporidiosis.  
C. hominis continues to cause outbreaks across the world, despite regular 
decontamination attempts through means such as filtration and UV treatment of water 
supplies, and continues to be implicated as one of the primary causes of diarrhoea-
associated morbidity and mortality in much of the developing world (Sow et al. 2016). 
Hence, it is crucial to understand the true nature of this parasitic species 
epidemiologically, expand on this to characterise the genetic differences driving 
divergence for host-parasite interactors, and combine these features to form steadfast 
links between clinical outcomes and specific allele-types. Not only will this help to 
establish a validated and reliable genotyping approach for C. hominis isolates worldwide, 
but it will help pave the way towards virulence factor elucidation and possibly identify 
new cellular targets for treatment and prevention. This chapter aims to describe GP60 
from both an epidemiological and population genetics perspective in Cryptosporidium 
hominis, defining the distribution patterns and host types for the various subtypes 
worldwide, and analysing how intra- and inter-population dynamics are shaped from an 
evolutionary perspective. Through this, a better understanding will be gained of the 
manner in which selection and divergence act on geographically-diverse populations of C. 
hominis across the world. The potential implication of host behaviour on how 
diversification of allele-types manifests itself will also be discussed and explored.   
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3.2  METHODS 
 
(i) Systematic review of C. hominis GP60 sequences 
 
NCBI’s online archives PubMed (https://www.ncbi.nlm.nih.gov/pubmed) and GenBank 
(https://www.ncbi.nlm.nih.gov/genbank/) were used to identify and extract data for this 
study (1999 to present). Search terms included “Cryptosporidium”, “Cryptosporidium 
hominis”, “C. hominis”, and “GP60”. Data was initially extracted from all GenBank 
submissions described specifically as GP60 in Cryptosporidium hominis (search phrase 
“(GP60) AND "Cryptosporidium hominis"[porgn:__txid237895]”). Each submission was 
traced to the original publication (except for unpublished submissions) to identify missing 
descriptive data (e.g. host), and to confirm listed details from GenBank records. This was 
then supplemented to include all non-GenBank submitted data for GP60-sequenced 
isolates in C. hominis through systematic review and manual extraction of all relevant 
PubMed hits (search term “C. hominis” or “Cryptosporidium hominis”). Additional C. 
hominis GP60 sequences on GenBank that were missed due to ambiguous labelling 
(simply Cryptosporidium spp.) or mislabelled as C. parvum were identified by homology 
searches against representative sequences from each C. hominis subtype family (Ia, Ib, Id, 
Ie, If, Ig, Ih, Ii, Ij, and Ik) using BLASTn 
(https://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE_TYPE=BlastSearch). The data collected 
during this systematic review included (where detailed in the associated publication or 
GenBank entry): the year of submission, country of origin, host type, GP60 subtype family 
(e.g. Ia, Ib, etc.), specific GP60 subtype (e.g. IbA10G2), and the associated DNA sequences. 
Submissions that were eligible for inclusion belonged to the C. hominis species-type, were 
ones where GP60 had been sequenced from DNA extract derived directly from collected 
stool samples, and for which direct submissions had been made to GenBank, or for which 
the GP60 subtype had been specified in the original publication. Sequences that derived 
from outbreak investigations or had been isolated from environmental samples (e.g. 
sewage, wild animal droppings) were excluded. GP60 sequences were also categorised 
based on the geographic region of isolate origin, in order to achieve detailed population 
genetics analyses within a geographic context. These regions were defined as Australasia, 
Central Asia, Europe, East Asia, North Africa/Middle East, North America, South America, 
and Sub-Saharan Africa (Figure 3.2.1).   
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Figure 3.2.1. Boundary descriptions for geographic regions defined in this study as Australasia, Central Asia, East Asia, Europe, North 
Africa, North America, South America, and Sub-Saharan Africa 
 
(ii) Multiple sequence alignment and phylogenetic analysis 
 
Consensus sequences across all subtype families were prepared prior to alignment. The 
selected fragment was positioned along the GP60 coding sequence between 5’-
GATGTTTCTGTT-3’ and 5’-TGTGGTACTTCA-3’ (Ia), 5’-GATGTTTCTGTT-3’ and 5’-
GTGCGGTACTTC-3’ (Ib), 5’-GATGTTTCTGTT-3’ and 5’-GTGCGGTACTTC-3’ (Id), 5’-
GATGTTTCTGTT-3’ and 5’-GTGCGGTACTTC-3’ (Ie) and 5’-GATGTTTCTGTT-3’ and 5’-
TGTGGTACTTCA-3’ (If), 5’-GATGTTTCTGTT-3’ and 5’-TGCGGTACTTCA-3’ (Ig), 5’-
GATGTTTCTGTT-3’ and 5’-TGCGGTACTTCA-3’ (Ih), 5’-GATGTTTCTGTT-3’ and 5’-
TGCGGTACTTCA-3’ (Ii), 5’-GATGTTTCTGTT-3’ and 5’-TGCGGTACTTCA-3’ (Ij), and 5’-
GATGTTTCTGTT-3’ and 5’-TGCGGTACTTCA-3’ (Ik). All sequence editing, alignment, and 
phylogenetic analysis was performed in using the Molecular Evolutionary Genetics 
Analysis tool (MEGA v 7.0; Kumar et al. 2016). Sequence formatting and alignment was 
performed in the alignment explorer window, according to the ClustalW algorithm for 
codons (Thompson et al. 1994). Pairwise phylogenetic distances were calculated using the 
Maximum Composite Likelihood (MCL) method, estimating the Maximum Likelihood (ML) 
topology using the Tamura-Nei model. All positions with less than 95% site coverage were 
excluded from the final estimation of distances, meaning less than 5% alignment gaps, 
missing data, and ambiguous bases were permitted at any position of the alignment. 
Phylogenetic distances were subsequently exported to FigTree graphical design software 
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(http://tree.bio.ed.ac.uk/software/figtree/) for formatting and preparation of the final 
phylogeny. The final tree is scaled according to the number of nucleotide substitutions 
per site.  
 
(iii) Population genetics analysis of C. hominis GP60 sequences 
 
GP60 sequences belonging to subtype families Ig, Ih, Ii, Ij, and Ik were so few and 
genetically homogeneous that they were excluded from further population analyses, 
leaving only subtypes Ia, Ib, Id, Ie, and If. As most of the bioinformatics approaches that 
were used in this study to describe population genetics require a minimum of 4 
sequences, and/or a minimum of one single nucleotide polymorphism (SNPs) between 
sequences, the subtype families that did not meet these criteria (in this instance Ig, Ih, Ii, 
Ij and Ik) could not be included. Intra-subtype levels of allelic diversity, gene flow, and 
genetic differentiation among aligned GP60 consensus sequences were assessed using 
the DnaSP program v. 5.10.1 (Librado & Rozas, 2009). Signals of selection and predicted 
gene flow within subtype families were determined using Tajima's D (Tajima, 1989) and 
Fu & Li's D (Fu & Li, 1993) tests, for geographically-defined populations of four or more 
sequences, estimating values as moderately significant (P < 0.05), significant (P < 0.01), or 
highly significant (P < 0.001). Sequence diversity (π) and allelic diversity (AD) within these 
populations were determined using Nei's method (Nei, 1987) for populations of two or 
more sequences. Genetic differentiation between geographically-isolated populations (N 
> 2) was described using Fst (Hudson et al. 1992), providing a model of population 
structure that defined differentiation as negligible (Fst < 0.15), moderate (0.15 < Fst < 
0.25), and high (Fst > 0.25) (Wright, 1978). Absolute diversity between these defined allele 
populations was further assessed using Dxy, according to Nei’s model (Nei, 1987). 
Phylogeographic analyses were performed based on ratios between allelic frequencies 
(Gst) and similarities (Nst) between regional populations (Lowe et al. 2004). The greater 
Nst > Gst, the more likely two C. hominis allele sequences (i.e. genetic variations of the 
same gene) are to co-occupy two geographic regions under comparison; alternatively, Nst 
< Gst indicates that alleles are less likely to coincide geographically. Nst = Gst 
demonstrates an absence of phylogeographic associations, and describes a scenario when 
no trend in either direction could be identified between two sequences. Selective 
pressure between C. hominis alleles was assessed using a ratio of non-synonymous (Ka) to 
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synonymous (Ks) substitution rates, with Ka/ks > 1 indicating a significant signature of 
adaptive evolution (Kryazhimskiy & Plotkin, 2008). Instances of Ks = 0 were overcome by 
implementing the equation Ka/((Ks + 1)/S), with S representing the total number of 
synonymous sites (Stoletzki & Eyre-Walker, 2011). Evolutionary distances were also used 
to investigate intra-subtype population diversity, determined according to the P-distance 
method (Nei & Kumar, 2000), using the pairwise distance calculator in MEGA v 7.0 (Kumar 
et al. 2016). An independent student’s t-test was used to assess statistical significance of 
variances between compared populations (sig. p-value < 0.05), and the F-test was used to 
assign significance to regression models for correlated variables (sig. p-value < 0.05), both 
in SPSS v 22.0 (IBM Corp., 2013). All figures and tables were produced and edited in 
Microsoft Excel and Microsoft PowerPoint (2013).  
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3.3  RESULTS 
 
(i) Systematic review of GP60-subtyped C. hominis isolates reveals novel geographic 
disparities and highlights significant information gaps worldwide 
 
The purpose of the systematic review conducted in the study served three primary 
purposes: (1) to describe geographic distributions and allelic diversities of C. hominis 
GP60 subtypes, (2) to identify host range patterns, and (3) to highlight areas across the 
world where C. hominis-specific GP60 data is scarce or non-existent (i.e. “data deficient 
regions”). A total of 2,972 individual isolates, from 103 peer-reviewed articles and 25 
unpublished GenBank submissions, were identified and included in this study (Appendix 
VI). The geographic origins of these isolates spanned 71 countries (36.2% of the total 196 
countries recognised worldwide), but half of these isolates (50.2%) derived from only 
three countries, Australia, Spain, and The Netherlands (Figure 3.3.1), and more than half 
of the 71 countries (56.3%) had GP60-subtyped less than ten individual C. hominis 
isolates. A total of seventeen separate host types were identified across these geographic 
localities. Aside from the vastly predominant human host type (95.6%), the other host 
types identified (130 of 2972) included donkeys (2.1%), rhesus monkeys (0.6%), cattle 
(0.6%), sheep (0.4%), baboons (0.2%), horses (0.1%), kangaroos (0.07%), and single 
instances (0.03% each) of a chimpanzee, cynamolgus monkey, deer, fish, flying fox, 
gibbon, goat, squirrel monkey, and a wallaby. These 130 non-human isolates derived from 
only ten countries: China (65.4%), the United Kingdom (10.0%), New Zealand (9.2%), 
Australia (6.9%), Kenya (3.8%), Papua New Guinea (1.5%), Algeria (0.8%), Brazil (0.8%), 
India (0.8%), and the United States (0.8%). 
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Figure 3.3.1. Distribution and host range of C. hominis GP60 subtype families, and quantitative evaluation of available isolate 
sequence data worldwide 
A total of 2,972 individual GP60-subtyped, non-outbreak related, C. hominis isolate sequences were identified and included, through 
exhaustive literature review of all published Cryptosporidium studies (PubMed search: https://www.ncbi.nlm.nih.gov/pubmed), and by 
homology searches of GenBank sequences to identify unpublished submissions (https://www.ncbi.nlm.nih.gov/genbank/). A total of 
103 published and 25 unpublished sources were identified, covering 71 countries and 17 unique host types. Countries were assigned 
heat-mapped values based on number of C. hominis isolates GP60-sequenced to date. The proportions of GP60 subtype families 
identified, as well as the host type from which isolates originated, were characterised globally and by defined geographic regions. 
Unknown GP60 subtypes refer to isolates exhibiting <95.0% sequence identities with any of the 10 defined subtype families (Ia, Ib, Id, 
Ie, If, Ig, Ih, Ii, Ij, and Ik). Pie chart data describing regional distributions of subtype families are also presented in more detail in Figure 
3.3.2. Individual data points are outlined and referenced in Appendix VI. 
 
To overcome the shortcomings of a widespread geographical bias and absence of C. 
hominis GP60 subtype data, locations of origin were characterised by continental regions 
rather than on a country-by-country basis. This made it possible to draw more powerful 
associations between distributions, host types, and allelic diversities. On a global level, 
GP60 subtype family Ib was the most predominant, representing 59.0% of all subtyped C. 
hominis isolates, followed by Id (15.6%), Ia (11.0%), Ie (7.0%), Ig (2.5%), If (2.3%), Ik 
(2.2%), Ii (0.2%), Ih (0.03%) and Ij (0.03%). There were also 8 isolates (0.3%) that were 
classified as “unknown”, as they exhibited less than 95.0% overall sequence identities to 
any of the hitherto described subtype families.  Individual subtypes showed clear 
phenotypic distinctions in terms of host range and distribution. Subtype Ib isolates were 
overwhelmingly derived from Europe (56.8%) and Australasia (26.2%), and were 
identified in ten different host types. In contrast to this, subtype Ia, which constitutes the 
original C. hominis TU502 reference strain subtype, was most frequently identified in Sub-
Saharan Africa (26.3%), South America (20.8%), and Central Asia (18.7%) (Figure 3.3.1 and 
3.3.2), and was found in only two host types, humans (99.1%) and three rhesus monkeys 
(0.9%). Subtype Id, the second most prevalent globally, predominantly originated from 
Australasia (33.4%) compared to the seven other geographical regions (2.5-18.1%), and 
like Ib had a more expansive host range including one isolate each from cattle, a fish, a 
gibbon, a goat, a kangaroo, and a rhesus monkey (0.2% each). Subtype Ie resembled 
subtype Ia in terms of distribution patterns, predominating in Sub-Saharan Africa (33.1%), 
Central Asia (25.0%), and South America (20.2%), and was also only identified in human 
(99.5%) and rhesus monkey (0.5%) hosts. Subtype If was not identified in North or South 
American isolates, predominating in Central Asia (32.8%), Sub-Saharan Africa (26.9%), and 
Australasia (22.4%), and was found in humans (95.5%), baboons (3.0%), and rhesus 
monkeys (1.5%). Subtype Ig was entirely anthroponotic and found almost exclusively in 
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Australasia (95.9%) in addition to one single isolate each from Eastern Asia (1.4%), Europe 
(1.4%) and North America (1.4%). Only a single instance of subtypes Ih and Ij could be 
identified, the first in a human, and the latter in a baboon, both from Sub-Saharan Africa. 
Subtypes Ii and Ik were identified as predominantly zoonotic in the study. Although both 
were identified in humans (28.6% and 1.6% of isolates, respectively), subtype Ii was also 
found in donkeys (28.6%), a horse (14.3%), a rhesus monkey (14.3%) and a cynomolgus 
monkey (14.3%), and subtype Ik was predominantly identified in donkeys (93.8%) and less 
frequently in horses (4.7%).  
 
Figure 3.3.2. Geographic distribution of C. hominis GP60 subtype families  
The geographic origins of C. hominis GP60 sequences is shown, describing the proportion of each subtype family that originated in a 
given region. Included subtype families here are Ia (N=327), Ib (N=1752), Id (N=464), Ie (N=208) and If (N=67), and include only non-
study duplicate sequences. The remaining subtypes were excluded due to insufficient sequence data, or because they originated from 
less than 50.0% of the included geographic regions.  
 
(ii) C. hominis GP60 sequences reveals phenotypic disparities that may be subject to 
selection  
 
A total of 631 GP60 C. hominis sequences were initially identified and retrieved from 
GenBank, all of which were submitted between the years of 2002 and 2016. These 
sequences were all accurately annotated as C. hominis, and so were extracted from the 
GenBank depository directly using the search phrase “Cryptosporidium hominis” and 
filtering out non-GP60 sequences. 72 of these were immediately excluded for 
phylogenetic interpretation, as they constituted environmental wastewater samples (N = 
19) or clones obtained through laboratory-based animal propagation systems (N=53). A 
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further 79 isolates were inaccurately labelled as either Cryptosporidium parvum or simply 
Cryptosporidium sp. (submitted to GenBank between 1999 and 2016), and so had to be 
identified through homology searches of representative sequences from each C. hominis 
GP60-subtype family using BLASTn (https://blast.ncbi.nlm.nih.gov/Blast.cgi) and manually 
extracting significant sequence hits (>95.0% sequence identities). A further refinement 
made prior to phylogenetic analyses was the removal of study duplicates, i.e. 100% 
identical sequences and corresponding host types identified within a single study. This 
was done to improve the interpretability of a dataset that already contained a high 
number of replicate sequences, and because the inclusion of duplicate study sequences 
would not have added any improvements to the resolution of phylogenies or genetic 
distances at the intra- or inter-subtype level comparisons. This resulted in a final dataset 
of 480 individual GP60 C. hominis sequences for phylogenetic and diversification analyses 
(Figure 3.3.3).  
 
Figure 3.3.3. Flow chart of C. hominis GP60 sequence systematic review and extraction for evolutionary and divergence analyses 
C. hominis GP60 sequence data was initially identified by retrieving all hits for the search term “Cryptosporidium hominis” in 
combination with “GP60”, “GP15”, “GP40”, and “GP40/15” on GenBank (http://www.ncbi.nlm.gov/genbank/); these hits were 
subsequently filtered to remove all environmental or laboratory-propagated samples. Each known C. hominis GP60 subtype family 
sequence (Ia, Ib, Id, Ie, If, Ig, Ih, Ii, Ij, and Ik) was subsequently blasted against NCBI’s BLASTn database 
(https://blast.ncbi.nlm.nih.gov/Blast.cgi) to identify C. hominis GP60 sequences that had been mislabelled as “C. parvum” or 
“Cryptosporidium sp”. This resulted in a preliminary dataset of 638 sequences, which was subsequently filtered to remove all 100% 
identical study duplicates. The final dataset consisted of 480 C. hominis GP60 sequences.  
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C. hominis GP60 subtype families clustered into two very distinct superclades: The B-E-F 
clade, and the A-D-G-H clade. Subtypes I and K additionally formed an isolated outgroup 
clade that was completely separate from any of the other subtype families, as did subtype 
J, however this subtype appeared to be a distant outgroup within the A-D-G-H superclade 
(figure 3.3.4) and so could be characterized as evolutionarily, albeit distantly, part of this 
clade. Subtypes E and F, and subtypes A and G, further formed minor clades within their 
respective superclades, while subtypes B and D remained phylogenetically distinct. 
Subtype Ib was represented by the largest proportion of non-duplicate study isolates, but 
only exhibited the third largest intra-family diversity (range in nucleotide diversity: π = 0-
0.021, mean = 0.0045 ± 0.00005). In contrast, subtype Ia, the second most prevalent in 
the phylogeny, had the largest range in nucleotide diversity between strains out of all of 
the included families (π = 0.00-0.085, mean = 0.0083 ± 0.000161).
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Diversity and selective pressure of global isolates within their respective GP60 subtype 
families was assessed for human, non-study duplicate isolates (N=427), and was only 
possible where intra-subtype isolates displayed some degree of SNP-based divergence; 
this led to the exclusion of subtype families Ig, Ih, Ii, Ij, and Ik. Subtypes Ia, Ib, Id, Ie, and If 
possessed a number of SNPs at the intra-family level (see Table 3.3.1), and were taken 
forward in the subsequent analysis. Subtypes Ia and Id exhibited the greatest degree of 
allelic diversity, with Ka/Ks ranges of 0.000-4.484 (mean(±SEM) = 0.368 ± 0.006) and 
0.000-4.138 (0.298 ± 0.008), and evolutionary distances ranging between π=0.000-0.085 
(0.008 ± 0.0001) and π=0.000-0.057 (0.005 ± 0.0001), respectively (Figure 3.3.5; Table 
3.3.1). Both of these subtypes had significantly negative Tajima’s D-values (P<0.01 and 
0.001, respectively) (Table 3.3.2). A negative Tajima’s D indicates a relative excess of low 
frequency SNPs, which could be the result of a recent population size expansion and/or a 
selective sweep. Subtype If also had a comparably high Ka/Ks range (0.000-3.500, (0.480 ± 
0.028)), but a substantially lower evolutionary distance (0.000-0.028), and a Tajima’s D-
value that was not significantly deviating from zero (P>0.10), consistent with a population 
that is in a mutation-drift equilibrium. The two remaining subtypes, Ib and Ie, showed a 
substantially lower range of selective pressure (Ka/Ks ranges 0.000-1.573 (0.319 ± 0.004) 
and 0.000-1.256 (0.172 ± 0.007), respectively) and diversity (π ranges 0.000-0.021 (0.005 
± 0.00005) and 0.000-0.018 (0.002 ± 0.00008), respectively), and were associated with 
non-significant Tajima’s D-values (P>0.01) (Table 3.3.2). These data indicate an absence of 
significant selective pressure (neither positive or negative) and no evidence of a recent 
population size expansion of these subtypes.  
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Table 3.3.1. Population genetics summary statistics for C. hominis GP60 subtypes 
 
Subtype No. human 
samples 
(study 
duplicates 
removed) 
No. 
synonymous 
SNPs 
No. non-
synonymous 
SNPs 
Ka/Ks (mean ± 
SEM) 
Nucleotide variation 
π (mean ± SEM) 
Ia 128 12 31 0.000-4.484 
(0.368 ± 0.006) 
0.000-0.0850 (0.008 ± 
0.0001) 
Ib 130 7 13 0.000-1.573 
(0.319 ± 0.004) 
0.000-0.021 (0.005 ± 
0.00005) 
Id 91 21 40 0.000-4.138 
(0.298 ± 0.008) 
0.000-0.057 (0.005 ± 
0.0001) 
Ie 52 4 8 0.000-1.256 
(0.172 ± 0.007) 
0.000-0.018 (0.002 ± 
0.00008) 
If 26 4 10 0.000-3.500 
(0.480 ± 0.028) 
0.000-0.028 (0.008 ± 
0.0004) 
Ig 8 0 0 N/A N/A 
Ih 1 N/A N/A N/A N/A 
Ii 3 0 0 N/A N/A 
Ij 1 N/A N/A N/A N/A 
Ik 3 0 0 N/A N/A 
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Intra-subtype comparisons between strains of shared geographical origin revealed that 
allelic diversity had interesting global disparities within each of the subtype families 
analysed (Appendices VI-XI). Subtype Ia strains originating in Central Asia, North Africa, 
and Europe showed the greatest degree of GP60 divergence, with little to no variation 
between isolates from Sub-Saharan Africa, Australasia, Eastern Asia, and the Americas. 
Subtype Ib isolates were substantially more variable if they originated from Australasia 
than any of the other defined regions, once again highlighting inverse associations 
between prevalence and diversity, as the overwhelmingly predominant European Ib 
isolates showed a negligible degree of variance. Subtype Id, on the other hand, had a 
strong correlation between isolate prevalence and diversity across most of the geographic 
regions (Regression: R-squared: 0.851, F = 11.77, p < 0.05). The only outliers were South 
American isolates, which were the fourth most prevalent and appeared monomorphic at 
the GP60 locus. Subtype Ie had similar patterns to Ia, with Central Asian isolates 
exhibiting the greatest degree of variation, and minor diversity in Australasia and South 
America, while the remaining regions showed overwhelming genetic identity. Subtype If 
was interesting in that showed allelic diversity primarily in Australasian isolates. A single 
instance of allelic diversity was additionally revealed for isolates from Sub-Saharan Africa, 
with the remaining four geographic regions (Central Asia, Eastern Asia, Europe, and North 
Africa) showing no variation between isolates. Although Australasian samples were the 
most common (38.5%), a significant number of isolates also came from other regions e.g. 
Central Asia (23.1%) and Europe (15.4%), so the heightened allelic diversity within 
Australasian strains could indicate a unique external driver for selective pressure acting 
upon infectious pathogens of this subtype in this region of the world. 
 
(iii) Genetic differentiation of GP60 C. hominis alleles show geographic and intra-subtype 
family disparities  
 
In order to evaluate whether any regionally-defined GP60 sequences exhibited a 
deviation from mutation drift equilibrium (neutrality), thereby evidencing a potential 
recent population contraction or expansion event, Tajima’s D was used to assess genetic 
differentiation. The relatively elevated frequencies of rare alleles for within-subtype 
sequence comparisons, as indicated by significantly negative (P<0.05) Tajima’s D values, 
were identified only in three geographic areas: Central Asia, Europe, and Sub-Saharan 
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Africa (Table 3.3.2). This is consistent with a recent selective sweep and/or recent 
population expansion (e.g. after a founder event or bottleneck). In Central Asia, three 
subtype family showed highly significant values for Tajima’s D<0 (Ia, Id, and Ie), while in 
Sub-Saharan Africa the same trend was identified for subtypes Ia and Id, and in Europe 
subtype Id isolates seemed to harbour an excess of uncommon alleles. These negative 
Tajima’s D values were most significant for subtype Ia in Central Asia (P<0.001) and for 
subtype Id in Sub-Saharan Africa (P<0.001). All of the remaining Tajima’s D-values were 
non-significantly different from zero, indicating that the populations for this gene are in a 
mutation drift equilibrium.   
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Table 3.3.2. C. hominis GP60 intra-subtype family sequence samples size (N), allele number, allelic diversity (AD), 
nucleotide diversity (π), Tajima’s D, and Fu & Li’s F values, for human-derived Cryptosporidium hominis isolates 
worldwide. Results are segregated based on subtype and subcategorised by geographic region. 
 
Ia 
Region Seq (N) No. Alleles AD (±SE) π (±SE) Tajima’s D Fu & Li's F 
AU 3 3 1.000 (±0.272) 0.01434 (±0.00421) ‡ ‡ 
CA 39 9 0.372 (±0.100) 0.00533 (±0.00192) -2.53736*** -4.29086** 
EA 7 3 0.524 (±0.209) 0.00207 (±0.00093) -1.23716 -1.37408 
EU 15 7 0.819 (±0.082) 0.01081 (±0.00448) -1.68507 -2.21738 
NAF 9 8 0.972 (±0.064) 0.01811 (±0.00426) -1.06317 -1.40289 
NAM 14 4 0.659 (±0.090) 0.00382 (±0.00128) -1.04237 -1.72592 
SAM 18 5 0.719 (±0.091) 0.00326 (±0.00063) -0.65623 -0.02902 
SSA 23 5 0.628 (±0.072) 0.00709 (±0.00425) -2.19418** -3.80205** 
Ib 
Region Seq (N) No. Alleles AD (±SE) π (±SE) Tajima’s D Fu & Li's F 
AU 24 11 0.862 (±0.053) 0.00855 (±0.00120) -1.76358 -1.76358* 
CA 9 2 0.222 (±0.166) 0.00073 (±0.00055) -1.08823 -1.08823 
EA 9 2 0.222 (±0.166) 0.00222 (±0.00166) -1.51297 -1.51297 
EU 47 3 0.198 (±0.074) 0.00120 (±0.00047) -0.98279 -0.98279 
NAF 12 5 0.667 (±0.141) 0.00387 (±0.00093) 0.47201 0.47201 
NAM 9 2 0.556 (±0.090) 0.00550 (±0.00089) 1.94806 1.94806 
SAM 11 2 0.182 (±0.144) 0.00180 (±0.00142) -1.59996 -1.59996 
SSA 9 3 0.639 (±0.126) 0.00685 (±0.00146) 0.49704 0.49704 
Id 
Region Seq (N) No. Alleles AD (±SE) π (±SE) Tajima’s D Fu & Li's F 
AU 12 8 0.894 (±0.078) 0.01618 (±0.00401) -0.43316 -0.44922 
CA 20 9 0.705 (±0.111) 0.00700 (±0.00222) -2.26073** -3.68715** 
EA 7 2 0.286 (±0.196) 0.00078 (±0.00054) -1.00623 -1.10146 
EU 13 6 0.641 (±0.150) 0.00551 (±0.00211) -2.15214** -2.96683** 
NAF 4 1 0 0 N/A N/A 
NAM 3 2 0.667 (±0.314) 0.00179 (±0.00084) ‡ ‡ 
SAM 10 1 0 0 N/A N/A 
SSA 22 8 0.545 (±0.128) 0.00640 (±0.00272) -2.47774*** -3.97522** 
Ie 
Region Seq (N) No. Alleles AD (±SE) π (±SE) Tajima’s D Fu & Li's F 
AU 5 4 0.900 (±0.161) 0.00402 (±0.00110) -0.17475 -0.17531 
CA 13 4 0.423 (±0.164) 0.00309 (±0.00157) -2.14681* -2.69137** 
EA 7 2 0.571 (±0.119) 0.00164 (±0.00034) 1.34164 1.10146 
EU 6 1 0 0 N/A N/A 
NAF 4 2 0.500 (±0.265) 0.00144 (±0.00076) -0.61237 -0.47871 
NAM 3 2 0.667 (±0.314) 0.00192 (±0.00090) ‡ ‡ 
SAM 6 2 0.333 (±0.215) 0.00192 (±0.00124) -1.13197 -1.19511 
SSA 8 2 0.250 (±0.180) 0.00072 (±0.00052) -1.05482 -1.20353 
If 
Region Seq (N) No. Alleles AD (±SE) π (±SE) Tajima’s D Fu & Li's F 
AU 10 6 0.889 (±0.075) 0.01077 (±0.00182) -0.06612 -0.17822 
CA 6 1 0 N/A N/A N/A 
EA 1 1 0 N/A N/A N/A 
EU 4 1 0 N/A N/A N/A 
NAF 1 1 0 N/A N/A N/A 
NAM 0 N/A N/A N/A N/A N/A 
SAM 0 N/A N/A N/A N/A N/A 
SSA 4 2 0.500 (±0.265) 0.01020 (±0.00541) -0.80861 -0.77723 
‡ Tajima’s D and Fu & Li’s F values require a minimum of 4 input sequences  
* Sig. P-value < 0.05, ** Sig. P-value < 0.01, *** Sig. P-value < 0.001 
N/A No intra-subtype diversity or sequence data  
 
   
126 | P a g e  
 
(iv) Intra-family allelic diversity reveals globally-dominant allele types for GP60 subtypes 
 
Allelic diversity was characterised further within C. hominis GP60 subtypes from a 
phylogenetic perspective, to identify whether subtype families contained dominant allele 
types causing human infections worldwide. This provided better insight into the global 
distribution and population structure of alleles at the intra-subtype level (Appendices XIII-
XVII).  A striking similarity between all of the five subtype families included in this analysis 
was that alleles predominantly grouped into two distinct allotypes when gaps and 
microsatellites were excluded from phylogenetic constructs (Appendices XIII-XVII, panel 
A). The existence of two such major SNP-based allotypes creates a simplified approach for 
understanding both the population structure and spread of C. hominis isolates worldwide, 
allowing genotyping approaches to focus on only three classes of GP60 alleles, namely 
“A”, “B”, and the less frequent “Other” types (Figure 3.3.6). Using this approach, intra-
family GP60 alleles were categorised geographically, revealing clear distribution 
disparities between the various allele types (Appendices XIII-XVII, panel B).  Allotype A 
was more than twice as prevalent as the other two classes for all subtype families except 
If. This indicates the existence of a single, dominant genotype within subtypes Ia-Ie that 
accounts for a substantial proportion of human cryptosporidiosis. From a geographic 
perspective, there were proportional disparities between and within the various 
allotypes; Ia type A was, for example, overwhelmingly present in Central Asian and Sub-
Saharan African samples (>75.0% of type A), while South American and North American 
samples comprised more than two-thirds of Ia type B alleles. In contrast, Ib type A (which 
corresponds to the well-known IbA10G2 C. hominis subtype), was most common in 
European samples (>50.0%), while Ib type B was slightly more prevalent in isolates that 
had Central Asian origins. Subtypes Id and Ie had relatively even proportions across all 
geographic regions for allotype A, but for type B showed a predominance in Central Asian 
and East Asian samples, respectively. Proportions of allotypes were entirely dissimilar 
across the geographic categories and subtype families analysed. GP60 subtypes Ia and Ib 
were the most heterogeneous in terms of global allelic distribution, with 62.5% and 75.0% 
of geographic regions harbouring both A and B allotypes, respectively, and all of the 
remaining geographic regions containing either allotype A or B together with another less 
common (“other”) allotype (Appendices XIII-XVII, panel C). For subtype Id, on the other 
hand, only half of the geographic regions contained a mixture of types A and B, and two 
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regions (North Africa and South America) revealed an apparently homogeneous allelic 
population structure comprised of allotype A only.  Subtype Ie was similarly 
homogeneous in European samples (100.0% allotype A), and in subtype If homogeneity 
outweighed heterogeneity for analysed GP60 sequences (62.5% of geographic regions 
comprised entirely of type A, type B, or “other”), although the bias introduced by the 
significantly smaller sample size in this instance makes If allelic diversity more difficult to 
assess reliably. The overall pattern across the entirety of comparisons points towards a 
relatively heterogeneous global GP60 allelic population structure, with less than one-fifth 
of the geographic regions analysed (7 of 38 comparisons, 18.4%) exhibiting an entirely 
homogeneous sample. This study revealed an epidemiological feature (i.e. geographic 
distribution and composition of alleles) that appears as diverse at the intra-subtype level 
as it is at the inter-subtype level, indicating a ubiquitous spread of C. hominis allotypes 
and the absence of any defined associations between geographic boundaries and 
population structure for global GP60 alleles. 
 
 
Figure 3.3.6. GP60 sequences form binary dominant allele types across C. hominis subtype families 
Relative proportions of dominant allele types A and B, along with composite proportions of rare allele types ‘other’, are here illustrated 
for C. hominis GP60 subtype families Ia-If. Allele types A, B, and ‘other’ were based on the following no. of sequences per subtype 
family: Ia (73, 25, 30), Ib (76, 27, 27), Id (49, 17, 25), Ie (38, 6, 8), and If (10, 9, 7). Allele type frequencies were calculated using DnaSP v 
5.10.1 (Librado & Rozas, 2009) for aligned GP60 sequences excluding gaps, and are presented here in combination with the relative 
phylogenetic distribution of subtype families. The radial view phylogeny was generated as a maximum likelihood tree according to the 
Tamura-Nei model and Maximum Composite Likelihood approach, with scale bars describing branch lengths according to the number 
of substitutions per site (MEGA v 7.0; Kumar et al. 2016). 
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(v) Fst reveals contrasting population structures between regions and GP60 subtype 
families 
 
Population structure of subtype families was further evaluated through Fst analyses, to 
evaluate whether regionally-divergent populations are well-defined and genetically 
isolated (Fst = 1) or freely interbreeding (Fst = 0). Geographically-defined GP60 isolates 
showed a wide spectrum of genetic differentiation, from apparent panmixia to strongly 
defined population structure across all of the comparisons (Table 3.3.3). Values ranged 
from 0 to 1, with subtype Ib showing both the highest mean Fst values (mean Fst = 0.423) 
compared to the other four subtypes Ia, Id, Ie, and If (mean Fst = 0.208, 0.075, 0.088, and 
0.353, respectively), and the highest proportion of significant (P<0.05) Fst values as well 
(53.6% of intra-Ib geographic comparisons). This indicates that the genetic variation 
observed in Ib isolates is largely accounted for by strong population structure amongst 
global sub-populations, and that a relatively low degree of gene flow is expected between 
geographically-diverse populations. Conversely, subtypes Id and Ie showed mostly weak 
to no genetic differentiation, with only one-tenth of regional comparisons exhibiting a 
significant Fst. For subtype Id, significant population structuring was only observed 
between isolates from Central Asian versus East Asian, North African and South American 
isolates, whereas for subtype Ie, the same Fst trend was found between isolates from 
Eastern Asia and European, North African and Sub-Saharan African samples. A reasonable 
proportion of Ia sequences demonstrated strong genetic differentiation (35.7%), with 
almost all geographic regions (barre Australia) exhibiting significant Fst values for at least 
one of the cross-regional comparisons. Subtype If contained too few samples for any 
comprehensive genetic differentiation to be assessed across geographic regions, although 
it was interesting to observe moderately strong and very strong Fst signals for Central 
Asian isolates versus Sub-Saharan African and European isolates, respectively (Fst = 0.248 
and 1.000).  
 
Central Asian and East Asian isolates separately showed the greatest proportion of 
significantly positive Fst values across all intra-subtype comparisons (most notably within 
subtype Ib), with nearly half of Central Asian and East Asian isolates exhibiting strong 
genetic differentiation compared to other geographic regions (46.7% each).  This indicates 
significant population structuring and absence of genetic admixture of isolates between 
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these regions and other geographic localities. It is also an interesting contrast to the 
Australasian and European samples, which show a substantially lower overall degree of 
genetic differentiation (2/35 and 7/35 significant Fst values, respectively). This could point 
to a greater incidence of interbreeding and/or a more recent introduction of C. hominis 
isolates within these regions, based on genetic differentiation at the GP60 locus.  
 
Table 3.3.3. Fst (bottom left) and Dxy (top right) values for inter-regional comparisons of C. hominis GP60 alleles 
 
 
*Sig. P-value < 0.05 
ND: No Data 
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(vi) Human migration as a possible determinant of GP60 population structure for C. 
hominis subtypes Ia and Ib  
 
In order to investigate the potential link between human movement (emigration and 
immigration) and GP60 subtype allele population structures (i.e. Fst values), standard 
regression analyses between fixation indices and net migration values were performed 
(Figure 3.3.7). Estimates of the net migration rate were taken from the last global census 
in 2015 (The World Bank, 2015), which represent the difference between numbers 
leaving versus numbers entering a country for a given year. This revealed an overall 
inverse association between regional composite (mean) Fst values and net migration. The 
regression model was only statistically significant for subtypes Ia and Ib (Regression: R-
squared: 0.954, F = 41.79, p < 0.05 and R-squared: 0.936, F = 29.96, p < 0.05, 
respectively), while an absence of any statistically significant correlation was determined 
for subtypes Id and Ie (Regression: R-squared: 0.004, F = 0.01, p > 0.05 and R-squared: 
0.441, F = 1.58, p > 0.05, respectively). The phenomenon of human movement (and 
thereby intra-regional population expansion or contraction) and the effect this may have 
on C. hominis population changes hence only applies to the Ia and Ib alleles within this 
dataset.  
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Figure 3.3.7. Regressions of Fst values for C. hominis GP60 alleles versus regional patterns of human migration 
Fst values within geographically-defined C. hominis GP60 allele groups (Table 3.3.3) were coupled with net migration values defined for 
the same geographic regions, and statistically significant correlations were assessed using standard regression curve analyses (R-
squared and F-test P-values, Sig. < 0.05).  Net migration estimates from the last global census in 2015 indicate regional values for 
immigration (positive) and emigration (negative), and provides a generalised notion of the degree of diversification amongst the 
described geographic regions (The World Bank, 2015).  
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(vii) Intra-subtype phylogeography reveals potential geographic overlaps of closely-
related allele types for GP60 subtypes Ia and Ib 
 
C. hominis intra-subtype phylogeography of GP60 alleles was assessed across the five 
subtype families Ia, Ib, Id, Ie, and If. In this analysis, the differentiation of allele 
frequencies (Gst) was compared to nucleotide similarities of the alleles (Nst), taking into 
account all intra-subtype geographic comparisons (Appendix XVIII). This analysis revealed 
a number of differential associations between genealogy and geographic distribution. An 
initial evaluation of the spread of Gst-Nst values within subtype families revealed that 
closely related Ia, Ie, and particularly Ib GP60 alleles have the tendency to overlap 
geographically. This would suggest that the rate of gene flow is lower than the mutation 
rate for these subtypes. In contrast, subtype Id alleles were more likely to occupy 
separate defined geographic regions (Figure 3.3.8). Subtype If showed a relatively even 
distribution around the mean and contained relatively equal degrees of phylogeographic 
overlap versus differentiation. This analysis was performed more formally to identify 
geographic comparisons with particularly significant phylogeographic associations (µ ± 
2SD). Hence, normal distribution curves for Gst-Nst values were analysed (Appendix XII), 
which showed an absence of statistical significance for a vast majority of the geographic 
intra-subtype comparisons (94.1% non-significant). However, significant phylogeographic 
correlations were found across the various subtype families for a limited number of inter-
regional comparisons. For subtype Ia alleles, isolates from North Africa and South 
America appear to show geographic overlap of closely-related alleles (Nst>Gst). For 
subtype Ib alleles, the only statistically significant phylogeographic association was 
identified between Central Asian and European isolates (Nst>Gst), while subtype Id 
showed a similarly significant geographic overlap of closely-related alleles from 
Australasia and Central Asia, and an absence of geographic overlap (Nst<Gst) for 
Australasian and South American alleles. Subtype Ie alleles contained two comparisons 
with statistically significant Nst>Gst, namely between East Asian and North African isolates, 
and between East Asian and Sub-Saharan African isolates, while subtype If contained no 
statistically significant phylogeographic comparisons. Significant associations were more 
likely to follow a pattern of overlap between phylogeny and distribution (Nst>Gst; 71.4% of 
significant comparisons), which correlates with the frequently homogenous population 
structure of worldwide isolates, as indicated by the predominantly insignificant Fst values 
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(69.5% of regional comparisons across subtypes). Both results suggest that genetic 
migration is a less important evolutionary force than the mutation rate for the allelic and 
nucleotide diversity of GP60. 
 
 
 
Figure 3.3.8. Intra-subtype phylogeography of global C. hominis GP60 alleles 
Differentiation of allele frequencies (Gst) was quantitatively compared to allelic similarities (Nst) of all pairwise geographic 
comparisons (Australasia, Central Asia, East Asia, Europe, North Africa, North America, South America, and Sub-Saharan Africa), The 
figure illustrates the associations between phylogeny and geographic grouping of allele types (= phylogeography). The greater Nst > 
Gst, the more likely closely related alleles are to co-occupy two geographic regions under comparison; alternatively, Nst < Gst indicates 
that closely related alleles are less likely to coincide geographically. Nst = Gst demonstrates an absence of phylogeographic 
associations between intra-subtype allele-types (Lowe et al. 2004). 
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3.4  DISCUSSION 
 
The present study describes the first comprehensive analysis of population genetics for C. 
hominis GP60 alleles from a global perspective, providing new insight into the genetic 
drivers of strain diversification for this species. One of the most significant findings from 
the divergence analyses was a substantial difference in signals of selection and population 
diversities between the various subtype families and geographic regions. Isolates 
belonging to subtypes Ia and Id, specifically those originating in Central Asia and Sub-
Saharan Africa, revealed the highest degrees of nucleotide diversity and selective 
pressure, and were associated with the most significantly negative Tajima’s D values. This 
points towards a recent population expansion event for these isolates, possibly following 
a bottleneck event. The ecological basis for this apparent selective sweep amongst certain 
geographically-defined isolates is difficult to infer in this instance, as the potentially 
relevant epidemiological and clinical data is too scarce and sporadic to establish any 
significantly associated drivers of adaptation. One possible explanation is that these 
subtypes have been introduced to certain regions more recently than others, and that 
heightened selective pressure may be reflective of an ongoing adaptation event between 
the parasite and its newfound host population. From another speculative perspective, 
part of the answer may derive from largescale historical immunological changes in certain 
human populations, and the capacity of certain allelic variants to rapidly adapt to said 
changes with a new heightened degree of pathogenicity and survival. Immunology and 
specifically a compromised versus competent immunity have long been associated with a 
differential propensity for Cryptosporidium to cause disease in humans (O’Connor et al. 
2011), and hence a rise in immunodeficiency amongst a substantial proportion of a 
population might induce a previously avirulent allele type to rapidly adapt and expand. 
The significantly higher intra-allelic divergences and positive selective pressures that were 
identified for subtypes Ia and Id in Central Asia and Sub-Saharan Africa may therefore be 
reflective of a comparatively recent and novel divergence event, and possibly one that 
correlates with changes in human immunity (Rocha et al. 2006; Weber et al. 2014). In 
reviewing recent worldwide epidemics with disproportionately higher immunological 
impacts on resource-poor regions such as Central Asia and Sub-Saharan Africa, the 
outbreak and spread of HIV/AIDS since the 1970s stands out. Sub-Saharan Africa and 
Central Asia have consistently harboured the first and second highest proportions of 
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global cases, together accounting for 74.8%, 87.8%, and 83.4% of people living with HIV in 
1990, 2000, and 2015, respectively (UNAIDS Global Report, 2000 and 2016). If the 
Cryptosporidium parasite experienced an opportunity to improve its evolutionary fitness 
through the enhanced ability of Ia and Id alleles to cause severe disease and infection in 
this new and rapidly expanding population of immunodeficient individuals, then this 
would explain the strong signals for a selective sweep and recent population expansion 
identified at the GP60 locus. GP60 is further predicted to be GPI-linked, a 
posttranslational modification that allows for the anchored extension of a protein in the 
outer cell membrane. This reinforces the accessibility of factors involved in parasite-host 
interactions, and therefore often links proteins to important roles within virulence and 
host immunity (Paulick & Bertozzi, 2008).  
 
Fixation indices were used to assess genetic differentiation of subtypes across geographic 
regions, and together with allelic diversity provided a preliminary view of GP60 
population structure amongst global C. hominis isolates. Signatures of divergent selection 
were inferred from significantly elevated Fst values amongst regional comparisons, and 
highlighted a particularly strong signal for divergent selection amongst Central Asian and 
East Asian isolates belonging to subtype Ib (Fst range: 0.33-0.85). This describes 
genetically-isolated population structures with limited gene flow, and is mirrored by the 
absence of the widespread and most frequent Ib GP60 allele type “A” in either of these 
geographic localities (Appendix XIV). Moderate genetic differentiation (Fst ≈ 0.3) amongst 
Ib alleles was further identified between European and North American, and North 
American and South American, isolates, but for all of the remaining comparisons low to 
no genetic structuring could be identified (Fst < 0.2), which speaks to a largely ubiquitous 
distribution of Ib allele types worldwide, and complements the relatively low degree of 
heterogeneity identified across all geographic regions (Appendix VIII).  The remaining 
subtypes (Ia, Id, Ie, and If) showed variable degrees of differentiation between geographic 
regions, with no single region exhibiting unilaterally high Fst values, which could be 
reflective of the high rates of inter-allelic divergence. This may be particularly true for 
subtypes Ia and Id, where a higher rate of rare allele types may have blurred any potential 
outlines of a defined population structure. The differential degree of genetic 
differentiation across and between the geographic comparisons did give rise, however, to 
one particular trend: the association between net human migration rates and average Fst. 
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Although the link between human behaviour and the parasite’s genetic structure is 
entirely theoretical in this instance, the idea that higher immigration (or indeed foreign 
travel) rates would give rise to more parasites entering a region, and hence a greater 
potential diversity of allele types, is entirely plausible.  Subtype Ib exhibited the most 
significant difference in mean Fst values between Central/East Asian samples, and 
Australasian/European samples (Central Asian mean = 0.643 [95% CI: 0.460 – 0.826]; East 
Asian mean = 0.689 [95% CI: 0.583 – 0.794]; Australasian mean = 0.023 [95% CI: -0.016 – 
0.062]; European mean = 0.113 [95% CI: -0.014 – 0.239]; p < 0.005). Net migration may 
indeed have played a role, but another equally plausible explanation is that subtype Ib is 
in fact native to the two regions in which it is also the most prevalent, i.e. Australasia and 
Europe. A relatively recent introduction of type Ib C. hominis isolates to Central and East 
Asia could explain the rather homogenous population structure of isolates, because a 
short divergence timeframe could have limited its ability to significantly differentiate, or 
because the opportunity to diverge has been limited as there are other more efficiently-
adapted (and more prevalent) allele types already present in the population, such as 
subtype Ia.  
 
Allelic diversity was used to further characterise the population structure and distribution 
of C. hominis GP60 alleles in this study. Of the 142 allele types identified (defined in this 
context as intra-subtype alleles that differed by at least one SNP, disregarding indel 
diversities), Ia alleles showed the highest mean allelic diversity (mean AD = 0.712, range: 
0.372-1.000), and If alleles showed the lowest (mean AD = 0.232, range: 0.000 – 0.889), 
although If sample size was not adjusted for and this almost certainly affected the 
observed absence of allelic diversity for most geographic regions. Australian isolates 
exhibited a significantly greater allelic diversity across all subtypes (mean AD = 0.909, 
range: 0.862 – 1.000; p < 0.05), while South American isolates showed the lowest mean 
allelic diversity (mean AD = 0.309, range: 0.000 – 0.719), but this was not statistically 
significant compared to the remaining six geographic regions (p > 0.05). The reason for 
this apparent excess of allelic diversity in Australian C. hominis isolates is difficult to 
assess in the absence of associated epidemiological or clinical data, and could not in this 
study be attributed to sample size (following the assumption of “more sequences = more 
potential for diversity”).  However, it is interesting to note that the geographic region 
with the highest diversity simultaneously was the region with the highest net immigration 
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rate. In the most recent global census, a net immigration rate of 10.3 migrants per 1,000 
inhabitants was estimated for Australasia, a figure which is more than double that of 
North America (4.76 immigrants/1,000 population), which had the second highest net 
migration rate (The World Bank, 2015). South America, on the other hand, had a net 
emigration rate of -2 migrants per 1,000 inhabitants, which comprised the highest 
regional emigration rate worldwide. The phenomenon of immigrants, refugees, and 
travellers importing intestinal parasitic infections has repeatedly been demonstrated, 
with prevalences of up to 66% identified in newly-arrived immigrants from East Africa and 
Southeast Asia to Australia (Caruana et al. 2006), and a 3-30 times higher notification rate 
for intestinal protozoa in immigrants and refugees to Europe (Ekdahl & Andersson, 2005). 
In one Cryptosporidium-specific example, a prospective study in Sweden found that more 
than 83% of positive samples were from travellers, versus only 17% in non-travellers. This 
provides some level of support that human movement may impact global patterns in 
GP60 diversity, although the significant limitations of sample size inherent in this study 
means that a much greater and diverse sample set is required in order to truly trace the 
genetic origins and spread of Cryptosporidium parasites across the world, both past and 
present.  
 
Another defining feature of C. hominis GP60 subtype families was the existence of two 
predominant inter-allelic subgroups, designated allele types A and B, which revealed 
themselves through clusters on the radial phylogenies (Appendices XIII-XVII). This study 
sought to investigate the global relationship between geography and said allele-types, but 
instead found that there were few consistent associations to be made. For subtypes Ia 
and Ib, both predominant allele types were present (albeit at variable proportions) in 
most of the geographic regions identified (Appendices XIII & XIV), although it important to 
note that the most common C. hominis allele type worldwide, Ib type A (commonly 
referred to as IbA10G2), was entirely absent from Central and East Asian samples. For 
subtypes Id and Ie, allele type A was ubiquitous, but for allele type B a more stringent 
distribution pattern seems to emerge. Id type B was only found in Australasian, Central 
Asian, European, and North American samples, and Ie type B was found only in 
Australasian, East Asian and North American samples. Subtype If showed completely 
divergent patterns across regions for which sequences were available, but sample size 
was again such a limiting factor for this (and indeed all) GP60 subtype families that the 
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reliability and interpretability of these results remain constrained. But should these 
preliminary trends hold true for more expansive sequence datasets, the question remains 
as to whether there is a biological basis (such as host differences) that drive intra-subtype 
allele population formations. 
 
Exhaustive characterisation of intra-subtype allele types also served to evaluate how 
effectively current subtyping approaches, which are largely based on GP60 repeat 
elements, describe true phylogenetic distances between global C. hominis isolates. For 
many of the notorious (i.e. most frequently-reported) C. hominis GP60 subtypes 
described in humans, such as IbA9G3 (Gatei et al. 2007; Jex, et al. 2008; Geurden et al. 
2009; Hijawi et al. 2010; Waldron et al. 2011; Flecha et al. 2015), IdA15G1 (Gatei et al. 
2007; Areeshi et al. 2008; O’Brien et al. 2008; Ng et al. 2010; Hira et al. 2011; Koehler et 
al. 2013; Mbae et al. 2015), IeA11G3T3 (Waldron et al. 2009; Ajjampur et al. 2010; Ye et 
al. 2012; Valenzuela et al. 2014; Eibach et al. 2015; Mbae et al. 2015; Peralta et al. 2016), 
and IfA12G1 (Hadfield et al. 2007; Jex & Gasser, 2008; O’Brien et al. 2008; Ng et al. 2010; 
Abu Samra et al. 2013; Mbae et al. 2015), conventionally-subtyped isolate groups 
produced repeat-based phylogenies that were in agreement with those resulting from the 
360bp consensus sequences. This indicates a strong homogeneity within some of the 
major described GP60 subtype groups, and supports the use of traditional subtyping 
approaches for understanding allelic diversity within global C. hominis populations. One 
very important and significant exception to this, however, was identified for the most 
prevalent and well-known C. hominis GP60 subtype, IbA10G2. This study found that more 
than 15% of sequences labelled online as IbA10G2 did not follow the expected SNP 
pattern for the predominant allele type ‘A’, and that certain alleles were more divergent 
from type ‘A’ than was allele type ‘B’, or IbA9G3 (Figure 3.4.1). Although these sequences 
did in fact possess the ‘IbA10G2’ nucleotide repeat profile, and the designation as such is 
therefore not flawed, the potential for misinterpretations and confusion outside of the 
Cryptosporidium community is a valid concern. Individuals who are unfamiliar with the 
approach to GP60 subtype classification may be misled by the excess reporting of subtype 
IbA10G2 worldwide, and incorrectly assume that this shared subtype designation 
indicates allelic homogeneity amongst sampled populations.  Even more troubling is the 
closer proximity of certain IbA10G2 subtypes to non-IbA10G2 subtypes. The need for new 
and improved genotyping markers for Cryptosporidium isolates is not unique to C. 
   
139 | P a g e  
 
hominis, but applies to all human-infective species and subspecies, and is a need which 
has already been highlighted by past research (Widmer & Lee, 2010). The release of new 
whole genome sequences in higher quantities will undoubtedly help fill this need, as they 
will provide a much-anticipated insight into the true allelic diversity at this and other loci, 
and help us understand how allelic divergence correlates with pathogenicity and 
virulence on a larger scale.  
 
 
 
Figure 3.4.1. Maximum Likelihood Phylogeny of ‘IbA10G2’ sequences reveals lack of genetic identity between GenBank submissions 
All previously-submitted C. hominis GP60 sequences labelled as “IbA10G2” on GenBank (http://www.ncbi.nlm.gov/genbank/) were 
retrieved and edited to achieve a 303bp consensus sequence, and aligned through ClustalW using MEGA v 7.0 (Kumar et al. 2016). The 
phylogenetic relationship between sequences was subsequently analysed using the Tamura-Nei model to construct a Maximum 
Likelihood tree, estimating pairwise distances using the Maximum Composite Likelihood (MLC) method.  
 
 
A final point to discuss in this chapter is the improved epidemiological classification of C. 
hominis GP60 subtypes that was achieved. For the first time, systematic review of all 
available GP60 sequences has been used to characterise the geographic distributions and 
host types of subtype families on a global scale. Subtype Ib was reaffirmed as the most 
frequently-isolated GP60 subtype in European and Australasian samples (Jex & Gasser, 
2008; Waldron et al. 2009), and is the overall most prevalent subtype characterized to 
date, accounting for more than half (59%) of the 2,972 published C. hominis GP60 
sequences reviewed. This reaffirms subtype Ib isolates as the leading cause of sporadic 
human cryptosporidiosis cases due to Cryptosporidium hominis worldwide, as has been 
previously reported (Xiao et al. 2010; Waldron et al. 2011). The overlay of epidemiological 
and population genetics data becomes somewhat telling here, as the most common 
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subtype Ib largely revealed lower levels of nucleotide diversity and selective pressure 
than other subtypes, particularly in samples isolated outside of European and 
Australasian regions (Appendix VIII). This phenomenon may be explained, in a 
counterintuitive way, by the vast predominance itself; by hypothesizing that the most 
widely distributed and hence potentially the most pathogenic GP60 subtype isolates 
would achieve said success due to an already optimized host adaptation, and hence has 
little evolutionary incentive to diverge. The identified link between prevalence and 
divergence is further not unique to Cryptosporidium hominis, or in fact protozoans, as the 
most widespread and prevalent HTLV (Human T-cell Lymphotropic Virus) subtype “A” 
similarly exhibits the lowest overall divergence amongst all global subtypes at the 
hypervariable GP21 locus (Angus & Weiss, 1999). Geographic data also reaffirmed 
subtype Ia as being particularly present in developing regions, with the largest proportion 
of samples (~70%) originating from Sub-Saharan Africa, South America, and Central Asia 
(Figure 3.3.2). Subtype Ie closely mirrored this trend, with more than three-fourths 
(>75.0%) of samples originating in Sub-Saharan Africa, Central Asia, and South America. In 
addition to distribution data, host range patterns have also been expanded and refined 
through this epidemiological review. C. hominis subtypes Ii and Ik demonstrated 
predominantly zoonotic host ranges, having most frequently been isolated from equine 
hosts in the Eastern Asian region (specifically China). This may reflect a recent host switch 
from humans that is unique to this region. Evaluating the genomic changes between 
these zoonotic and other anthroponotic C. hominis isolates may provide insight into the 
nature and chronology surrounding this jump from humans to equines, and could be an 
important priority for future work. Subtype Ib demonstrated the broadest host range of 
the classically anthroponotic subtypes, having been isolated from ten different host 
species to date. A number of reports exist that describe subtype Ib as more virulent than 
other subtypes (Ng et al. 2010; Li et al. 2013; Ng-Hublin et al. 2017), and this heightened 
virulence may thus account for the broader range of hosts this subtype seems to infect. 
Host range data for subtype Id seems to complement this trend, as this similarly ‘more 
virulent’ subtype (Cama et al. 2007) also exhibited a broader host range compared to the 
remaining anthroponotic subtypes. In direct contrast to this, subtype Ia which frequently 
is classed as less or ‘avirulent’ (Mbae et al. 2015) had a much narrower host range, 
isolated from humans only with the exception of three cases in rhesus macaques. This 
clear distinction in terms of distribution, host range, virulence and allelic diversity 
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between certain subtype families, such as Ia and Ib, means it is important to understand 
the types and degrees of genomic changes that may account for the observed phenotypic 
variations. Comparative genomics studies are therefore key to understanding the genetic 
basis of phenotypic traits that define and divide C. hominis subtypes and/or subspecies.  
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             CHAPTER 4 
 
 
Genomic comparison of C. hominis subtypes Ia and Ib reveals the 
major modalities of lineage-specific evolution 
 
4.1  INTRODUCTION 
 
The aim of this study was to perform an exhaustive comparative genomics review of two 
C. hominis WGS from different GP60 subtype families. Leading on from the previous 
chapter, this study intended to explore GP60 variability within a genomic context, but 
also to assess how this and other hypervariable loci (or those under significantly 
heightened selective pressure) may contribute to phenotypic disparities within C. 
hominis. This whole genome comparison specifically focused on the GP60 subtype 
families Ia and Ib. Inclusion of these specific subtypes was based on a number of criteria, 
such as the worldwide predominance of subtype Ib and the fact that the original C. 
hominis TU502 reference genome belonged to subtype Ia, but the most compelling 
criteria was the seemingly different host ranges and global distributions described in 
chapter 3 (Figure 4.1.1). Although both are predominantly anthroponotic, Ia has 
infrequently been isolated from rhesus monkeys, while Ib has been found in rhesus 
monkeys as well as baboon, cattle, chimpanzee, deer, flying fox, kangaroo, sheep, and 
wallaby hosts. This associates subtype Ib with a tentatively broader host range, and 
warranted investigating whether any genotypic disparities could explain the increased 
(albeit limited) propensity for zoonotic infection. The predominance of subtype Ia in 
resource-poor settings (Central Asia, South America, and Sub-Saharan Africa), compared 
to the more developed origins of Ib isolates (Europe and Australasia) was also of interest, 
as genomic changes such as elevated selective pressure could be footprints left behind 
from recent population-defined host adaptation events. As such, this study aimed to first 
broadly describe divergence in terms of the degree and genomic location of significantly 
elevated SNP rates and positive selective pressure. Divergence was subsequently 
dissected to explore specific features such as protein function, telomeric proximity, and 
drivers of variation (SNPs versus gaps), as well as identify subtype-specific coding regions. 
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By illustrating and describing these features, this study provides the first comprehensive 
overview of the genomic differences that separate C. hominis subtypes Ia and Ib, and 
explores how divergence may influence and drive some of the variation in phenotype and 
epidemiology previously observed and described. 
 
 
 
 
Figure 4.1.1. Host range and geographic distribution of Ia and Ib-type GP60 alleles reveals phenotypic and epidemiological 
differences  
Host types and geographic origins of C. hominis GP60 sequences belonging to subtype families Ia and Ib are shown, adapted from 
figure 3.3.1.  
 
 
A number of studies have reported variable virulence and infectivity between certain C. 
hominis GP60 subtype families, as discussed in the previous chapter, but the potential 
genomic features driving these and other phenotypic differences have yet to be explored. 
This limits the data that currently exists to describe the degree and nature of divergence 
between Cryptosporidium hominis isolates. Molecular characterization has 
overwhelmingly focused on two genetic targets, the highly-conserved 18S rRNA gene and 
the hypervariable GP60 gene. The former has primarily been used to differentiate C. 
hominis from other Cryptosporidium spp., rather than facilitate any phenotype-associated 
molecular discrimination within C. hominis, while the latter describes and explores 
genetic heterogeneity in diverse C. hominis populations, and designates isolates into 
distinct subtype groups (Figure 4.1.2). Although these targets are used for entirely 
contrasting purposes, together they provide an insight into the co-existence of 
conservation and variability within C. hominis populations. This provides an important 
incentive for exploring genome-wide features between divergent C. hominis GP60 
subtype families. Other frequent targets for molecular characterization of C. hominis 
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include COWP (Cryptosporidium oocyst wall protein), heat shock proteins (primarily 
HSP70), microsatellite regions, CP47 (glycoprotein), and β-tubulin (Table 4.1.1), but a 
majority of the associated studies provided molecular discrimination of single targets 
rather than using a multilocus approach. Furthermore, studies focused on C. hominis tend 
to be geographically confined, and only rarely have associations between clinical and 
genetic features been performed. The predominant use of GP60 as a typing tool has also 
confounded our understanding of C. hominis genome diversity, due to its inability to 
provide an accurate portrayal of genomic proximity between certain strains. Describing 
the specific genomic changes between varying GP60 subtype WGS is therefore key to 
understanding how distinct C. hominis lineages have arisen through time. The genomic 
comparison will also identify potential drivers of phenotypic differences, such as unique 
virulence patterns and host niches, and will hopefully reveal novel markers for molecular 
typing of strains in a manner that correlates site-specific polymorphisms with whole 
genome divergence.       
 
 
 
 
   
145 | P a g e  
 
 
 
Figure 4.1.2.  Maximum likelihood trees for 18S rRNA and GP60 sequences reveal dissimilar phylogenetic grouping and distances 
between C. hominis isolates  
Maximum likelihood trees for C. hominis 18S rRNA (top tree) and GP60 (bottom tree) sequences are shown. All 18S rRNA sequences 
for C. hominis deposited to GenBank were retrieved (https://www.ncbi.nlm.nih.gov/genbank/), and single examples of genotypes were 
edited to achieve a 734bp consensus (N=34) and aligned using the alignment editor in MEGA v 7.0 (Kumar et al. 2016). A single 
representative sequence for each C. hominis GP60 subtype family (N=10) was also retrieved and a 976bp consensus sequence was 
similarly aligned. Where available, descriptions of GP60 subtype families of 18S rRNA-sequenced isolates are included. Maximum 
likelihood phylogenies were created to obtain evolutionary distances for the respective trees, according to the Tamura-Nei model and 
the Nearest-Neighbour-Interchange heuristic method (MEGA 7.0; Kumar et al. 2016). Branch lengths are illustrated in units of number 
of substitutions per site between consensus sequences, as indicated by the scalebars. Final tree figures were produced using the 
FigTree graphical phylogeny editor (http://tree.bio.ed.ac.uk/software/figtree).   
   
146 | P a g e  
 
Table 4.1.1. Molecular typing and sequence submission of C. hominis isolates has predominantly relied on 10 genetic targets 
Genomic DNA/RNA GenBank submissions for Cryptosporidium hominis (N = 1,393) were extracated and reviewed, to quantitatively 
evaluate the ten most frequent molecular targets used (https://www.ncbi.nlm.nih.gov/genbank/). 
 
Molecular Target Number of GenBank Nucleotide 
Submissions 
GP60 648 
18S rRNA 238 
COWP (Oocyst wall protein) 97 
Heat shock Protein 92 
 Microsatellite 87 
CP47 (glycoprotein) 52 
Beta Tubulin  44 
Serine repeat antigen 39 
Hydroxyproline-rich glycoprotein 
precursor (DZHRGP) 18 
Actin 14 
 
 
In addition to the largely GP60-biased approach to molecular exploration of intra-C. 
hominis heterogeneity (Table 4.1.1), only two whole genome comparative studies 
between C. hominis strains exists (Isaza et al. 2015; Guo et al. 2015). The primary focus in 
Isaza et al. was the release of a new C. hominis WGS genome, along with an improved 
annotation of the already-published C. p. parvum Iowa II reference, and as such, the 
whole genome comparisons between C. hominis strains was a minor component. The 
strains included in this comparative analysis were the IbA10G2 isolates “UKH1” and 
“TU502 New” (both available on CryptoDB), and a novel WGS belonging to subtype 
IeA11G3T3 (“UdeA01”; BioProject ID: PRJEB10000). The results from this comparison 
were limited to the delineation of the genome-wide proportion of non-synonymous 
versus synonymous SNPs, and identifying polymorphic loci based on regions that 
exceeded a pre-determined threshold for SNP density (2.1 SNPs/kb), calculated based on 
the sum of two standard deviations of the median for SNPs/kb across protein coding 
sequences. Although loci with higher-than-average SNP rates were further annotated 
based on gene ontologies, Isaza et al. (2015) did not elaborate on the chromosomal 
locations (such as telomeric proximity) or evaluate selective pressures and potential 
recombination signals. There was little attempt to highlight epidemiological differences 
between the included C. hominis GP60 subtype families or to associate phenotypic 
differences with specific divergence traits. The potential biological implication of genes 
containing “higher-than-average” SNP rates was also only briefly discussed. Guo et al. 
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(2015) provided more detail in their comparative genomics approach, discussing 
hypervariable virulence factors from a functional perspective and annotating possible 
recombination events between C. hominis subtypes Ia and Ib, but selective pressure was 
not explored and genomic differences were only discussed in a phenotypic context to a 
limited degree. This means there still exists a significant need to perform enhanced, 
comprehensive comparative genomics studies, so that the molecular determinants of 
lineage-specific traits between and within C. hominis subtype families can be described.  
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4.2  METHODS 
 
(i) C. hominis WGS – empirical data 
 
The genomes of two C. hominis isolates belonging to GP60 subtype families Ia and Ib were 
selected for this comparative analysis. These isolates, known commonly as UKH4 and 
UKH1, belong to subtypes IaA14R3 and IbA10G2, respectively, and were both derived 
from human clinical samples in the United Kingdom. Methodology describing the DNA 
extraction, purification, and next generation sequencing of UKH4 has previously been 
described (Hadfield et al. 2015), but for UKH1 there is no protocol available as the WGS 
was submitted without an associated publication. The whole genome sequences for 
subtypes Ia (UKH4) and Ib (UKH1) are both publicly available, and were retrieved in FASTA 
format from their respective BioProject records on NCBI (Accession: PRJNA253838 and 
PRJNA222837). Sequence data in the form of contigs from each WGS were manually 
reassembled and rearranged against the C. parvum Iowa II reference sequence 
(http://www.cryptoDB.org; Abrahamsen et al. 2004) into eight complete chromosomes, 
and the two genomes were subsequently aligned using the ClustalW algorithm, all 
performed in MEGA v 7.0.  
 
(ii) Computational approaches for comparative genomics 
 
Intergenomic analyses were all performed using DnaSP v 5.10.1 (Librado & Rozas, 2009). 
Nucleotide (π) and indel (πi) diversities were both assessed by the ‘DNA polymorphism’ 
test, and were computed using a sliding window approach for a 1000bp window and 
1000bp step size. Microsoft Excel (2013) was used to create databases describing SNP 
frequencies and chromosome locations, to determine associations between divergence 
and telomeric proximity. In order to determine genome-wide Ka/ks trends, as well as 
compare rates of SNPs and indels in coding versus non-coding regions, concatenated 
sequences of predicted open reading frames (ORFs) were prepared. A minimum ORF size 
of 300bp (100 amino acids) was selected, as this arbitrary cut-off level has previously 
been implemented for extracting coding sequences from whole genome coding datasets 
(McDougall, 1990; Oliver et al. 1992; Swanson, 2001). All putative coding sequences 
above this 300bp threshold were automatically extracted from WGS in FASTA format, 
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excluding stop codons (EMBOSS GetOrf; http://www.bioinformatics.nl/cgi-
bin/emboss/getorf), and manually concatenated chromosome-by-chromosome in the 5’ -
> 3’ direction. Species-specific ORFs were manually identified and removed, and final 
concatenations were aligned according to the ClustalW codon alignment function in 
MEGA v 7.0.  Ka/ks ratios were calculated using a sliding window approach (150bp 
window, 75bp step) in the ‘Polymorphism and Divergence’ function of DnaSP v 5.10.1. 
Phylogenetic analysis of species-specific coding sequences was conducted in MEGA v 7.0, 
using the Maximum Likelihood test according to the Tamura-Nei model, with the highest 
log likelihood topology selected to construct the final tree.  
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4.3  RESULTS 
 
(i) Whole genome comparison between C. hominis subtypes Ia and Ib identifies putative 
drivers of host specificity and virulence 
 
In order to characterise putative genomic drivers of host-parasite interactions, a whole 
genome comparison between two phenotypically-diverse C. hominis subtypes (Ia and Ib) 
was performed. Divergence analyses between C. hominis subtypes Ia and Ib whole 
genome sequences revealed only a limited number of loci that showed significant degrees 
of nucleotide diversity and selective pressure (figure 4.3.1). Only seven of the 1000bp π 
windows exhibited significantly higher rates of genomic nucleotide diversity (>3SD of 
mean π), all of which encompassed putative coding sequences previously annotated on 
CryptoDB (chromosome 1: Chro.10427; chromosome 2: Chro.20050, Chro.20051, and 
Chro.20052; chromosome 6: Chro.60016, Chro.60138, and Chro.60606; chromosome 7: 
Chro.70055, and Chro.70447; Table 4.3.1). The window spanning GP60 (Chro.60138) 
exhibited a four-fold higher diversity compared to the next highest pi-value (0.084 versus 
0.021), indicating an incomparable degree of hyperpolymorphism at this locus compared 
to the rest of the genome. Of the 9 highly-divergent coding sequences, six were 
annotated as putative mucins or glycoproteins (66.7%), with the remaining three each 
annotated as a putative cell surface anchor, a protein ligase, and as hypothetical. The 
sliding window ka/ks analysis revealed only five significant signals of selective pressure 
(ka/ks>1) across the whole genome alignment. These 150bp windows indicating positive 
selective pressure were all nested within five of the 9 highly-divergent coding sequences 
(Chro.10427, Chro.20050, Chro.20051, Chro.20052, and Chro.60606), the most significant 
of which was identified for Chro.20050 (ka/ks: 5.534).  
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Table 4.3.1. Summary characteristics for genetic loci exhibiting hyperpolymorphism between C. hominis subtypes Ia and Ib 
Coding sequences exhibiting >3 SD from the mean SNP rates are characterized here by gene ID (Chromosome no., and CD no. relative 
to 5’-end), corresponding CryptoDB ID, C. parvum ortholog, location relative to the 5’-telomeric repeat, size, and putative protein 
function (BLAST hits E-value < 10-5; http://www.uniprot.org). 
 
Gene ID CryptoDB ID C. parvum 
ortholog 
Chromosome Start (bp) End (bp) CD size 
(bp) 
Protein 
size (AA) 
Putative Protein 
Function 
C1_481 Chro.10427 cgd1_3810 1 853504 856230 2727 909 Cell surface anchor 
C2_5 Chro. 20050 cgd2_430 2 7711 7115 585 195 Mucin 
C2_4 Chro. 20051 cgd2_440 2 6670 6266 405 135 Mucin 
C2_3 Chro. 20052 cgd2_450 2 5863 5267 561 187 Mucin 
C6_6 Chro. 60016 cgd6_60 6 17239 21948 4710 1570 Glycoprotein 
C6_133 Chro. 60138 cgd6_1080 6 264544 263513 1008 336 Glycoprotein 
C6_675 Chro. 60606 cgd6_5270 6 1245813 1246295 483 161 Uncharacterized 
C7_69 Chro. 70055 cgd7_420 7 130093 124031 5958 1986 Protein ligase 
C7_506 Chro. 70447 cgd7_4020 7 936147 930805 5334 1778 Mucin 
 
 
Figure 4.3.1. Sliding window divergence between C. hominis subtypes Ia (UKH4) and Ib (UKH1) reveals lineage-specific allelic 
variation 
Sliding window diversity analyses (1000bp window, 1000bp step) were performed on concatenated whole genome alignments (C. 
hominis WGS UKH1 and UKH4) to determine genome-wide nucleotide and indel diversity (top and middle panels, respectively). Sliding 
window ka/ks (150bp window, 75bp step) was additionally performed on concatenated coding sequence alignments (bottom panel), 
constructed by extracting all potential CDs based on a 150bp minimum ORF size (EMBOSS GetORF; Rice et al. 2000). Significance cut-
off values were set at 3 standard deviations from the mean for indel and nucleotide diversity, and at 1.00 for ka/ks. All alignments 
were created using the ClustalW algorithm in MEGA (Tamura-Nei Model, MEGA v 7.0), and all sliding window analyses were run using 
DnaSP (DnaSP v 5.10.1; Librado & Rozas, 2009). Putative protein functions of highly-divergent loci were annotated by BLASTing amino 
acid sequences in UniProt and selecting hits with E-values <10-5 (http://www.uniprot.org; UniProt Consortium, 2015). 
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(ii) Lozalization of genomic divergence between C. hominis subtypes Ia and Ib reveals 
subtelomeric bias 
 
The relative distribution of nucleotide polymorphisms (SNPs) across the genomes was 
additionally assessed, to determine whether there existed a bias towards higher rates of 
mutations closer to telomere ends versus the centromeres (Figure 4.3.2). Subspeciation 
events in other species often exhibit some form of preferential localization of divergence 
(Carneiro et al. 2009; Bishop et al. 2000), so it was important to investigate whether any 
such significant polymorphism trends accompanied the split of C. hominis into subtypes Ia 
and Ib. An assessment of genome-wide SNP distribution revealed a significant, albeit 
moderate linear regression (R2 = 0.5884, F. sig < 0.01), indicating an association between 
decreasing SNP rates and increasing distance from the telomeres, and the proportion of 
SNPs located within 10% of either telomere end (5’ or 3’) was found the be statistically 
significantly higher than the internal regions (75.0 ± 29.6 vs 39.5 ± 7.38, P = 0.0259). 
Individual chromosomes did not conform to this trend, however, with chromosomes 4 
and 5 exhibiting no association between SNP rates and telomere proximity (F. sig > 0.5), 
and chromosome 6 showing only a weak, non-significant association (R2 = 0.1107, F. sig > 
0.1). There was a statistically significant difference between mean Ka/Ks values within 
10% genomic distance of the telomeres compared to the rest of the genome (0.65 ± 0.23 
vs 0.34 ± 0.03, P = 0.013), indicating an enhanced positive selective pressure in regions 
proximal to the telomere ends. 
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Figure 4.3.2. Distribution of single nucleotide polymorphisms (SNPs) relative to telomere ends show evidence of increased telomeric 
and subtelomeric divergence 
SNPs were categorised into groups based on their proximity to the telomere ends. This was done by creating blocks of % proximity to 
describe relative position to either the telomere or centromere on the chromosome. SNPs that were located along sequence positions 
within 10% of the total distance from either telomere end (3’ and 5’) comprise block 1, SNPs located between 10% and 20% of the 
total distance comprise block 2, and so on; this continues until block ten, which represents the centromere, or middlemost, portion of 
the chromosome. Polymorphism data was collected using DnaSP (DnaSP v 5.10.1; Librado & Rozas, 2009), and manually organised into 
blocks. Regression fit (R2) and strength (F. sig) were assessed genome-wide and for each consecutive chromosome; genomic (R2 = 
0.5884, F. sig < 0.01), chromosome 1 (R2 = 0.5607, F. sig < 0.05), chromosome 2 (R2 = 0.4115, F. sig < 0.05), chromosome 3 (R2 = 0.6516, 
F. sig < 0.01), chromosome 4 (R2 = 0.004, F. sig > 0.5), chromosome 5 (R2 = 0.0132, F. sig > 0.5), chromosome 6 (R2 = 0.1107, F. sig > 
0.1), chromosome 7 (R2 = 0.5934, F. sig < 0.01), and chromosome 8 (R2 = 0.5758, F. sig < 0.05). 
 
 
(iii) Indel diversity exceeds nucleotide diversity in driving lineage-specific evolution 
between C. hominis subtypes Ia and Ib 
 
Predicted coding sequences made up 76.74% of the genome, and this composition did 
not differ significantly between the eight chromosomes (mean = 76.66%, 95% C.I.: 75.29-
78.04; Appendices XIX-XXVI). Genetic changes were categorised based on nucleotide 
diversity (π) and indel diversity (πi), to assess patterns of divergence across the genome, 
and found that single indels occurred at 1.5 times the frequency of single nucleotide 
polymorphisms (SNPs) for both coding and non-coding regions across the genomes 
(Figure 4.3.3). This divergence pattern was consistent across all of the chromosomes, with 
the exception of chromosomes 2, 3, and 6. Two of these (chromosomes 2 and 6) 
exhibited patterns that reflect the unusually elevated rate of polymorphisms and 
significant selective pressure previously outlined in figure 4.3.1.  
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Figure 4.3.3. Distribution of nucleotide (π) and indel (πi) diversity between C. hominis subtype Ia and Ib whole genome sequences 
reveals nature of divergence driving lineage-specific development 
The average number of differences per site between C. hominis Ia and Ib WGS were defined in terms of nucleotide (π) and indel (πi) 
diversity, for both coding and non-coding regions. This analysis revealed notably higher diversity rates for non-coding versus coding 
sequences across most chromosomes, and indels were frequently found to be the cause of more sequence diversity than SNPs. All 
analysis was performed using DnaSP v 5.10.1 (Librado & Rozas, 2009). 
 
 
A detailed characterization of indel divergence between coding and non-coding 
sequences was additionally performed, identifying a strikingly differential nature in the 
manner indels appear to manifest themselves throughout the genomes (Figure 4.3.4). 
There was a statistically significant difference for indel event diversity between coding 
and non-coding sequences (πie = 0.00005 ± 0.00001 vs 0.00035 ± 0.00006, p < 0.0001) as 
well as for mean indel length between coding and non-coding sequences (πie = 12.33 ± 
2.38 vs 2.23 ± 0.43, p < 0.0001). This reflects a significantly lower incidence of indel events 
in coding regions, but simultaneously shows that these less common events result in 
significantly larger gaps and hence substantial changes in ORF sizes. More than 90.0% of 
gaps in coding sequences greater than 6 bp in size affected microsatellite regions in C. 
hominis Ia and Ib WGS, and hence indels appear to have constituted an important 
mechanism for regulating the size of amino acid repeats and hence intra-species 
divergence in protein coding sequences. 
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Figure 4.3.4. Indel event diversity (πie) versus mean indel event length (bp) reveal fewer but longer indel events for coding versus 
non-coding sequences between C. hominis Ia and Ib WGS 
The nature of indel manifestation between C. hominis Ia and Ib WGS was analysed for coding versus non-coding chromosome 
sequences. Linked sequence gaps were characterised as single indel events and genomic diversity due to these events was 
subsequently calculated (πie). Mean indel size representing the average base pair length of indel events per chromosome was also 
determined. Results for coding sequences are illustrated in red, while non-coding sequences are illustrated in black, and data points 
are linked to corresponding chromosomes (1-8) numerically. All analysis was performed using DnaSP v 5.10.1 (Librado & Rozas, 2009). 
 
 
(iv) Missing subtelomeres and subtype-specific genes: possible drivers of phenotypic 
differences between C. hominis subtypes Ia and Ib  
 
A total of 5,645 bp of subtype-specific subtelomeric sequence data was identified in C. 
hominis Ia and Ib subtype whole genome sequences, of which 5319 bp constituted 
deletions at the 5’ and 3’-ends of chromosome 2 in C. hominis Ia, and 326 bp constituted 
a deletion at the 3’-end of chromosome 6 in C. hominis Ib (Figure 4.3.5). The absence 
and/or presence of subtype-specific sequence data was confirmed for subtype Ia in the 
reference C. hominis IaA25R3 TU502 whole genome sequence data (http://cryptoDB.org), 
and for subtype Ib in two novel IbA10G2 whole genome sequences (UKH3 and UKH5) 
available to this study (source: Cryptosporidium Reference Unit; Singleton Hospital, 
Swansea, Wales).  
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Figure 4.3.5. Missing subtelomeric sequence data encodes subtype-specific coding sequences in C. hominis Ia (UKH4) and Ib (UKH1) 
subtype WGS 
   
157 | P a g e  
 
Figure 4.3.5. Missing subtelomeric sequence data encodes subtype-specific coding sequences in C. hominis Ia (UKH4) and Ib (UKH1) 
subtype WGS 
Whole chromosome alignments of C. hominis Ia and Ib genomic sequence data, stretching from 5’- to 3’-end telomeric repeats, were 
constructed by the ClustalW algorithm and analysed in an alignment viewer to identify missing sequence data >250 bp (MEGA v 7.0; 
Kumar et al. 2016). Subtype-specific sequence data was subsequently extracted from the WGS, and putative open reading frames were 
annotated using EMBOSS GetORF (Rice et al. 2000). Three subtype-specific stretches of subtelomeric sequence data were identified, 
two of which are specific to C. hominis Ib subtype “UKH1” and are located at either end of chromosome 2, and one C. hominis Ia 
(UKH4)-specific sequence at the 3’-end of chromosome 6. Single open reading frames encoding putative genes were identified within 
each subtype-specific sequence, with variable sizes of 132 bp (UKH4, chromosome 6, 3’-end), 990 bp (UKH1, chromosome 2, 5’-end) 
and 1263 bp (UKH1, chromosome 2, 3’-end).  
 
 
Single open reading frames comprising >150 bp were identified within each of the three 
subtype-specific subtelomeric sequences, with the two C. hominis Ib subtype-specific 
genes encoding significantly larger putative proteins of 330 and 421 amino acids in length. 
The larger of the two, located at the 3’-end of chromosome 2, was formerly annotated as 
a C. parvum-specific gene (CryptoDB ID: cgd2_4380) due to its absence in the original C. 
hominis Ia subtype TU502 reference genome (Bouzid et al. 2013). However, this 
comparative study revealed that the absence or presence of this gene is variable across C. 
hominis, and attributable to the loss of subtelomeric sequence data in distinct C. hominis 
subtypes. The second Ib-specific gene at the 3’-end of chromosome 2 is a duplicate gene, 
homologous to Chro.00007, which is located at the telomeric 5’-end of chromosome 5. 
This Ib-specific homolog is similarly present in a variety of C. parvum subtypes (confirmed 
in C. parvum IIa (UKP4), C. parvum IId (UKP8), C. parvum IIcA5G3a (UKP15), and C. parvum 
IIcA5G3j (UKP16).  
 
In addition to these major subtelomeric deletion events, minor genomic changes resulting 
in frameshifts similarly resulted in a small number of subtype-specific genes (Table 4.3.2). 
In total, six subtype-specific coding sequences were identified, five of which (83.3%) 
resulted in the absence or significant alteration of putative coding sequences (ORFs > 
300bp) in UKH4. Putative protein functions of these subtype-specific coding sequences 
were additionally explored, revealing two possible adhesins, a proteophosphoglycan, and 
a protein kinase, as well as two uncharacterised (hypothetical) proteins. Subtelomeric 
location was a predominant feature, with four out of six subtype-specific coding 
sequences (66.7%) located within the first 15,000 bp extending from the closest telomere 
end. Phylogenetic relationships were explored for subtype-specific coding sequences in C. 
hominis I and Ib WGS and their orthologous counterparts in a number of zoonotic (C. 
   
158 | P a g e  
 
parvum IIa (UKP4), C. parvum IId (UKP8), and C. meleagridis) and anthroponotic (C. 
parvum IIc (UKP15)) Cryptosporidium spp. (Figure 4.3.6). This illustrated a closer 
evolutionary proximity of C. hominis Ib-specific genes to C. parvum isolates than to C. 
hominis Ia for all but one of the phylogenies (UKH4C4_553).    
Table 4.3.2. Subtype-specific coding sequences in C. hominis Ia (UKH4) and Ib (UKH1) whole genome sequences 
Subtype-specific coding sequences are characterized by gene ID (WGS, chromosome no., and CD no. relative to 5’-end), 
corresponding CryptoDB ID, location relative to the 5’-telomeric repeat, length, underlying molecular cause, and putative protein 
function (BLAST hits E-value < 10-5; http://www.uniprot.org). 
Figure 4.3.6. Maximum likelihood phylogenies of subtype-specific coding sequences in C. hominis Ia and Ib WGS 
Protein coding sequences for subtype-specific genes in C. hominis Ia (UKH4) and Ib (UKH1) were extracted from whole genome 
datasets, along with corresponding orthologous protein coding sequences in C. parvum IIa (UKP4), C. parvum IId (UKP8), and C. 
parvum IIc (UKP15), with C. meleagridis (UKMEL) included as the outgroup. Amino acid sequences were aligned using the ClustalW 
algorithm, and maximum likelihood trees were subsequently constructed according to the Tamura-Nei model to illustrate 
phylogenetic relationships and distances (MEGA v 7.0; Kumar et al. 2016). 
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4.4  DISCUSSION 
 
The current study provides a detailed illustration of the degree, nature, and potential 
biological impact of divergence between two closely-related C. hominis WGS belonging to 
GP60 subtypes Ia and Ib. Localized, limited genomic divergence appears to driven the 
evolution and co-adaptation of these separate lineages, and the discovery of subtype-
specific coding sequences in either acts as a preliminary explanation for the minor 
phenotypic differences known to date. A majority of hyperpolymorphic loci were 
identified within close proximity (<20,000 bp) of either telomere end, which re-iterates 
the potential importance of subtelomeric location for proteins associated with lineage-
specific evolution and adaptation. Selective pressure was also found to act strongest on 
subtelomeric loci, with three significant ka/ks signals (>1) affecting loci directly adjacent 
to telomeric repeats (Figure 4.3.1). These high subtelomeric evolutionary rates have been 
a common feature of many studies on protozoan divergence and adaptation (Kuo & 
Kissinger, 2008), particularly due to the frequent clustering of important virulence factors 
and host-parasite interactors in multi-copy form near the telomeres (Freitas-Junior et al. 
2000; Barry et al. 2003; Dreesen et al. 2007). Surface antigens in protozoan parasites such 
as Plasmodium spp. and Trypanosoma spp. are particularly significant causes of 
heightened subtelomeric divergence, and this phenomenon has potential relevance for 
one of the major findings of this study – namely, the discovery that the highest rates for 
selective pressure were identified for three consecutive mucins at the 5’-end of 
chromosome 2. These mucins lie amongst an array of seven, all of which are annotated as 
putative mucins or surface glycoproteins, and the selective manifestation of 
hyperpolymorphism in some but not all of these genes could imply variable expression 
that is linked to host immune responses. The discovery that several other glycoproteins 
and a cell surface anchor were among the hypervariable loci further reveals potential key 
host-parasite interactors that evolved as the separate C. hominis lineages emerged, 
possibly as a result of adaptation to novel or altered host immune environments. 
Divergent evolution of surface glycoproteins has previously been described for closely-
related lineages of other infectious organisms, and associations between prolonged 
immune response exposure and increased heterozygosity have been described (Holmes 
et al. 1992). The refinement of interactions between parasite glycoproteins and host 
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responses may thus have driven lineage-specific divergence as observed between C. 
hominis subtypes Ia and Ib.        
 
Another key feature of lineage diversification was the presence of subtype-specific coding 
sequences, several of which appear to have resulted from major insertion or deletion 
events at the subtelomeres (Table 4.3.2). Gene loss and gain can have potent effects on 
an organism’s physiological processes, and are therefore commonly identified in lineage- 
or species-specific adaptations. The biological purpose and/or consequence of these can 
differ significantly, however, and it is important to note that in silico findings cannot 
determine whether a subtype-specific coding sequence arose from loss versus gain 
through this type of single pairwise comparison alone. Broader gene repertoires can be 
associated with generalist versus specialist host ranges (Agrawal et al. 2016), increased 
virulence (Strouts et al. 2012; Linz et al. 2016), or an enhanced ability to withstand 
external stressors or regulate resistance (Xiao et al. 2009; Donoghue et al. 2011). The Ib-
type WGS (UKH1) was found to contain five subtype-specific genes that were not present 
in the Ia-type WGS (UKH4), but that were conserved in C. parvum WGS belonging to 
subtypes IIa, IIc, and IId. A number of the encoded proteins were annotated as having 
adhesin or proteophosphoglycan-type properties, which could indicate potential roles in 
attachment and invasion or pathogenicity. The slightly extended host range in subtype Ib 
(Figure 4.1.1) and higher global human prevalence (chapter 3) could thus indicate that 
this lineage retained some generalist properties through specific gene conservation as it 
evolved from the common C. hominis/C. parvum ancestral strain, or that C. parvum and C. 
hominis subtype Ib separately gained certain advantageous genes through convergent 
evolution. On the other hand, gene loss during evolution can have equally beneficial 
effects. Deletion of genes during lineage-specific evolution and adaptation has been 
found to improve fitness, drive host specialization processes and even increase resistance 
to drugs for a range of pathogenic organisms (Gu et al. 2016). The loss or pseudo-
functionalization of a handful of genes in Ia-type C. hominis lineages may therefore reflect 
evolutionary changes that occurred when Ia split from Ib and adapted towards a 
narrower anthroponotic lifestyle. The closer phylogenetic proximity of UKH1 to C. parvum 
versus UKH4 to C. parvum at a majority of these loci further lends support to this theory 
(Figure 4.3.6), and illustrates how variable conservation and adaptation of certain 
proteins may have shaped the phenotypic and epidemiological differences as they 
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currently stand (Figure 4.1.1). Although the presence of frameshift-causing InDels and 
subtype-specific sequence data was confirmed in other WGS of similar GP60 subtypes, it 
is important to note that the raw sequence reads from which the genomes were 
assembled were not examined to determine the reliability of these sequenced positions. 
This means that some uncertainty remains regarding the confidence of these findings. 
Performing an added level of quality control by referring to these reads in future may 
thus add or retract credibility surrounding the presence or absence of subtype-specificity 
at certain loci of these genomes, and is an important priority for intra-C. hominis 
comparative genomics moving forward. 
     
GP60 variability quite literally towered over any other nucleotide divergence that could 
be detected across the genome, and was the only locus to produce a phylogeny that 
revealed potential evidence of recombination between C. hominis and C. parvum (Figure 
4.4.1). The phylogenetic grouping of subtype Ib within the C. parvum clade, specifically its 
proximity to the anthroponotic C. parvum subtype IIc, provides some insight into the 
potential importance of this hypervariable locus in determining host-parasite interactions, 
especially in light of the comparable host ranges (predominantly anthroponotic with 
incidental zoonotic transmission) between subtypes IIc and Ib. The Ka/Ks ratio was 
insignificant and notably lower at this recombinant locus (~0.605) than the remaining 
divergent loci identified (mean Ka/Ks > 1.0), which is a typical occurrence for genomic 
fragments which have been imported from more distant lineages (Castillo-Ramírez et al. 
2011). The retention of these highly-diverged recombinant GP60 alleles and absence of 
inter-subtype selective pressure could indicate a successful and rapid niche specialisation 
event. Intra-subtype divergences further imply a more recent timescale for Ia-subtype 
emergence than for Ib, as heightened levels of non-synonymous mutations often suggest 
a more recent diversification. Through this chronological hypothesis, the proximity of 
subtype Ib to zoonotic strains at GP60, and differential phenotypic traits we gain insight 
into the evolution of host specialisation in this species, which may imply that truly 
anthroponotic strains such as subtype Ia have only recently emerged within the 
Cryptosporidium genus, and that recombination at the GP60 locus was one of the key 
events involved.   
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Figure 4.4.1. GP60 protein sequence phylogeny reveals potential phenotype-driven recombination between zoonotic and 
anthroponotic Cryptosporidium spp.  
Whole gene GP60 sequences were extracted from WGS, translated into protein sequences, aligned (ClustalW), and evaluated 
phylogenetically using the Maximum Likelihood (ML) method, according to the Tamura-Nei model (MEGA v 7.0; Kumar et al. 2016), for 
C. hominis Ia (UKH4), C. hominis Ib (UKH1), C. parvum IIa (UKP4), C. parvum IId (UKP8), C. parvum IIc (34044), and C. meleagridis 
(UKMEL).  
 
In addition to GP60, a further eight highly-divergent coding sequences were identified 
across the genome, along with six species-specific genes resulting from subtelomeric 
deletions and frameshifts. This finding limits the list of putative phenotype drivers to 
fifteen candidates, many of which have predicted protein functions in line with known 
host-parasite interactors, such as mucins (Hicks et al. 2000), glycoproteins (Ravidà et al. 
2016), and adhesins (Boulanger et al. 2010). The three variable mucins directly adjacent 
to the 5’-telomere on chromosome 2 (Chro. 20052, 20051, and 20050) emerged as the 
most positively selected for according to Ka/Ks, reaching values above 5.0 (Figure 4.3.1), 
raising the question as to whether these proteins are selectively activated or modified in 
a manner that resembles antigenic variation in other parasitic pathogens (Andreas & 
Gojobori, 2004; Baranasic et al. 2014). These three mucins are the first in an array of 
seven, and the differential variability of certain members in this mucin array in zoonotic 
versus anthroponotic strains are a possible sign of antigenic variation. In zoonotic C. 
parvum subtypes IIa and IId, for example, the three mucins identified as divergent within 
C. hominis are entirely conserved (100% nucleotide identities), while the subsequent two 
in the array (Chro.20049 and Chro.20048) are divergent within C. parvum but entirely 
conserved between C. hominis subtypes Ia and Ib. In this chapter I also found a significant 
association between telomeric proximity and elevated SNP rates, which mirrors the 
genomic changes that seem to have accompanied speciation events separating C. hominis 
and C. parvum, as discussed in chapter 1.2. The C. hominis/C. hominis and C. hominis/C. 
parvum comparisons also shared the feature of significant sequence deletion or insertion 
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events at the telomeres, and an excess of frameshift-causing mutations across the 
genome, resulting in a number of species-specific genes. If the rule of ‘more genes = more 
hosts’ (or more virulence) applies, these species-specific genes may explain the 
phenotypic variations observed between C. hominis subtype Ia and Ib whole genome 
sequences. Thus, the level and nature of divergence between these two isolates, in 
conjunction with the unique host ranges and distributions they exhibit, may be enough to 
describe them as subspecies rather than subtypes, in a similar manner to which C. parvum 
IIc was recently re-classified as C. parvum anthroponosum. The only limit to this 
designation is that the epidemiological and clinical data seem too scarce at present to 
definitively describe true phenotypic differences, and that further WGS would be needed 
to determine whether genome-wide divergences are preserved across all Ia and Ib-type 
isolates.   
Although in silico analyses on their own can only generate hypothetical scenarios of how 
protein changes affect biology, the results from this study provide the first 
comprehensive genomic hypothesis on how host specificity and virulence may be 
modulated in Cryptosporidium hominis at the molecular level.  It also provides a new C. 
hominis species- and subtype-specific list of putative targets for genotyping, and has 
thereby expanded the range of molecular options for inter- and intra-molecular 
discrimination (Table 4.3.2). The next step forward inevitably lies in translation of in silico 
findings into an applied method. This involves validating whether the putative markers of 
virulence and host specificity identified in this study are more efficient at phylogenetic 
discrimination of strains (in a way that associates genetic features with phenotype) than 
the classic GP60-based approach. Investigating the molecular epidemiology of the 
hypervariable loci identified in this study across a broad range of C. hominis parasites is an 
important component of this, as extended associations between divergence and host 
data (such as clinical manifestations, immune responses, even geographic location) could 
reveal more about the functional consequence of gene diversification. Further 
exploration of the potential cellular role these proteins may play in host-parasite 
interactions is also needed, both to better understand the infection biology behind 
cryptosporidiosis but also to identify potential cellular pathways that could be targeted 
and interrupted through novel vaccination and/or treatment approaches. Preliminary 
work on recombination between C. hominis isolates has already begun to identify a 
number of recombinant fragments between divergent GP60 subtype families, which 
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means that much more remains to be learned about the nature of divergence between 
and within Cryptosporidium spp. This study provides a basis upon which such future 
studies can build, highlighting the types and consequences of genetic changes to look for. 
As epidemiological and clinical knowledge on C. hominis subtypes worldwide continues to 
grow, the results from this study may help to understand some of the genetic changes 
that impact phenotypic differences and accompany lineage-specific evolution. C. hominis 
lineages Ia and Ib appear to have arisen from a combination of gene loss/gain, 
hyperpolymorphism in a limited number of putative host-parasite interactors and 
significant positive selective pressure acting on telomerically-encoded surface antigens. 
Our understanding on how Cryptosporidium species and subtypes evolve and adapt is 
thereby improved, and may create a useful reference for future whole genome 
comparisons. The missing subtelomeric sequence data also provides a particularly useful 
opportunity to develop new molecular diagnostic methods, such as those that require 
subtype-specific sequence targets to achieve reliable florescence-based detection and 
discrimination.  The data from this study has thereby introduced novel data on 
Cryptosporidium genomics that molecular techniques may benefit from. Through this, we 
get one step closer to understanding more about the genetic diversity and virulence that 
characterizes human infections for this largely neglected tropical disease.     
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                              CHAPTER 5 
 
 
Novel In Situ PCR/Fluorescence In Situ Hybridization (IS-PCR/FISH) 
technique for sensitive and specific detection of C. p. parvum 
oocysts 
 
5.1  INTRODUCTION 
 
Throughout most of the twentieth century, Cryptosporidium diagnosis was largely reliant 
on a trio of interdependent methods: concentration, staining, and microscopy. 
Concentration and staining have long been pre-requisites for the identification of the 
infectious stages of the parasite, the former due to the persistent presence of oocysts in 
low numbers (particularly in asymptomatic infections), and the latter due to the 
invisibility of oocysts through direct smears or less potent stains such as iodine. Many 
staining methods were successfully tailored to cryptosporidiosis very early on in the era of 
non-molecular detection, and few non-molecular diagnostic revolutions (i.e. largescale 
popularizations of new or improved methods) have taken place since this parasite 
entered into the limelight only decades ago.  The advent of AIDS-related cryptosporidiosis 
and the consequential need for more sensitive and reliable DNA-based technologies in 
the 80s and 90s brought Cryptosporidium detection to an entirely new level, and 
simultaneously revolutionized our understanding of the genetic diversity and 
phylogenetic structuring of species and subtypes within this genus. This short review aims 
to discuss how Cryptosporidium detection methods have evolved through time, 
describing both the advancements that have been made through the introduction of 
DNA-based molecular technologies, as well as evaluating areas where the type and range 
of molecular information retrieved through diagnostics can still be improved.    
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(i) A history of diagnoses in cryptosporidiosis 
 
For the first half of the twentieth century only a handful of studies were published 
describing Cryptosporidium infections, and these were limited to mice and chickens in the 
United Kingdom (Tyzzer 1907; Tyzzer 1910; Tyzzer 1912; Tyzzer 1929; Elton et al. 1931) 
and snakes in Uganda (Hoare 1933). Through these studies the first two species were 
described, Cryptosporidium muris and nondescript species in chicken simply referred to as 
Cryptosporidium sp. (later renamed Cryptosporidium tyzzeri; Levine, 1961), but no reliable 
host range patterns or epidemiological characterisations were available. In all of the pre-
1950 studies that were published, histological sections of the intestine were used in order 
to detect and describe oocysts and other life cycle stages such as schizonts, merozoites, 
gametocytes and gametes. Most reported the use of a haematoxylin- and eosin-based 
(HE) staining approach (Tyzzer 1907-1929; Hoare 1933), with a single exception where 
Gram’s stain had been used (Elton et al. 1931). The accepted description of 
Cryptosporidium as a parasite of limited and entirely zoonotic concern at the time 
explains the scarce and sporadic interest demonstrated by the scientific community 
between 1900 and 1950; interest during this era was instead focused on other coccidian 
parasites, such as Eimeria, which was published on more than 100 times before 1950 
(database search ‘Eimeria’: PubMed, https://www.ncbi.nlm.nih.gov/pubmed and Wiley 
Online Library, http://onlinelibrary.wiley.com/). This trend was mirrored in academic 
textbooks and public health manuals of the time, where Cryptosporidium consistently 
received only brief mentions or single paragraphs, compared to entire chapters dedicated 
to other protozoa (Figure 5.1.1; Minchin, 1922; Wenyon, 1926; Manter, 1938; Zeliff, 
1947).  Reviewing the literature that would have been available to academics and lay 
persons alike during this time period therefore shows a striking lack of information and 
understanding, and drastically contrasts with the >4000 peer-reviewed articles that have 
been published on Cryptosporidium since 1950.  
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Figure 5.1.1. Scanned excerpt showing the only included description for Cryptosporidium in an early parasitological manual, from 
‘Manual of medical parasitology with techniques for laboratory diagnosis and notes on related animal parasites’ (Page 34; Zeliff, 
1947) 
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In the 1950’s and 1960’s a few more published articles started to trickle through, 
extending the range of hosts to include an Australian dingo (Bearup, 1954), Indian cat 
(Dubey & Pande, 1963), a North American guinea pig (Jervis et al. 1966), and Scottish 
turkeys (Slavin, 1955). One of the first comprehensive textbook descriptions of 
Cryptosporidium was also published in 1961 (Levine, 1961), providing a summary of what 
limited preliminary data existed regarding geographic distribution, pathogenesis, 
prevalence, morphology and life cycle (Figure 5.1.2). Reviewing the diagnostic approaches 
in this time period proved difficult, as two of the studies had no full text available (Dubey 
& Pande, 1963; Jervis et al. 1966) and one of the studies did not include a methodology 
section (Bearup, 1954). The fourth study reported use of the MacNeal staining procedure 
(Slavin, 1955), which similar to pre-1950 Cryptosporidium staining methods used eosin 
but also incorporated methylene blue as a counterstain (Adwan, 1952). Two more species 
emerged during this period, Cryptosporidium meleagridis (Slavin, 1955) and 
Cryptosporidium tyzzeri (Levine, 1961), bringing the total accepted species-types to four. 
This started to increase public understanding and thereby interest in cryptosporidiosis, 
and in the decades that followed the availability of data (and by association the range of 
diagnostic techniques) started to increase, eventually reaching exponential proportions 
during the 1980’s AIDS era and beyond.  
 
 
Figure 5.1.2. Scanned excerpt showing one of the first comprehensive textbook entries for Cryptosporidium, from ‘Protozoan 
parasites of domestic animals and of man’ (Pages 245-246; Levine, 1961) 
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The 1970’s marked a significant shift in our understanding of Cryptosporidium and its 
pathogenic impact, with the first human case documented in a 3-year-old child suffering 
from acute, self-limiting gastroenteritis in 1976 (Nime et al. 1976). By the end of the 70’s, 
two further cases in humans had been reported, both in immunocompromised adults 
(Meisel et al. 1976; Lasser et al. 1979), providing a first insight into what would become a 
defining feature of cryptosporidiosis in humans. The spectrum of animal hosts also 
continued to broaden, with Cryptosporidium now being identified in rhesus monkeys 
(Kovatch & White, 1972; Cockrell et al. 1974), a goose (Proctor & Kemp, 1974), lambs 
(Berg et al. 1979), calves (Barker & Carbonell, 1974; Schmitz & Smith, 1975; Pohlenz et al. 
1978), pigs (Bergeland, 1977; Kennedy et al. 1977), foals (Snyder et al. 1978), a number of 
snake species (Brownstein et al. 1977; McKenzie et al. 1978), parrots (Doster et al. 1979), 
and rabbits (Rehg et al. 1979; Inman & Takeuchi, 1979). First reports of respiratory 
cryptosporidiosis in birds had also begun to appear (Hoerr et al. 1978). Diagnostic 
approaches seemed surprisingly standardized during this decade, with available studies 
universally reporting use of an HE-based staining technique, and a few describing slight 
modifications by adding Giemsa and/or periodic acid-Schiff (PAS) staining (Figure 5.1.3; 
Vetterling et al. 1971; Nime et al. 1976; Meisel et al. 1976; Brownstein et al. 1977; Snyder 
et al. 1978). This decade also features one of the first reports of a stool concentration 
technique to improve oocyst recovery (Vetterling et al. 1971), through Ritchie’s 
formaldehyde and ether-based sedimentation technique (Ritchie, 1948). This would 
eventually be incorporated into routine clinical and epidemiological diagnosis of 
Cryptosporidium worldwide, and many studies today still use Ritchie’s technique (or 
modified versions thereof) as an indispensable part of oocyst detection. 
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Figure 5.1.3. Microscopy images of various non-molecular Cryptosporidium staining techniques 
(A) Haematoxylin and Eosin, (B) Giemsa, (C) Iodine, (D) Kinyoun’s, (E) Direct, (F) Ziehl-Neelsen, (G) Periodic-acid Schiff (Sources: 
http://www.atlas-protozoa.com/gallery.php?SOT_CAP=CRIPTO#0, https://www.cdc.gov/dpdx/cryptosporidiosis/, Nakamura & 
Meireles 2015, Barugahare et al. 2011). Images reproduced with written permission from the publishing authors.  
 
The birth and spread of the global HIV/AIDS epidemic in the early 1980’s projected 
Cryptosporidium into an entirely new category of public health concern. In the preceding 
years, scientists had uncovered a tentative link between immune status and the risk of 
cryptosporidiosis, but it is difficult to imagine anyone having predicted the scale of 
devastation this parasite was about to inflict upon a new global population of 
immunodeficient hosts. This was no longer the rare zoonotic parasite of limited human 
importance, but one of the primary causes of substantial morbidity and mortality in the 
ever-increasing number of HIV-positive individuals worldwide. Hundreds of reports and 
published studies on cryptosporidiosis emerged throughout the 80’s, more than 10-fold 
the number in the preceding 70 years, which appears to correlate with the continuously 
increasing number of individuals living with HIV (Figure 5.1.4). With this sharp rise in 
importance and interest came the need for improved diagnostic methods that would 
effectively gather as much information on the epidemiology and pathogenicity of this 
parasite as possible. One of the major diagnostic introductions throughout this decade 
was the adaptation of Ziehl-Neelsen staining for Cryptosporidium detection. The Ziehl-
Neelsen (ZN) acid-fast staining technique, which had been developed more than a century 
before (Koch, 1882; Ehrlich, 1882; Ziehl, 1882; Rindfleisch, 1882; Neelsen, 1883; Bishop & 
Neumann, 1970), was first introduced for Cryptosporidium diagnosis in 1983 when Garcia 
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et al. found that the Mycobacterium tuberculosis stain was more sensitive at detecting 
Cryptosporidium oocysts than any alternative diagnostic technique available at the time 
(Garcia et al. 1983). This study also popularized a number of other methods such as the 
Kinyoun acid-fast method, variations of which still remain in use today (Neres-Norberg et 
al. 2014; Ghaffari et al. 2014; Uysal et al. 2016). ZN microscopy was a method that proved 
so successful at staining and picking up oocysts, that it became the most frequently used 
technique for decades to follow, and is still often used in place of molecular approaches 
for largescale prevalence studies (Maurya et al. 2016; Kiani et al. 2016; Rzymski et al. 
2017). Preservation of stools in 10% formalin became routine practice during the 80’s, as 
did stool concentration by means such as Sheather’s sugar flotation method, formalin-
ether or formalin-ethyl acetate sedimentation (Current et al. 1983). The use of membrane 
filters (Ongerth & Stibbs, 1987) and cartridge filters (DoE/SCA, 1989) for diagnostic 
processing of very large environmental samples was also introduced. 
Immunofluorescence and antigen-based serological tests were increasingly developed 
and implemented for rapid and simple detection of Cryptosporidium antibodies, but the 
presence of a serological response long after an infection had passed meant this type of 
method had to tendency to overinflate prevalence estimates, and would not become the 
preferred approach for a majority of largescale prevalence and incidence surveys of 
cryptosporidiosis (Tzipori & Campbell, 1981; Campbell & Current, 1983; Casemore, 1987; 
Garcia et al. 1988). Direct fluorescence was also integrated into the diagnostic repertoire 
during the 80’s, which simplified initial screening procedures by producing brightly 
fluorescing and easily-identifiable oocysts, commonly through Auramine (Ratnam et al. 
1985; Stibbs & Ongerth, 1986; Ley et al. 1988) or acridine orange (Garcia et al. 1983) 
staining. The acceleration of detection methods experienced in this decade reflects the 
urgency that was felt across the public health community, and demonstrates the rapid 
attempt that was made to meet the diagnostic needs of this parasite of increasing public 
health importance. While none of the methods developed during this pre-molecular era 
were developed with the capacity of more advanced species and subtype discrimination, 
they facilitated the integration of routine diagnosis of Cryptosporidium in a rapid, 
sensitive, and efficient way, and further laid a solid platform of techniques and 
methodology upon which the molecular era would build. 
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Figure 5.1.4. Total number of published Cryptosporidium studies (PubMed: https://www.ncbi.nlm.nih.gov/pubmed) and global 
number of HIV-positive individuals (WHO/UNAIDS/UN, 2009), 1975-2000 
 
Throughout the 1980’s, heightened interest in Cryptosporidium led to improved 
knowledge about its infectivity and epidemiology, and by the end of the decade, 
comprehensive descriptions on topics such as geographic distribution, life cycle, 
pathogenesis, transmission, and diagnosis were beginning to form (Garcia & Current, 
1989), and 19 individual species had already been described (Current, 1986). Taxonomic 
relationships based on biological traits such as morphology and reproduction placed 
Cryptosporidium spp. somewhere between Isospora belli and Sarcocystis spp. on the 
protozoan tree of life, but it was only during the molecular era that followed that the true 
phylogenetic relationships between and within Cryptosporidium species began to emerge.  
 
(ii) FISH in Cryptosporidium 
 
The first adaptations of the polymerase chain reaction (PCR) for Cryptosporidium spp. 
started to appear in the early 1990s  
(Goozé et al. 1991; Laxer et al. 1992; Cai et al. 1992). Initially only capable of 
discriminating Cryptosporidium from other protozoa (Johnson et al. 1995), this method 
would evolve within a few years to achieve inter-species discrimination (Leng et al. 1996; 
Morgan et al. 1997), and shortly after the new millennium begin to describe intra-species 
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and even intra-subtype phylogenies and divergences as well (Zhou et al. 2003; Alves et al. 
2006). Previous chapters in this thesis have described some of the popular targets of PCR-
based diagnostics through the years, and discussed the degree, consistency, and accuracy 
of discrimination, demonstrating the significant advancements yet room for improvement 
that exists within molecular diagnosis of Cryptosporidium. One molecular technique that 
has shown significant promise in recent years is the use of fluorescence in situ 
hybridization (FISH) for simple, sensitive, and informative discrimination between 
phenotypically-unique species. Even before reference genomes first became available for 
Cryptosporidium spp. in 2004, this method was able to successfully identify and 
discriminate C. parvum oocysts in environmental and clinical samples (Vesey et al. 1998, 
Graczyk et al. 2003; Smith et al. 2004). Studies in Cryptosporidium have predominantly 
used the popular DNA target ‘18S rRNA’ (Lemos et al. 2005; Taguchi et al. 2006; 
Bednarska et al. 2007; Sunderland et al. 2007; Graczyk et al. 2008; Lucy et al. 2008; 
Alagappan et al. 2008; Örmeci & Linden, 2008; Alagappan et al. 2009; Zintl et al. 2010; 
Bougiouklis et al. 2013), as it is the only currently-known target that exists in enough 
copies to facilitate a strong enough fluorescence signal for detection. However, the 
largely conserved nature of 18S rRNA across Cryptosporidium spp. means there are 
limitations in terms of discriminatory power within subspecies and subtypes. Studies in 
other apicomplexan parasites such as Neospora caninum have attempted to overcome 
this by combining FISH with a preceding In Situ PCR (IS-PCR) step (Löschenberger et al. 
2004). This method uses viable parasites in place of DNA extract and performs PCR within 
the cell (i.e. In Situ), and can theoretically target and amplify any genetic fragment to 
which primers can successfully bind, thereby expanding the list of suitable multi-copy 
FISH targets to a seemingly endless number of candidates. No such combined method has 
previously been validated and/or published on in Cryptosporidium, but with the true 
genetic diversity of human-infective species beginning to emerge, the value of having 
access to this type of diagnostic method is increasingly evident.  
 
The simple and rapid identification and numeration of oocysts through fluorescence 
microscopy (Deere et al. 1998), as well as its ability to directly differentiate between 
viable and non-viable oocysts, makes this method an appealing alternative for 
Cryptosporidium diagnostics compared to some of the more laborious gold standard 
molecular techniques such as PCR. Despite being able to differentiate between species 
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types (Alagappan et al. 2009), current FISH methods in Cryptosporidium do not include 
multi-copy targets that exhibit enough variation between strains to facilitate 
discrimination of oocysts based on subtype and subspecies. This study saw an opportunity 
to fill this diagnostic gap, by advancing and broadening the specificity of fluorescence 
detection through a combined In Situ PCR/Fluorescence In Situ Hybridization (IS-
PCR/FISH) approach. The initial aim was to demonstrate whether this method was 
sensitive enough to consistently produce visible fluorescence signals for routine 
diagnosis. The secondary aim involved comparative application of the technique on 
phenotypically-diverse human-infective specie – to demonstrate that species-specific 
targeting of the technique could in fact be achieved.  
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5.2  METHODS 
 
(i) Oocysts 
 
Two sets of oocysts were used for validation of the C. p. parvum IS-PCR/FISH detection 
method - one belonging to the C. parvum species group and another belonging to C. 
hominis. Purified C. p. parvum oocysts belonging to GP60 subtype IIaA19G2R1 (stock 
concentration 108/ml) were generously provided by the Moredun Research Institute (Dr. 
Frank Katzer; Midlothian, Scotland, United Kingdom). Purified C. hominis oocysts 
belonging to GP60 subtype family Ia (stock concentration 106/ml) were generously 
provided by the Cryptosporidium Reference Unit (Guy Robinson; Singleton University 
Hospital, Swansea, Wales, United Kingdom). Both oocyst suspensions were provided in a 
1X concentrated solution of phosphate-buffered saline (137 mM NaCl, 2.7 mM KCl, 8 mM 
Na2HPO4, and 2 mM KH2PO4; pH 7.4) and stored under sterile conditions at 4°C for the 
duration of this study. 
 
(ii) Primers and Probe 
 
PCR primers for In Situ PCR were designed based on optimal feature specifications 
regarding size, melting temperature (Tm), GC content (%), and self-complementarity 
(Chavali et al. 2005). A ~8,200 bp C. parvum-specific fragment at the 3’-end of 
chromosome 6 was blasted using NCBI’s Primer-BLAST software tool (Ye et al. 2012) to 
identify effective forward and reverse primers for a pre-specified amplicon length of 100-
300 bp. Primer sequence hits were then manually checked for cross-reactivity against C. 
p. anthroponosum, C. hominis, and a range of zoonotic species for which WGS were 
available through the present study (C. meleagridis, C. baileyi, C. muris, C. cuniculus, and 
C. ubiquitum). The selected primer pair, titled CPP6T3 (CPP = C. p. parvum, 6 = 
chromosome 6, T3 = 3’-telomere) was subsequently checked to ensure 100% 
conservation across the C. p. parvum subspecies. A 208 bp target sequence is amplified by 
the primers chosen for this study (Figure 5.2.1). 
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Table 5.2.1. Primer ID’s and specifications for C. p. parvum-specific In Situ PCR protocol 
ID Sequence (5’ -> 3’) Length Tm GC 
content 
CPP6T3F (forward primer) 5’-AAAACCGCCAGCATACAAGA-3’ 20 bp 58.1 
°C 
45.0% 
CPP6T3R (reverse primer) 5’-TCGGAAGCCATAATGATCCCG-3’ 21 bp 60.0 
°C 
52.4% 
 
The 6-FAM (6-carboxyfluorescein)-labelled oligonucleotide probe sequence was similarly 
designed based on pre-determined specifications for optimised binding efficiency. 
Hybridization probe design was accomplished using the ARB software package (Ludwig et 
al. 2004), which identified the optimal 20 bp CPP6T3 probe (5’- 
TCCTTATTAGTAGACCAGGA-3’) used in this study. The CPP6T3 DNA probe was designed to 
include a 5’-6-FAM modification, for visualization under a FITC fluorescence microscope 
channel upon successful hybridization to the target sequence. All primers and probe used 
in this study were ordered through Life Technologies (Thermo Fisher Scientific, United 
Kingdom), at a desalted purification and a synthesis scale of 25 nmol.  
 
 
Figure 5.2.1. Primer and probe positions along 208 bp IS-PCR/FISH target sequence 
The primer and probe target sequences along the 208 bp IS-PCR amplicon are here shown. Two C. p. parvum GP60 subtype (IIa and IId) 
target sequences are illustrated, to demonstrate successful binding capacity of the designed primers and probe across a range of C. p. 
parvum subtypes. The forward primer CPP6T3F, reverse primer CPP6T3R, and CPP6T3 probe are shown in blue, green, and orange, 
respectively.   
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(iii) Optimization of oocyst permeabilization/fixation and the IS-PCR/FISH protocol 
 
The initial approach for permeabilization and fixation of Cryptosporidium oocysts was 
based on a 10 to 20-minute incubation of oocysts in 1:1 PBS/ethanol absolute solution at 
80°C (Deere et al. 1998; Dorsch & Veal, 2001; Smith et al. 2004; Chu et al. 2011). Through 
numerous trial-and-error approaches to investigate the strength and sensitivity of the IS-
PCR/FISH method, this was subsequently adapted to a 60-minute incubation period in 1:1 
PBS/ethanol absolute at 4°C. An additional reagent step was later added, largely to 
ensure sufficient permeabilization of the thick-walled Cryptosporidium oocysts, through 
addition of a 15-minute incubation (room temperature) in 0.5% Triton X-100, as this 
detergent has proved effective at permeabilizing cell walls in Cryptosporidium and a 
number of other protozoa (Elliott & Clark, 2000; Paluszynski et al. 2014; Bandini et al. 
2016; Currà et al. 2016).  
 
The PCR reagent set-up and cycling conditions were developed through a range of 
troubleshooting approaches, and were initially based on the reagents and concentrations 
generally used for standard PCR (Butler, 2005), and the manufacturer’s thermocycling 
recommendations outlined for the DNA polymerase kit used (Qiagen Non-Hot Start Taq 
DNA polymerase; 3 min 94°C initial denaturation, followed by 25-35 cycles of: 94°C 
denaturation for 0.5–1 min, 50–68°C annealing for 0.5-1min (approximately 5°C below Tm 
of primers), and 1 min 72°C extension, followed by a final extension for 10 min at 72°C). 
Protocols using a broad spectrum of PCR reagent volumes and combinations were 
designed and tested (1mM-5mM MgCl2; 12mM-20mM Tris HCl; 30mM-50mM KCl; 12μM-
20μM dNTPs (each), 0.1μM -1.0μM primer (each), and 0.5-5 units Non-Hot Start Taq 
polymerase), adjusting ingredients and temperatures based on the final outcome of each 
IS-PCR/FISH experiment. An unconventional change was further made through the 
addition of 0.1% Triton X-100 in the PCR master mix, based on promising results from an 
IS-PCR/FISH protocol in Neospora caninum (Löschenberger et al. 2004). The process of 
conducting all steps before, during, and directly after IS-PCR directly in a single PCR tube 
was also incorporated, as it improved the oocyst recovery rate compared to shifting 
between various Eppendorf and PCR tubes during the many permeabilization, fixation, 
centrifugation and amplification steps 
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Oocyst fixation and dehydration post IS-PCR in preparation for probe hybridization was 
adapted from previous protocols recommending air drying slides through 37°C incubation 
and ethanol dehydration series ranging from 70.0-100.0% (Erlandsen et al. 2005; Gookin 
et al. 2006; Timur & Wang, 2006; Kernohan & Bérubé, 2014). The recipes for hybridization 
buffer and wash buffer were retrieved through personal communication with FISH 
specialists at the University of Vienna (Dr. Sílvia Cervero-Aragó, Dr. Alexander Kirschner; 
Institute for Hygiene and Applied Immunology, Medical University of Vienna), and later 
adapted according to similar published protocols (Seviour & Nielsen, 2010; Kumar et al. 
2013). Hybridization times varied significantly in previously-published studies, ranging 
from a few hours (Kumar et al. 2013) to several days (Hasegawa et al. 1991; Acloque et al. 
2008), although the most commonly reported duration seemed to lie somewhere 
between 14 and 18 hours (Sirinarumitr et al. 2000; Fuyita et al. 2012; Matthiesen & 
Hansen, 2012; Li et al. 2015; Eyada et al. 2016). As a result, experiments were consistently 
run in quadruplicates at four separate hybridization durations (2 hours, 8 hours, 16 hours, 
and 24 hours), until the optimal time for hybridization of probe to target was achieved.   
 
 
(iv) IS-PCR/FISH protocol for identification of purified Cryptosporidium parvum oocysts 
 
• Fixation and permeabilization 
 
Briefly, the purified oocyst suspension (concentration 104/ml to 106/ml) was centrifuged 
at 13,000 rpm (18,928 rcf) and the supernatant was removed. 1ml of 1:1 PBS/Ethanol was 
added and the mixture was incubated for 60 minutes at 4°C, followed by two washes at 
13,000 rpm (18,928 rcf); supernatant was removed. Subsequently, 500 μl of 0.5% Triton 
X-100 in PBS was added and the solution was incubated for 15 minutes at room 
temperature, followed by two washes at 5,000 rpm (2,800 rcf); supernatant was removed 
except ~5 μl. 
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• In Situ PCR 
 
A 50 μl amplification mixture was prepared containing 18 μl H2O, 5 μl 10X buffer (500 mM 
KCl, 100 mM Tris-HCl (pH 9.0 at 25°C)), 6 μl MgCl2 (50 mM), 2 μl dNTP mix (10 mM), 6 μl 
Forward primer (10 μM), 6 μl Reverse primer (10 μM), 1 μl Non-Hot Start Polymerase (5 
U/μl; Qiagen, Hilden, Germany), and 1 μl 0.1% Triton X-100; the PCR mastermix was 
added to the permeabilized and fixated 5 μl oocyst suspension. PCR was conducted using 
a Veriti™ Thermal Cycler (Applied Biosystems, California, United States). An initial 
denaturation step at 94°C for 3 minutes was followed by 35 cycles of 94°C for 30 seconds, 
56°C for 30 seconds, and 72°C for 50 seconds, followed by a final extension at 72°C for 10 
minutes and 10°C for 10 minutes. PCR product was subsequently washed twice in 1X PBS 
by centrifugation at 2,500 rpm (700 rcf) for 30 seconds. 
 
• Hybridization and Washing 
 
10 μl of IS-PCR product was inserted onto a multiwell Teflon-coated microscope slide 
(Tekdon® Inc., Florida, United States), and incubated at 37°C for 30 minutes. The fixed 
slides subsequently underwent ethanol dehydration by insertion into 50%, 80%, and 96% 
ethanol solutions for 3 minutes each. Slides were subsequently air-dried under a fume 
hood. 8 μl of hybridization buffer (20% formamide, see table 5.2.2) plus 1 μl of FISH probe 
(0.3 mM working concentration) were mixed using a pipette and added to the well. A 
humid hybridization chamber was prepared, and the slide was carefully inserted and 
incubated at 46°C for 10-16 hours.  
 
Following hybridization, 50ml of washing buffer (10% EDTA, see table 5.2.3) was pre-
heated in a 48°C water bath, and the slide was added directly from the hybridization 
chamber. The slide was subsequently incubated in a dark water bath at 48°C for 15 
minutes. Following hybridization washing, the slide was briefly dipped into ice-cold MiliQ 
water and air-dried under dark conditions under a fume hood. In preparation for 
microscopy visualisation, 5 μl of DAPI mixture (1 µg/ml DAPI) was applied to the well and 
mounted using a coverslip.  
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Hybridization Buffer 
 
 
180 μl 5M NaCl 
20 μl 1M Tris/HCl, pH 8 
Xy MQ 
Xy Formamide 
1 μl 10% SDS 
 
 
Table 5.2.2. Reagent volumes for FISH hybridization buffer according to varying formamide concentrations 
FA% 0% 5% 10% 20% 25% 30% 35% 40% 45% 50% 55% 70% 
NaCl 180 μl 180 μl 180 μl 180 μl 180 μl 180 μl 180 μl 180 μl 180 μl 180 μl 180 μl 180 μl 
Tris 20 μl 20 μl 20 μl 20 μl 20 μl 20 μl 20 μl 20 μl 20 μl 20 μl 20 μl 20 μl 
MQ 800 μl 750 μl 700 μl 600 μl 550 μl 500 μl 450 μl 400 μl 350 μl 300 μl 250 μl 100 μl 
FA 0 μl 50 μl 100 μl 200 μl 250 μl 300 μl 350 μl 400 μl 450 μl 500 μl 550 μl 700 μl 
SDS 1 μl 1 μl 1 μl 1 μl 1 μl 1 μl 1 μl 1 μl 1 μl 1 μl 1 μl 1 μl 
 
 
Washing Buffer 
 
 
1 ml 1M Tris HCl, pH 8 
Xy 5M NaCl 
Xy 0.5M EDTA pH 8 
Top up with ddH2O 
 
Table 5.2.3. Reagent volumes for FISH washing buffer according to varying formamide concentrations 
FA% 0% 5% 10% 20% 25% 30% 35% 40% 45% 50% 55% 70% 
NaCl 9 ml 6.3 ml 4.5 ml 2150 μl 1490  1020 700 460 300 180 100 0 
Tris 1 ml 1 ml 1 ml 1 ml 1 ml 1 ml 1 ml 1 ml 1 ml 1 ml 1 ml 1 ml 
EDTA 0 0 0 500 ml 500 ml 500 ml 500 ml 500 ml 500 ml 500 ml 500 ml 500 ml 
MQ  Add to 
50 ml 
Add to 
50 ml 
Add to 
50 ml 
Add to 
50 ml 
Add to 
50 ml 
Add to 
50 ml 
Add to 
50 ml 
Add to 
50 ml 
Add to 
50 ml 
Add to 
50 ml 
Add to 
50 ml 
Add to 
50 ml 
 
 
(v) Microscopy 
 
A mounting medium was used to mount microscopy slides post IS-PCR/FISH, which 
contained mounting and antifade properties plus a generic nuclear counterstaining agent 
(1X phosphate-buffered saline, VECTASHIELD®, Fluoromount™, and DAPI (1.0 µg/ml); 
source: Medical University of Vienna). After application of the medium and a coverslip to 
the IS-PCR/FISH slide, visualization and photographic documentation of fluorescence was 
achieved using a Leica TCS SP2 confocal laser scanning microscope (Leica Microsystems 
GmbH, Wetzlar, Germany). DAPI staining was visualised through an ultraviolet/violet 
excitation (340-380 nm) band pass fluorescence filter, and 6-FAM green fluorescence was 
visualised through a blue excitation (450-490 nm) filter.  
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5.3  RESULTS 
 
(i) Selection of IS-PCR/FISH primer and probe targets from whole genome comparisons 
 
The selection of a C. parvum-specific DNA target for IS-PCR amplification largely relied on 
results from the cross-species genomic comparative analysis in chapter 1, which revealed 
a number of significant (>500 bp) stretches of sequence data that were present in C. 
parvum but absent from C. hominis (Figure 1.3.6). The C. parvum-specific target selected 
for this study comprises a ~8,200 bp sequence that extends from the 3’-end telomeric 
repeat (5’-CCTAAA-3’) on chromosome 6 (Figure 5.3.1). This large subtelomeric fragment 
and its encoded gene sequences appear to be associated with a broader spectrum of 
zoonosis, as it has been conserved in C. meleagridis, a species which similar to C. parvum 
infects a number of animal hosts, and is furthermore the third most frequently isolated 
human-infective cause, but was absent from C. baileyi, which like C. hominis has evolved 
to become a more specialist Cryptosporidium spp. with a narrow host range. 
 
 
 
Figure 5.3.1. Cross-species ACT alignment at the 3’-telomere of chromosome 6 reveals sequence specificity to broad-range zoonotic 
Cryptosporidium spp.  
Annotated views of putative protein coding sequences (ORFs > 150 bp) extending from the 3’-telomere of chromosome 6 were 
generated using the Artemis Comparison Tool WebACT (Abbott et al. 2007). FASTA files containing the first 40,000 bp of sequence data 
adjacent to the 3’-end of chromosome 6 were extracted and uploaded to WebACT from WGS sequence data for C. parvum subtype 
IIaA15G2R1 (UKP6, source: this study), C. hominis subtype IaA14R3 (UKH4, source: this study), C. meleagridis (UKMEL, source: 
http://www.cryptoDB.org), and C. baileyi (TAMU-09Q1, source: http://www.cryptoDB.org).  
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A 208 bp fragment within this species-specific target was chosen for the design of the In 
Situ PCR primers and FISH probe. The aim was to identify a target that was not only 
specific to the overall C. parvum species group, but in fact unique to the zoonotic C. p. 
parvum subspecies, which meant that the selected target further had to demonstrate 
sufficient intra-species polymorphism to ensure selective amplification. The 208 bp 
fragment used in this study was therefore chosen from a sufficiently polymorphic region 
of C. parvum/C. meleagridis-specific telomeric sequence data, which exhibited 100% 
conservation within C. p. parvum but a number of mismatched nucleotides between C. p. 
parvum and C. p. anthroponosum/C. meleagridis (Figure 5.3.2; Appendix XXVII).    
 
  
Figure 5.3.2. Maximum likelihood phylogeny of IS-PCR target amplicon reveals discriminatory specificity to the C. p. parvum 
subspecies 
The evolutionary history between 9 unique C. parvum GP60 subtype WGS (source: this study) and C. meleagridis UKMEL1 (source: 
http://www.cryptoDB.org) was inferred for the 208 bp IS-PCR target sequence, using the Tamura-Nei substitution model in MEGA v 7.0 
(Kumar et al. 2016).  Six of the C. parvum WGS belong to the C. p. parvum subspecies (UKP2, UKP3, UKP6, UKP7, UKP8, UKP16) and 
three belong to the C. p. anthroponosum subspecies (UKP13, UKP14, UKP15). Phylogeny was calculated using the Nearest-Neighbour-
Interchange (NNI) heuristic method, and 2,000 bootstrap replications were implemented to infer confidence values on the 
phylogenetic tree. 
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(ii) Molecular validation of new C. p. parvum-targeted PCR assay shows high species and 
subtype level specificity and sensitivity 
 
The approximate sensitivity of this C. p. parvum-specific IS-PCR assay was tested through 
a limit of detection (LOD) test using purified C. p. parvum Iowa II genomic DNA. Using a 
ten-fold serial dilution, starting at a stock concentration of 100 ng/μl of purified C. p. 
parvum Iowa II reference DNA and ending at a highly-diluted DNA concentration of 10-8 
ng/μl, the sensitivity of this assay (and hence the potential minimum detection capacity 
for Cryptosporidium oocysts) was evaluated. The dilution series showed that the PCR 
assay should be able to detect concentrations of C. p. parvum DNA as low as 10-4 ng/μl 
(Figure 5.3.3). At an approximate genomic weight of 3.9 x 10-5 ng DNA per oocyst (Figure 
5.3.4), the results therefore demonstrate a theoretical LOD of 3 oocysts per μl of input.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3.3. Limit of Detection of CP6T3 PCR protocol for C. parvum Iowa II genomic DNA 
A ten-fold serial DNA dilution from a C. parvum Iowa II stock concentration of 100 ng/μl was performed (100 to 10-8), to determine the 
approximate minimum no. of oocysts the IS-PCR protocol would be capable of detecting. A triplicate of negative controls containing no 
DNA were additionally included. 5μl PCR product was run at 120V for 45 minutes on a 1.5% agarose gel.   
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Mass (ng) of the C. parvum genome 
 
• C. parvum genome ≈ 9.1 Mbp (or 9,100,000 bp) 
• Single DNA base pair ≈ 650 daltons (or 1.67 x 10-24 g) 
 
1 C. parvum sporozoite genome = 9,100,000 bp x 650 daltons = 5.915 x 109 daltons 
 
 
(5.915 x 109 daltons) x (1.67 x 10-24 g) 
 
 
9.878 x 10-15 g 
 
 
         9.822095283 x 10-6 ng DNA per sporozoite 
 
 
1 oocyst = 4 sporozoites = (9.822095283 x 10-6) x 4 
 
 
                 3.9288381132 x 10-5 ng DNA per oocyst 
 
 
Figure 5.3.4. Flow diagram illustrating ng weight calculation of C. p. parvum haploid oocyst genomic DNA content 
In order to calculate the approximate weight of a single C. p. parvum oocyst, the reported genome size for the reference 
Cryptosporidium parvum parvum Iowa II WGS (~9.1 Mbp; Abrahamsen et al. 2004) and 650 dalton weight for a single base pair 
(http://www.epibio.com/tech-support/useful-calculations) were used. A single Cryptosporidium parvum parvum sporozoite is thereby 
estimated to contain 9.822095283 x 10-6 ng DNA, while an oocyst (containing 4 sporozoites) is estimated to contain 3.9288381132 x 10-
5 ng DNA. 
 
The sensitivity of the assay was further explored through molecular validation, by testing 
the C. parvum parvum-specific primers on a panel of C. p. parvum (IIaA15G2R1, 
IIdAG2R1), C. p. anthroponosum (IIcA5G3a) and C. hominis (IaA14R3, IbA10G2) isolates, in 
addition to zoonotic species C. meleagridis and C. cuniculus (Figure 5.3.5). Results from 
triplicate PCR tests showed strong and 100% specific amplification of C. p. parvum isolates 
only, with no cross-reactivity demonstrated for any of the remaining Cryptosporidium spp. 
tested. Importantly, no cross-reactivity was seen for the closely related C. p 
anthroponosum isolate IIcA5G3a, which illustrates that this assay can selectively target 
strains within the C. p. parvum species-group and therefore efficiently discriminate 
between zoonotic and anthroponotic human-infective oocysts. 
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Figure 5.3.5. Specificity of CP6T3 C. p. parvum-specific primers across a range of zoonotic and anthroponotic Cryptosporidium spp.  
The species-specificity of the PCR assay was determined by positive and negative amplification of DNA from a variety of 
Cryptosporidium spp. Standardized DNA concentrations of 1 ng/μl input from C. p. parvum Iowa II (subtype IIaA15G2R1), C. p. parvum 
IIdA22G1, C. p. anthroponosum IIcA5G3a, C. hominis IaA14R3, C. hominis IbA10G2, C. meleagridis and C. cuniculus were tested in 
triplicate, exhibiting specificity (100%) to the zoonotic C. p. parvum human-infective species group. 5μl PCR product was run at 120V 
for 45 minutes on a 1.5% agarose gel.   
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(iii) Novel IS-PCR/FISH technique shows promising discrimination between C. p. parvum 
and C. hominis oocysts 
 
A total of 127 trials were performed towards achieving optimization and validation of the 
proposed IS-PCR/FISH method, testing a variety of reagents at a number of 
concentrations and combinations based on previously-published recipes for IS-PCR and 
FISH in protozoa and bacteria. Out of 127 trials, 54 resulted in at least half (>50.0%) of 
observed oocysts exhibiting detectable fluorescence signals. These trials revealed a range 
of fluorescence, ranging from strong to no signal (Figure 5.3.6), but a majority of 
successful trials consistently showed significantly higher rates (p<0.001) of positive versus 
negative fluorescence for experimental versus control conditions (Figure 5.3.7). This trend 
was further validated through spectrophotometer absorbance readings at the optimal 
excitation wavelength for the FAM-labelled probe (495 nm), which repeatedly showed 
significantly (p<0.01) higher absorbance rates in the experimental compared to the 
control (Figure 5.3.8). 
 
 
Figure 5.3.6. Fluorescence microscope images of C. p. parvum oocysts reveals variable fluorescence strengths post IS-PCR/FISH 
Fluorescence microscopy images (60x magnification) of oocysts under the FITC channel demonstrates variable fluorescence stregths 
observed post IS-PCR/FISH trials. Oocysts are spherical/ovoid in shape and approximately 6 μm in size, and appear green with a black 
non-fluorescing background. Visualization strengths ranging from strong (+++), to moderate (++), to weak (+) and finally to negative (-) 
fluorescence are shown. 
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Figure 5.3.7. Average oocyst counts per 500 oocysts (with SEM error bars) detected for experimental versus control IS-PCR/FISH 
conditions, stratified based on strength of fluorescence (strong, moderate, weak, and no fluorescence) 
The total number of oocysts detected in successful IS-PCR/FISH trials (i.e. at least one fluorescing oocyst under experimental 
conditions) were tabulated based on strong (+++), moderate (++), weak (+), or no (-) fluorescence, and are presented here in terms of 
proportion of oocysts per 500 oocysts detected. Control conditions refer to IS-PCR/FISH trials when Taq polymerase and/or primer was 
excluded from the IS-PCR. A statistically significant difference at P<0.001, as determined through a one-tailed student’s T-test, was 
observed between the experimental and the control conditions for all fluorescence strengths.   
 
 
Figure 5.3.8. Absorbance rates of oocyst suspensions (with SEM error bars) following IS-PCR/FISH trials for experimental versus 
control conditions 
Absorbance measurements (10 mm) of oocyst suspensions were taken following the final hybridization wash step in the IS-PCR/FISH 
protocol, measured at a 495nm (FITC absorbance peak) wavelength using a NanoDrop 1000 spectrophotometer (NanoDrop® ND-1000 
Spectrophotometer V3.3; Thermo Fisher Scientific Inc). Control conditions refer to IS-PCR/FISH trials when Taq polymerase and/or 
primer was excluded from the IS-PCR. This experiment was performed in quadruplicate. A statistically significant difference at P<0.01, 
as determined through a one-tailed student’s T-test, was observed for all oocyst counts between experimental and the control trials.   
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Composite fluorescence results for this study reveal a reliable molecular sensitivity and 
specificity of detection for this novel IS-PCR/FISH method. Oocysts were consistently 
visible at a range of magnifications (40x, 63x, and 100x), and often revealed a 
fluorescence signal that exceeded that demonstrated by the generic blue-fluorescent 
DNA stain DAPI (Figure 5.3.9). A comparative overlay of the two staining techniques did 
reveal a higher oocyst detection rate for DAPI, but showed that the IS-PCR/FISH approach 
frequently picked up a high proportion of DAPI-positive oocysts. This detection rate 
averaged at 78.6% across the entirety of successful trials conducted in this study (range: 
57.1% - 100.0%, SEM± 0.07).  
 
A final important validation component of this study was to test the potential cross-
reactivity of this technique with non-C. p. parvum oocysts. A majority of trials therefore 
included C. hominis oocysts, which acted as both a negative control and species-
specificity indicator for the IS-PCR/FISH technique. Fluorescence images of FITC versus 
DAPI staining revealed that C. hominis oocysts were consistently “invisible” post IS-
PCR/FISH, a result which itself highlights the incomparably intense fluorescence 
frequently observed for the targeted C. p. parvum oocysts (Figure 5.3.10).  More than 
95% of trials revealed an absence of any fluorescence signal for runs involving C. hominis 
oocysts, with the remaining 5% infrequently showing oocysts with week to barely visible 
fluorescence (Figure 5.3.7). This demonstration of a reliable species-specificity of the 
designed primers and probe to the intended target, together with the high oocyst 
detection rate and sensitivity (both strength of fluorescence and the capacity to pick up 
oocysts at a range of magnifications), therefore speak to the overall success of this IS-
PCR/FISH method, and the potential expansion of this technique to target and 
discriminate between a greater range of Cryptosporidium species and subtypes in future.  
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5.4  DISCUSSION 
 
The current study presents results from one of the first validated IS-PCR/FISH protocols 
for molecular detection of Cryptosporidium parvum parvum oocysts. This fills a potentially 
important gap within Cryptosporidium diagnostics, as it provides the opportunity to 
approach species and subtype discrimination with an enhanced sensitivity and specificity 
control. Very few published protocols for IS-PCR in Cryptosporidium currently exist, which 
made methodological troubleshooting the most strenuous and time-consuming 
component of this study. The most comprehensive IS-PCR/FISH method that could be 
found through exhaustive review of the literature was presented as part of a 
“Cryptosporidium detection method” patent application to the United States government 
by Rochelle & Leon in 1997, but this protocol did not provide specific primer or probe 
sequences and only provided preliminary validation results (Rochelle et al. 1997), and the 
patent was deemed to be withdrawn in 2007. Another early study by Wagner-Wiening et 
al. (1998) similarly declined to include primer sequences and is only available in German, 
in addition to providing only limited agarose electrophoresis validation of the success of 
IS-PCR and without the incorporation of a FISH-based step. Only two more recent studies 
on IS-PCR in Cryptosporidium could be identified (Kimura, 2001; Chmura, 2010), both of 
which reported successful IS-PCR trials, but for neither study full text articles were 
available, and after repeated failed attempts to contact the authors the methodology 
remained inaccessible. The detailed methodology and extensive trial-and-error approach 
to optimization provided by this study is therefore somewhat novel within the field, and 
provides the opportunity for future adaptation, expansion or implementation of this 
technique for epidemiological and clinical purposes.  
 
The sensitivity and specificity of the IS-PCR technique were validated through a number of 
approaches, and focused around the inclusion of appropriate negative and positive 
controls. This methodological validation included testing of cross-reactivity of primers 
with non-C. p. parvum extracted DNA (Figure 5.3.5) and whole C. hominis oocysts (Figure 
5.3.10), both of which revealed significant specificity of the method by C. p. parvum. The 
inclusion of these negative controls and significant absence of cross-reactivity or false-
positive results demonstrated the ability of the IS-PCR/FISH to sensitively and specifically 
detect strong fluorescence signals in C. p. parvum oocysts. The theoretical LOD of the 
   
- 192 - | P a g e  
 
method, as described through PCR-based validation of a dilution series of C. p. parvum 
DNA, also revealed that the IS-PCR/FISH may be sensitive enough to pick up as few as 3 
oocysts per μl of input, making the designed targets potentially valuable for largescale 
evaluation of oocyst contamination in environmental sources. The results therefore 
demonstrate a potentially comparable efficiency of detection to that traditionally 
demonstrated by the more gold standard molecular approaches, such as standard and 
real-time PCR, although this was not evaluated in the present study. In addition, the 
described method can theoretically be adapted to any 100-300 bp DNA fragment across 
the Cryptosporidium spp. genomes, which means a seemingly endless trove of targets 
exists that can be utilised for diagnostic purposes. This potentially expands the current 
toolbox of fluorescence-based detection of cryptosporidiosis to include countless 
potential targets for specific subtype and even strain discrimination.  
 
Despite the initial success achieved through the novel IS-PCR/FISH technique, it is 
important to express and discuss a number of factors that imposed limitations on the 
present study. One important aspect to discuss is the choice of marker itself. The region 
of genomic sequence data that was chosen is present in C. parvum but absent from C. 
hominis (and divergent between C. p. parvum and C. p. anthroponosum), making it a good 
target for discrimination between the main human-infective strains. However, the 
sequence data is present in C. meleagridis, a more distantly related species, which means 
that the presence/absence of this stretch of DNA may not be evolutionarily stable. Since 
this sequence produces unexpected patterns of phylogenetic proximity between isolates 
compared to genome-wide topologies, it is possible that the presence and polymorphism 
of this subtelomeric stretch is variable at the intra-species and even intra-subtype level. 
Increased access to WGS across C. hominis and C. parvum subtypes to evaluate this 
genetic target is therefore an important next step in the validation of this method, and 
may eventually highlight an important potential limitation of the effective applicability of 
this technique for routine diagnosis. Sensitivity of detection was one aspect that showed 
significant promise overall, but the repeated presence of false-negative oocysts and 
predominance of moderate versus strong fluorescence in experimental trials indicate that 
extended troubleshooting may be needed to further enhance the ratio of positive versus 
negative fluorescence (Figure 5.3.7). However, FISH-based approaches for 
Cryptosporidium spp. in other studies similarly reported less than optimal (100%) levels of 
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fluorescence strength and rates of detection (Deere et al. 1998; Alagappan et al. 2008; 
Alagappan et al. 2009), which means that while there may be room for improvement, the 
coverage achieved by this preliminary IS-PCR/FISH method is possibly in line with 
acceptable scientific standards. The validation of assay specificity to C. p. parvum oocysts 
also experienced a number of limitations, most notably as a result of a lack of access to a 
wide panel of GP60 subtype oocysts. The unavailability of an inexpensive and simple in 
vitro approach to Cryptosporidium propagation means that only a very limited number of 
institutions around the world are capable of providing live oocysts, and the availability of 
oocysts from these institutions in turn depends on the success and frequency of oocyst 
harvesting from animal models. This means that only a few human-infective GP60 
subtypes (most often zoonotic IIa, which readily propagates in animal systems) are 
commonly available, and meant that the specificity of the IS-PCR/FISH method could only 
be validated in what happened to be available at the time of this study. Use of stored 
historical samples (available from large reference units such as the CRU in the United 
Kingdom) was also considered but subsequently excluded from the present study, as the 
extended storage of oocysts frequently damages oocyst viability and structural integrity 
(Deere et al. 1998; Bednarska et al. 2007). This meant that only fresh oocysts were 
applicable for validating the species-specificity of the IS-PCR/FISH method. The 
consequence of this limitation meant that only two oocyst subtypes could be compared, 
C. p. parvum (IIa-subtype family) and C. hominis (Ia-subtype family), and that the true 
strength and breadth of species and subspecies-specificity remains to be investigated. 
However, tests on DNA extracts from a number of zoonotic and anthroponotic 
Cryptosporidium spp. (Figure 5.3.5) showed that this method has a potentially promising 
discriminatory capacity. It also indicates that the extension of this technique into a 
multiplex IS-PCR/FISH, with differentially-labelled probes capable of simultaneous 
detection and discrimination of different subtypes in mixed samples, is within the realm 
of possibilities. 
 
The final topic of discussion worth having is the feasibility and applicability of 
implementation. This involves an honest evaluation of the benefits and disadvantages 
presented by the IS-PCR/FISH approach to Cryptosporidium diagnosis. The primary 
benefits of the current study can, in my mind, easily be defined: firstly, the specificity 
control one gains from being able to detect the species and potentially subtype of an 
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infectious organism through any single-copy genetic target; and secondly, the simple and 
rapid nature of the interpretation of the results. Many of the time-consuming and 
expensive preparatory steps of conventional PCR are additionally avoided, such as the 
not-so-easy process of DNA extraction and purification from oocysts, and the messy 
process of pouring and loading gels for electrophoresis. But what IS-PCR/FISH gains in 
terms of benefits and improvements, it more than makes up for in losses and 
impracticalities. The entire protocol described in this study takes more than twenty hours 
to complete, and requires an impressive list of more than 30 reagents and pieces of 
equipment, including a pricey thermocycler and fluorescence microscope. It also requires 
a range of storage and incubation conditions, spanning from sterile fume hoods to -20°C 
freezers to 4°C fridges to 37°C incubators to 48°C water baths. This means that there is a 
signifcant financial and logistical pre-requisite for being able to successfully implement an 
IS-PCR/FISH based strategy, which instantaneously segregates the accessibility of the 
technique between resource-poor and resource-rich settings. Hence, regions where 
cryptosporidiosis is associated with the greatest incidence rates, morbidity and mortality, 
such as poverty-stricken Sub-Saharan Africa, will likely lack the basic resources needed to 
apply this method routinely. Even in places where funding and resources may be 
available, such as the well-equipped reference laboratories of Western Europe, staff may 
consider the process too complex to incorporate it into routine diagnostic practices. The 
immediate integration of the IS-PCR/FISH method into widescale diagnostic use therefore 
does not seem practical or feasible; however, the potential relevance of this study for the 
development of new and advanced detection methods should nevertheless not be 
underestimated. One area of particular importance could be the adaptation of IS-
PCR/FISH probes into microfluidic DNA chip-based technologies for rapid diagnostic 
testing of cryptosporidiosis (Reinholt et al. 2014). In recent years, significant interest and 
investment in these “lab-on-a-chip” (LOC) pathogen detection devices that are fast, 
accurate, low maintenance and portable has increased (Yager et al. 2006; Mairhofer et al. 
2009; Lee et al. 2010; Foudeh et al. 2012), and a number of these have already been 
rolled out for use in field settings for diseases such as HIV (Sia et al. 2004; Lee et al. 2008), 
Malaria (Gascoyne et al. 2004; Antia et al. 2007), and Tuberculosis (Ke et al. 2004). A 
number of comparable microfluidic devices have been developed for detection of 
Cryptosporidium oocysts (Esch et al. 2001; Taguchi et al. 2007; Angus et al. 2012; Zhang et 
al. 2015), but most of these are only suitable for water samples and not evaluated or 
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adapted for clinical use. In addition, they are unilaterally developed for Cryptosporidium 
parvum detection and so cannot provide any discriminatory species data or even target 
non-C. parvum oocysts. With improved availability of WGS for Cryptosporidium spp., 
enhanced reports of the genetic diversity of human infections, and increasing knowledge 
of the true impact and consequences of cryptosporidiosis, there is an ever-growing need 
for enhanced diagnostic approaches that combine efficiency-of-use with accuracy-of-
detection. A rapid diagnostic tool that could discriminate between the many subtypes and 
species responsible for human cryptosporidiosis would be valuable for both clinical and 
epidemiological purposes. The evaluation of DNA probes for species-specific detection 
through colour-change technologies, as was one of the primary aims of this study, is 
therefore potentially crucial for bridging the gaps between in silico analyses, molecular 
adaptation, and clinical implementation in future. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
- 196 - | P a g e  
 
      CLOSING REMARKS 
 
 
Cryptosporidiosis is a disease that remained largely unresearched for the first three-
quarters of the 20th century. Subsequent advancements in understanding the severity of 
burden imposed by this disease worldwide, particularly in at-risk populations such as 
children under 5 years and immunocompromised individuals, led to the inclusion of this 
disease on the WHO Neglected Diseases Initiative in 2004 (Savioli et al. 2006), and since 
then the public health profile and scientific understanding of this disease continues to 
grow. To date, at least 26 species have been described, ubiquitous in nature and 
specialised to infect a broad range of hosts that includes humans, cattle, marsupials, 
amphibians, reptiles, felines, fish, rodents, pigs, sheep and rabbits (Rollinson & Stothard, 
2015). The genetic divergence that separates host-adapted isolates into species according 
to common molecular markers such as 18S rRNA is well-characterised, and GP60-based 
subtyping has provided insight into the heterogeneity and recombination that further 
separates human species into strains and subtypes. A number of comparative genomics 
studies have previously described how features such as gene loss/duplication events and 
hypervariability have driven species evolution and strain emergence in C. hominis and C. 
parvum, but the diversity of subtypes explored to date remains narrow, the 
recombination that has been characterised between phenotypically-diverse subtypes is 
limited, and the extent to which single-marker variability correlates with genomic 
divergence remains largely unexplored. This three-year PhD project was built around 
trying to fill some of these gaps, aiming to provide greater descrimination of evolutionary 
divergence between and within human-infective species, while simultaneously 
characterising the genetic drivers of host range and virulence and expanding on the global 
picture of subtype distribution, population genetics and host type epidemiology (Figure 
6.1). The concatenated phylogeny and whole genome divergence presented in chapter 1 
provided novel genetic validation that IIcA5G3a/k subtype Cryptosporidium isolates form 
a separate subspecies within the C. parvum species group, and that reclassification of 
zoonotic and anthroponotic subtypes as C. parvum parvum and C. parvum 
anthroponosum respectively is appropriate. The observation of a IIc-type GP60 locus in a 
predominantly IIa-type genome for subtype IIcA5G3j warranted the extensive 
recombination analyses presented in chapter 2, which provided a detailed 
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characterisation of genome-wide recombination events across subtypes IIaA15G2R1, 
IIcA5G5a, IIcA5G3j, and IbA10G2, and generated estimated divergence dates for some of 
the important speciation and subspeciation events in human-infective Cryptosporidium 
spp. Variability at the GP60 locus was reaffirmed as one of the predominant examples of 
recombination-driven divergence in both C. hominis and C. parvum, which motivated the 
population genetics piece presented in chapter 3. Defining population genetics and 
differentiation of GP60 in C. hominis isolates served to increase our understanding of 
allelic diversity at this locus, and assess how allelic distribution and population structure 
differ between the various subtype families. Results showed that subtype emergence and 
evolution are subject to differential degrees of selective pressure and divergence 
between subtype families, that certain subtype populations in defined geographic regions 
(such as subtypes Ia and Id in Central Asia and Sub-Saharan Africa) show evidence of 
recent population expansion events, and that population structures vary from well-
defined to poorly-defined for a majority of subtype Ib versus Ia/Id populations, 
respectively.  Significant epidemiological differences between ‘virulent’ Ib-type isolates 
and ‘avirulent’ Ia-type isolates also emerged through the GP60 systematic review, 
inspiring the exhaustive comparative genomics study presented in chapter 4. New data 
describing genomic restructuring (missing telomere ends), subtype-specific coding 
sequences and patterns of selective pressure supplement previous descriptions of the 
genome-wide drivers of lineage-specific divergence between subtypes Ia and Ib (Guo et 
al. 2015). The nature of divergence was further dissected to describe a subtelomeric 
localization bias of hypervariability and positive selective pressure, and the relative 
contribution of indels versus SNPs was additionally described, identifying indel diversity 
as the more prominent cause of genomic divergence. The final chapter of this thesis 
aimed to demonstrate the translation of in silico results into an applied method, using 
species-specific subtelomeric sequence data to develop a novel combined IS-PCR/FISH 
method for sensitive and specific detection of C. p. parvum oocysts. Extensive 
optimization and molecular validation of the primers and probe on a range of 
Cryptosporidium spp. DNA and C. hominis oocysts indicate efficient detection and 
discrimination of this technique. These results show promise for the further development 
of this technique to achieve strain discrimination, a technique that would be useful for 
tracking strain emergence and spread during outbreaks, as well as the adaptation of this 
method to microfluidics DNA chip-based rapid diagnostic tests. The advancements that 
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this thesis has achieved within Cryptosporidium genomics, epidemiology and molecular 
diagnostics are hereby summarized, and the improved understanding of how human-
infective strains, subspecies and species emerge, evolve, and adapt within this genus will 
hopefully provide a strong basis of knowledge on which future studies can build. The data 
presented in this thesis has thereby provided novel insight into the way genetic diversity 
manifests itself and influences phenotypic diversity in C. hominis and C. parvum, moving 
us one step closer towards accumulating vital in silico data to support the prevention, 
treatment, and eventual elimination of this neglected cause of diarrhoeal disease 
worldwide.  
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Figure 6. Summary of thesis study aims and results 
The aims and main results of individual chapters of this PhD thesis are described and summarized. Study aims are presented in blue, 
while results and conclusions are illustrated in dark grey.     
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                                                                          APPENDICES 
 
 
Appendix I 
 
Whole Genome Sequence (WGS) Assembly Summary Statistics 
Assembly summary statistics are reported for the 20 WGS presented in Table 1.2.1. These include the 
length of the WGS (bp), the number of scaffolds, mean scaffold length, longest scaffold length, scaffold N50, 
and the total number of non-specific (N) nucleotides. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
WGS ID Length (bp) No. 
Scaffolds 
Mean 
Scaffold 
Length 
Longest 
Scaffold 
Length 
N50 Total 
Length of 
(N) 
Characters 
RN66 9245251 97 95311.9 1182920 520347 6471 
TAMU-09Q1 8502994 145 58641.3 145259 203018 0 
UKCU2 7853083 7881 996.5 12218 1646 1 
UKH1 9141398 156 58598.7 245088 179408 0 
UKH4 9502496 2375 4001.1 283681 29100 22892 
UKMEL1 8973224 57 157425 732862 322908 0 
UKMEL3 12181424 15386 791.7 34869 4134 258412 
UKMEL4 9663721 4645 2080.5 54682 9598 55969 
UKP2 9759982 3084 3164.7 418246 105241 6400 
UKP3 9172817 919 9981.3 247529 57514 22631 
UKP6 9112937 18 506274.3 1296567 1013555 0 
UKP7 9035974 1158 7803.1 254551 30196 18798 
UKP8 9377202 1792 5232.8 302930 41951 20766 
UKP12 8038639 7357 1092.7 16726 1842 12 
UKP13 8416777 11108 757.8 16088 1315 7 
UKP14 8594935 4847 1773.2 36377 3661 36 
UKP15 10134261 6085 1665.4 102582 11563 4 
UKP16 9496690 3527 2692.6 127893 15768 2 
UKUB1 9060260 873 10378.3 223141 38238 14303 
UKUB2 9069162 680 13337 261712 46750 10231 
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Appendix II 
 
Nucleotide Composition (A, T, G, C) and Amino Acid Composition of Concatenated Sequences 
Sequence compositions of 21 Cryptosporidium spp. concatenations were generated in tabulated format 
using MEGA v5.2 (Molecular Evolutionary Genetics Analysis version 5.2; Tamura et al. 2011). High sequence 
similarity (>99.0% AA IDs) between WGS isolates belonging to C. hominis, C. parvum, and C. meleagridis 
species types resulted in average values being implemented for graphical representation of comparative 
trends.  
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Appendix III 
 
Amino acid composition, putative protein function and predicted protein localization of genes included in 
the concatenated phylogeny 
Putative protein function of 61 genes included in the concatenated phylogeny were ascertained through 
annotations on CryptoDB (http://cryptoDB.org) and through Blasting amino acid sequences against the 
UniProt Database Resource (Cut-off E-value 10-10; http://www.uniprot.org/). Predicted protein localizations 
were determined using WoLF PSORT (Protein Subcellular Localization Prediction Tool; 
https://wolfpsort.hgc.jp/). Localizations were categorized as follows: nucleus (nucl), cytoplasm (cyto), 
mitochondria (mito), cytoskeleton (cysk), plasma membrane (plas), golgi apparatus (golg), extracellular 
(extr), and peroxisome (pero). Microsoft Excel (2013) was used to determine the composition of amino 
acids for each protein, according to the twenty standard amino acids: alanine (A), arginine (R), asparagine 
(N), aspartic acid (D), cysteine (C), glutamine (Q), glutamic acid (E), glycine (G), histidine (H), isoleucine (I), 
leucine (L), lysine (K), methionine (M), phenylalanine (F), proline (P), serine (S), threonine (T), tryptophan 
(W), tyrosine (Y), and valine (V). 
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Appendix IV  
 
RDP4 recombination detection results for IIaA15G2R1, IIcA5G3a, IIcA5G3j, and IbA10G2 whole genome 
comparisons 
Summary of individual recombination events detected between C. parvum GP60 subtypes IIaA15G2R1 
(IIaA), IIcA5G3j (IIcAj), and IIcA5G3a (IIcAa), and C. hominis GP60 subtype IbA10G2 (IbA) by RDP4 
(Recombination Detection Program v. 4.66; Martin et al. 2015). Recombination events are characterised by 
start/end recombinant fragment breakpoints, major versus minor parental strains, E-values of 
recombination signals, and CDs/intergenic regions affected. Highly significant recombination events (E-
value < E-40) are additionally highlighted. Recombinant sequences covering or within 20,000bp of putative 
virulence factors (telomeric, glycoprotein-like, low-complexity, and/or hypervariable between species) are 
additionally annotated with a red star (   ). 
 
Breakpoint position in recombinant 
sequence (bp from 5’ telomere) 
Recombinant Major parent Minor 
Parent 
Detection 
Method 
CDs encoded within 
 
Beginning  
 
End 
    
RDP 
 
 
 
CHROMOSOME 1 
 
82251 
 
104422 
 
IIaA 
 
IIcAj 
 
Unknown  
 
8.28E-240 
 
cgd1_370 - cgd1_490 
82251 93181 IbA IIcA/IIcAj Unknown  4.46E-08 cgd1_370 - cgd1_430 
100170 100278 IIaA IIcA/IIcAj Unknown 3.07E-03 
cgd1_470 
100631 100831 IbA Unknown  IIaA 5.25E-04 
109846 110180 IbA Unknown  IIcAa 8.34E-13 Intergenic cgd1_510 - 
cgd1_520 
111232 111726 IIcAa IIaA/IIcAj IbA 1.26E-13 cgd1_530 
115061 116161 IIcAj/IIaA IIcAa IbA 2.78E-07 cgd1_550 
127173 136648 IIaA IIcAj IIcAa 2.93E-72 cgd1_580 - cgd1_590 
136649 140781 IIcAj IIaA IIcAa 1.18E-15 cgd1_590 - cgd1_600 
142478 150610 IIaA IIcAj IIcAa 8.96E-16 cgd1_610 - cgd1_640 
376602 386949 IIcAa Unknown  IIcAj/IIaA 2.92E-02 cgd1_1580 - cgd1_1640 
734690 744935 IIaA IIcAj IIcAa 4.18E-04 cgd1_3290 - cgd1_3340 
 
CHROMOSOME 2 
 
53785 
 
55454 
 
IIcAa 
 
IIaA/IIcAj 
 
IbA 
 
1.38E-14 
 
cgd2_160 
57056 57358 IIcAa IIaA/IIcAj IbA 1.54E-06 cgd2_140  
58483 58812 IIcAa IIaA/IIcAj Unknown 3.16E-08 cgd2_120  
61997 62206 IIcAa IIaA/IIcAj IbA 1.78E-09 Intergenic cgd2_110 - 
cgd2_100 
64582 65341 IIcAa IIaA/IIcAj IbA 8.90E-11 
cgd2_90 
67242 67933 IIcAa IIaA/IIcAj IbA 2.23E-10 
71503 72990 IIcA/IIaA IIcAj IbA 2.82E-19 cgd2_80 
75512 76343 IIcAa IIaA/IIcAj IbA 5.18E-08 cgd2_70 
79931 80238 IIcAa IIaA/IIcAj IbA 4.95E-10 Intergenic cgd2_70 - 
cgd2_60 
294024 294928 IIaA IIcAj Unknown 4.32E-10 cgd2_1370 
341750 405045 IIcAa Unknown IIcAj 4.28E-06 cgd2_1690 - cgd2_2040 
432700 506795 IIcAj IIaA15 Unknown 6.55E-04 cgd2_2170 - cgd2_2560  
625528 632428 IIaA IIcAj Unknown 1.93E-06 cgd2_3080 - cgd2_3110 
 
CHROMOSOME 3 
 
220866 
 
220932 
 
IIcAa 
 
IIcAj/IIaA 
 
Unknown  
 
4.15E-08 
 
cgd3_720 
272798 279815 IIcAj IIaA IIcAa 5.11E-04 cgd3_920 - cgd3_960 
319189 319570 IIcAa IIcAj/IIaA Unknown  9.41E-05 cgd3_1150 
321883 322660 IIcAj IIaA IIcAa 1.75E-15 cgd3_1160 
797968 799943 IIcAa IIcAj/IIaA IbA 1.43E-77 cgd3_3370  
995078 1030425 IIcAj IIaA IIcAa 2.18E-17 cgd3_4190 - cgd3_4280  
 
CHROMOSOME 4 
 
3370 
 
5132 
 
IIaA/IIcAj 
 
IIcAa 
 
IbA 
 
1.70E-24 
 
cgd4_20 
5137 5788 IIcAa IIaA/IIcAj IbA 5.46E-41 
848234 849840 IIcAj IIaA IIcAa 2.06E-13 cgd4_3630  
865724 865737 IIcAa IIaA/IIcAj IbA 1.89E-06 cgd4_3690  
1054213 1054636 IIcAa IIcAj/IIaA IbA 4.80E-14 cgd4_4480 
1057053 1058582 IIcAj/IIaA IIcAa IbA 1.27E-54 cgd4_4490 
1058583 1058932 IIcAa IIaA/IIcAj IbA 2.10E-13 Intergenic cgd4_4490 - 
cgd4_4500 
1059044 1059293 IIcAj/IIaA IIcAa IbA 5.69E-12 
cgd4_4500 1059418 1060146 IIcAa IIaA/IIcAj Unknown  3.67E-47 
1060336 1060469 IIaA/IIcAj IIcAa IbA 3.22E-07 
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1060678 1060737 IIcAa IIaA/IIcAj IbA 1.45E-06 
1061059 1061153 IIcAa IIaA/IIcAj IbA 2.89E-04 
1061156 1061888 IIcAj/IIaA IIcAa IbA 1.65E-77 
Intergenic cgd4_4500 - 3' 
telomere 
1061941 1062512 IIcAa IIcAj/IIaA Unknown  5.83E-27 
1062847 1063606 IIcAj/IIaA IIcAa IbA 1.97E-61 
       
CHROMOSOME 5 
 
3694 
 
6176 
 
IIaA 
 
IIcAj 
 
IIcAa 
 
1.03E-23 
 
Chro.50010 
585260 586337 IIcAj IIcA/IIaA IbA 3.76E-28 cgd5_2180  
649071 649362 IbA Unknown IIaA/IIcAj 8.09E-51 cgd5_1940 
1031972 1033136 IIcAj/IIaA IIcAa IbA 2.15E-45 cgd5_40 
CHROMOSOME 6 
 
49 
 
140 
 
IIcAj 
 
IIaA 
 
Unknown  
 
3.56E-05 
 
Chro.60010 
146 1792 IIcAj IIaA Unknown  2.59E-164  
1793 1905 IIcAj IIaA IbA 1.43E-12 
Intergenic Chro.60010 - 
cgd6_10 
1986 2351 IIcAj IIaA Unknown  7.34E-43 
2352 2537 IIcAj IIaA IbA 8.61E-23 
2538 2963 IIcAj IIaA Unknown 3.91E-09 
3510 3670 IIcAa IIaA IbA 3.10E-02 
4026 6334 IIaA IIcAj IIcAa 6.78E-144 cgd6_10 
7166 7713 IIcAj/IIaA IIcAa IbA 5.31E-18 Intergenic cgd6_10 - 
cgd6_20 
7784 7896 IIaA/IIcAj IIcAa IbA 2.21E-04  
8033 8972 IbA Unknown  IIcAa 2.03E-14 cgd6_20 
9758 9992 IIcAa IIaA IbA 1.12E-03  
10386 12685 IIcAj IIaA IIcAa 3.16E-32 cgd6_30 - cgd6_40 
13148 13482 IIcAa IIcAj/IIaA Unknown 7.84E-06 Intergenic cgd6_40 - 
cgd6_50 
14883 18178 IIaA IIcAj IIcAa 2.09E-24 cgd6_50 
20061 20401 IIcAa IIaA/IIcAj Unknown  3.04E-19 cgd6_60 
20936 21391 IIcAj/IIaA IIcAa IbA 7.46E-14  
186255 187077 IIaA/IIcAj IIcAa IbA 1.44E-06 cgd6_800 
240190 240717 IIaA/IIcAj IIcAa IbA 3.02E-06 cgd6_1020  
245902 247871 IIcAa Unknown  IIaA 2.52E-31 cgd6_1060 
247872 256568 IIaA IIcAj Unknown 2.04E-228 cgd6_1060 - cgd6_1100 
1225101 1225478 IIcAa IIaA/IIcAj IbA 1.49E-04 cgd6_5260  
1226191 1226342 IIcAa IIcAj/IIaA Unknown 1.28E-15 cgd6_5260 - cgd6_5270 
1226343 1226614 IIcAa IIaA/IIcAj IbA 8.40E-13 cgd6_5270 
1276817 1278061 IIcAa IIaA IbA 7.88E-28 cgd6_5450 
1278062 1278345 IIcAa IIaA Unknown  5.11E-07 Intergenic cgd6_5450 - 
cgd6_5500 
1278346 1280578 IIcAa IIaA IbA 4.13E-90 cgd6_5500 
 
CHROMOSOME 7 
 
285016 
 
292270 
 
IIcAj 
 
IIaA 
 
Unknown  
 
3.04E-06 
 
cgd7_1150 - cgd7_1170 
317243 319588 IIcAj IIaA IIcAa 3.97E-46 cgd7_1270  
878265 897621 IIcAj IIaA IIcAa 2.69E-08 cgd7_3910 - cgd7_4020 
897622 898690 IIcAj IIaA IIcAa 7.11E-24 
cgd7_4020 897728 898242 IIaA IIcAj Unknown 1.07E-62 
898691 899005 IbA Unknown IIcAj/IIaA 2. 16E-14 
899011 935740 IIcAj IIaA IIcAa 5.23E-25 cgd7_4020 - cgd7_4220  
1055570 1063864 IIcAj IIaA IIcAa 1.45E-03 cgd7_4710 - cgd7_4750  
 
CHROMOSOME 8 
 
80 
 
1150 
 
IIcAa 
 
IIaA/IIcAj 
 
Unknown  
 
9.69E-75 
 
cgd8_10 
1334 1408 IIcAa IIaA/IIcAj Unknown 2.72E-08 Intergenic cgd8_10 - 
cgd8_20 
1409 1526 IIcAa IIaA/IIcAj IbA 6.92E-07  
3201 3369 IIcAa IIaA/IIcAj Unknown  1.18E-08 
cgd8_20 3623 5676 IIcAj/IIaA IIcAa IbA 1.29E-110 
5677 5972 IIcAa IIcAj/IIaA IbA 7.91E-06 
6026 7033 IIcAj/IIaA IIcAa IbA 6.26E-40 
cgd8_30 
7274 9938 IIcA/IIcAj IIaA Unknown  2.95E-78 
10005 11970 IIcAj IIaA IIcAa 6.41E-07 cgd8_40 
12805 14933 IIcAj IIaA IIcAa 9.67E-17 cgd8_40 - cgd8_50 
15040 26389 IIaA IIcAj IIcAa 4.29E-19 cgd8_50 - cgd8_100  
42714 48676 IIaA IIcAj IIcAa 6.45E-14 cgd8_170 - cgd8_180 
75004 84938 IIcAj IIaA Unknown  4.04E-06 cgd8_300 - cgd8_350  
547697 563658 IIaA IIcAj IIcAa 5.21E-33 cgd8_2090 - cgd8_2150  
563659 564762 IIcAj IIaA IIcAa 2.16E-26 cgd8_2160 
564902 618348 IIaA IIcAj IIcAa 1. 76E-115 cgd8_2160 - cgd8_2400 
584382 584669 IbA Unknown  IIcAj 5.59E-04 cgd8_2260 
618349 628553 IIaA IIcAj Unknown 2.73E-08 cgd8_2400 - cgd8_2440 
1085940 1086106 IIcAa IIaA/IIcAj Unknown 9.40E-32 cgd8_4480  
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Appendix VI 
 
Summary Table: Worldwide distribution, host origin and GP60 subtype family characterisation of C. 
hominis isolates 
 
Publication 
Source of 
Isolate 
Host 
Subtype 
Family 
No. of 
Isolates 
GenBank Submission 
Submission 
year 
Insulander M et al. 2013 Afghanistan Human Id 1 N/A NS 
 Albania Human Ib 1 N/A NS 
Laatamna AE et al. 2015 Algeria Horse Ik 1 KJ941148.1 2014 
Peralta RH et al. 2016 Argentina Human Ia 2 KT381976.1 - KT381977.1  2015 
 Argentina Human Ib 3 N/A NS 
 Argentina Human Ie 1 N/A NS 
Ebner J et al. 2015 Australia Human Id 1 KT123175.1 2015 
Jex AR et al. 2007 Australia Human Ib 73 EU164805.1, EU164807.1 2007 
 
Australia Human Id 1 EU164806.1 2007 
Jex AR et al. 2008 Australia Human Ib 34 N/A NS 
 
Australia Human If 1 N/A NS 
 
Australia Human Ig 3 EU379544.1  2008 
Koehler AV et al. 2013 Australia Human Ib 53 KC632533.1 2013 
 Australia Human Id 12 KC632532.1  2013 
 Australia Human If 1 KC632534.1 2013 
 Australia Human Ig 5 KC632529.1 - KC632531.1  2013 
Koehler AV et al. 2016 Australia Wallaby Ib 1 KU531699 2015 
Ng J et al. 2008 Australia Human Id 1 N/A NS 
Ng J et al. 2008 Australia Human Ib 2 N/A NS 
Ng J et al. 2010 Australia Human Ib 39 GU933438.1  2010 
 Australia Human Id 88 GU933439.1 - GU933443.1  2010 
 Australia Human Ie 4 GU933444.1 - GU933446.1  2010 
 Australia Human If 3 GU933447.1 - GU933448.1  2010 
 Australia Human Ig 60 GU933449.1 - GU933452.1  2010 
Nolan MJ et al 2013 Australia Deer Ib 1 KC282993.1 2012 
O'Brien E et al. 2008 Australia Human Ia 1 N/A NS 
 Australia Human Ib 24 EF025578.1 - EF025579.1  2006 
 Australia Human Id 13 N/A NS 
 Australia Human If 3 EF025580.1  NS 
Pangasa A et al. 2010 Australia Human Ig 1 GU214344.1  2009 
 
Australia Human If 1 GU214355.1  2009 
Schiller SE et al. 2016 Australia Flying Fox Ib 1 N/A NS 
Sulaiman IM et al. 2001 Australia Human Id 1 AF402291.1  2001 
Unpublished (Monis et al) Australia Kangaroo Id 1 KX375347.1  2016 
 Australia Kangaroo Ib 1 KX375348.1 2016 
 Australia Cattle Ib 1 KX375349.1 2016 
Waldron LS et al. 2009 Australia Human Ia 2 FJ839878.1, FJ839883.1  2009 
 Australia Human Ib 28 FJ839881.1, FJ839882.1; 
FJ861209.1 - FJ861217.1; 
FJ861220.1 - FJ861224.1; 
FJ861227.1 - FJ861238.1  
2009 
 Australia Human Id 5 FJ839875.1, FJ861218.1 - 
FJ861219.1, FJ861225.1 - 
FJ861226.1  
2009 
 Australia Human Ie 1 FJ839874.1  2009 
 Australia Human If 1 FJ839873.1  2009 
Waldron LS et al. 2011 Australia Cattle Ib 3 JF727780.1 - JF727782.1  2011 
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 Australia Human Ia 4 JF727784.1  2011 
 Australia Human Ib 156 JF727751.1 - JF727752.1, 
JF727785.1 - JF727788.1  
2011 
 Australia Human Id 1 JF727753.1  2011 
 Australia Human Ie 1 JF727754.1  2011 
 Australia Human If 4 JF727789.1 - JF727791.1  2011 
 Australia Human U 1 JF727750.1  2011 
 Australia Human U 1 JF727783.1  2011 
Hira KG et al. 2011 Bangladesh Human Ia 8 AY700384.1, AY700390.1, 
AY700400.1; JF927177.1, 
JF927186.1, JF927190.1, 
JF927194.1, JF927196.1  
2004 & 
2011 
 Bangladesh Human Ib 8 AY700387.1, JF927172.1, 
JF927178.1, JF927180.1, 
JF927181.1, JF927192.1, 
JF927195.1, JF927198.1  
2004 & 
2011 
 Bangladesh Human Id 6 AY700388.1, AY700392.1, 
AY700398.1, JF927171.1, 
JF927179.1, JF927182.1  
2004 & 
2011 
 Bangladesh Human Ie 10 AY700383.1, AY700389.1, 
AY700399.1, JF927169.1, 
JF927184.1, JF927189.1, 
JF927193.1, JF927197.1, 
JF927199.1, JF927200.1  
2004 & 
2011 
 Bangladesh Human If 11 AY700391.1, AY700393.1, 
AY700397.1, JF927170.1, 
JF927173.1 - JF927176.1, 
JF927183.1, JF927185.1, 
JF927188.1  
2004 & 
2011 
 Bangladesh Human U 1 AY700386.1  2004 
Insulander M et al. 2013 Bangladesh Human Ia 1 N/A NS 
Geurden T et al. 2009 Belgium Human Ib 13 N/A NS 
Insulander M et al. 2013 Brazil Human Ib 1 N/A NS 
Peralta RH et al. 2016 Brazil Human Ib 13 N/A NS 
Unpublished (Inacio SV et al) Brazil Horse Ik 1 KT948748.1  2015 
Moore CE et al. 2016 Cambodia Human Ia 4 N/A NS 
 Cambodia Human Id 1 N/A NS 
 Cambodia Human If 1 N/A NS 
Thivierge K et al. 2016 Canada Human Id 14 N/A NS 
Trotz-Williams LA et al. 2006 Canada Human Ie 1 DQ192509.1  2005 
 Canada Human Ia 2 DQ192510.1 - DQ192511.1  2005 
 Canada Human Id 1 DQ192512.1  2005 
Jex AR & Gasser RB 2008 Caribbean 
Islands 
Human Ib 1 N/A NS 
Gu Y et al. 2016 China Rhesus 
monkey 
Ib 4 KU945279.1 - KU945282.1 2016 
 China Chimpanzee Ib 1 KU945283.1 2016 
 China Gibbon Id 1 KU945284.1 2016 
Insulander M et al. 2013 China Human Ib 1 N/A NS 
Jian F et al. 2016 China Horse Ik 1 N/A NS 
 
China Donkey Ik 60 N/A NS 
Jiang Y et al. 2014 China Human Id 1 KF851244.1  2013 
 
China Human Ib 1 KF851245.1  2013 
Karim MR et al. 2014 China Cynomolgus 
monkey 
Ii 1 KF679724.1  2013 
 
China Rhesus 
monkey 
Ib 7 KF679725.1  2013 
Liu X et al. 2015 China Squirrel 
monkey 
U 1 KP314263.1  2014 
Peng MM et al. 2001 China Human Ie 1 AF402286.1  2001 
 China Human Id 1 AF403169.1  2001 
 China Human Ib 1 AF403175.1  2001 
Unpublished (Wang L et al. 2013) China Human Ia 2 KC734574.1, KC734577.1  2013 
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 China Human Ib 1 KC734579.1  2013 
 China Human Id 2 KC734575.1 - KC734576.1  2013 
 China Human Ig 1 KC734578.1  2013 
Unpublished (Wang RJ et al.) China Human Ib 3 FJ707312.1 - FJ707314.1  2009 
 China Human Ia 1 FJ707315.1  2009 
 China Human Id 1 FJ707316.1  2009 
Unpublished (Zhang H et al.) China Human Ie 1 JQ796095.1  2012 
Unpublished (Zhang L & Jian F) China Horse Ii 1 KU200958.1  2015 
 
China Donkey Ii 2 KU200962.1 - KU200963.1  2015 
Unpublished (Zhu HL et al.) China Human Id 2 EF591785.1 - EF591786.1 2007 
Wang L et al. 2013 China Human Ib 2 JF691560.1  2011 
 
China Human Ie 1 JQ029724.1  2011 
Ye J et al. 2012 China Rhesus 
monkey 
Ia 3 JX000568.1 - JX000569.1  2012 
 China Rhesus 
monkey 
Id 1 N/A NS 
 China Rhesus 
monkey 
Ie 1 N/A NS 
 China Rhesus 
monkey 
If 1 JX000570.1 2012 
Insulander M et al. 2013 Congo Human Ib 1 N/A NS 
Gherasim A et al. 2012 Cuba Human Id 1 JQ028868.1  2011 
Pelayo L et al. 2008 Cuba Human Ia 1 N/A NS 
 Cuba Human Ib 3 N/A NS 
 Cuba Human Id 2 N/A NS 
Chalmers RM et al. 2008 Cyprus Human Ib 3 N/A NS 
Jex AR & Gasser RB 2008 Cyprus Human Ib 4 EU877240.1 2008 
 Denmark Human Ib 1 N/A 2008 
 Dominica Human Ib 1 N/A 2008 
 Ecuador Human Ie 1 EU877248.1 2008 
Insulander M et al. 2013 Egypt Human Ia 1 N/A NS 
Jex AR & Gasser RB 2008 Egypt Human Ia 1 EU877235.1  2008 
Unpublished (Abd El-Kader NM et 
al.) 
Egypt Human Ia 1 HQ389257.1  2010 
Unpublished (Beser J et al.) Egypt Human Ib 1 KU852722.1  2016 
Unpublished (Ghallab MMI et al.) Egypt Human Ib 6 KX397528.1, KX397533.1, 
KX397542.1, KX397549.1, 
KX397554.1, KX397567.1  
2016 
 Egypt Human Id 23 KX397527.1, KX397529.1, 
KX397531.1, KX397532.1, 
KX397534.1, KX397536.1, 
KX397537.1, KX397541.1, 
KX397543.1 - KX397546.1, 
KX397548.1, KX397551.1 - 
KX397553.1, KX397555.1, 
KX397558.1, KX397560.1, 
KX397562.1, KX397564.1, 
KX397565.1, KX397568.1  
2016 
 Egypt Human Ie 9 KX397530.1, KX397535.1, 
KX397538.1, KX397547.1, 
KX397550.1, KX397557.1, 
KX397559.1, KX397561.1, 
KX397569.1  
2016 
Blanco MA et al. 2014 Equatorial 
Guinea 
Human Ia 3 N/A NS 
 Equatorial 
Guinea 
Human Ib 1 N/A NS 
 Equatorial 
Guinea 
Human Id 3 N/A NS 
Insulander M et al. 2013 Eritrea Human Ia 1 N/A NS 
Adamu H et al. 2010 Ethiopia Human Ib 1 N/A NS 
Flecha MJ et al. 2015 Ethiopia Human Ib 1 KP026302.1  2014 
Insulander M et al. 2013 Ethiopia Human Id 2 N/A NS 
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Ethiopia  Human Ib 1 N/A NS 
Chalmers RM et al. 2008 France Human Ib 4 N/A NS 
Jex AR & Gasser RB 2008 France Human Ib 2 N/A NS 
Insulander M et al. 2013 France  Human Ib 1 N/A NS 
 
Gambia Human If 2 N/A NS 
Eibach D et al. 2015 Ghana Human Ia 25 N/A NS 
 Ghana Human Ib 17 N/A NS 
 Ghana Human Id 1 N/A NS 
 Ghana Human Ie 8 N/A NS 
Chalmers RM et al. 2008 Greece Human Ib 2 N/A NS 
Jex AR & Gasser RB 2008 Greece Human Ib 5 N/A NS 
Strong WB et al. 2000 Guatemala Human Id 1 AF178695.1 1999 
 
Guatemala Human Ie 1 AF178697.1 1999 
Sulaiman IM et al. 2001 Guatemala Human Ie 1 AF402290.1  2001 
Ajjampur SS et al. 2010 India Human Ia 16 GQ384438.1, GQ384443.1  2009 
 India Human Ib 11 N/A NS 
 India Human Id 7 N/A NS 
 India Human Ie 16 GQ384440.1, GQ384444.1  2009 
 India Human If 5 GQ384439.1, GQ384441.1, 
GQ384442.1  
2009 
Feng Y et al. 2007 India Cattle Id 1 DQ871347.1  2006 
Gatei W et al. 2007 India Human Ia 6 DQ665690.1, DQ665691.1, 
DQ665693.1, DQ665694.1  
2006 
 India Human Ib 13 DQ665688.1  2006 
 India Human Id 12 DQ665692.1, DQ665695.1  2006 
 India Human Ie 4 DQ665689.1  2006 
Insulander M et al. 2013 India Human Ib 1 N/A NS 
 
India Human Id 1 N/A NS 
Peng MM et al. 2001 India Human Ia 3 AF403171.1, AF403172.1, 
AF403785.1  
2001 
 India Human Ib 1 AF403173.1  2001 
 India Human Id 1 AF403165.2 2001 
Unpublished (Beser J et al.) India Human Ia 1 KU852723.1  2016 
Unpublished (Chamundeeswari S et 
al.) 
India Human Ia 2 JQ517310.1, JQ517311.1 2012 
Unpublished (Khalil S et al.) India Human Ia 3 KU169226.1, KU169227.1, 
KU169235.1  
2015 
 India Human Ib 3 KU169228.1 - KU169230.1  2015 
 India Human Id 2 KU169231.1, KU169234.1 2015 
 India Human Ie 2 KU169232.1, KU169233.1  2015 
Unpublished (Sharma P et al.) India Human Ia 12 HQ241930.1, JF268622.1 - 
JF268627.1, JF495136.1 - 
JF495138.1, JF495154.1, 
JF495155.1  
2010 & 
2011 
 India Human Ib 1 JF268628.1  2010 & 
2011 
 India Human Id 8 HQ241929.1, JF268629.1 - 
JF268633.1, JF495139.1, 
JF495156.1  
2010 & 
2011 
 India Human Ie 13 HQ241927.1, JF268634.1 - 
JF268640.1, JF495140.1 - 
JF495143.1, JF495157.1  
2010 & 
2011 
 India Human If 5 HQ241932.1, JF268641.1 - 
JF268643.1, JF495158.1  
2010 & 
2011 
Unpublished (Sharma P. & Khurana 
S) 
India Human Ia 3 KC813480.1, KC813486.1, 
KC813487.1  
2013 
 India Human Id 2 KC813481.1, KC813482.1  2013 
 India Human Ie 3 KC813483.1, KC813488.1, 
KC813490.1  
2013 
Nazemalhosseini-Mojarad E et al. 
2011 
Iran Human Id 1 AB560749.1  2010 
 
Iran Human If 2 AB560750.1  2010 
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Zintl A et al. 2009 Ireland Human Ib 25 N/A NS 
Del Chierico F et al. 2011 Italy Human Ia 1 HM371371.1 2010 
Wu Z et al. 2003 Italy Human Ib 2 AY167596.1 2002 
Gatei W et al. 2008 Jamaica Human Ie 1 EU141719.1  2007 
 
Jamaica Human Ib 1 EU141720.1  2007 
Jex AR & Gasser RB 2008 Jamaica Human Ib 1 N/A NS 
Abe N et al. 2006 Japan Human Ia 1 AB237130.1  2005 
 Japan Human Ib 1 AB237135.1 2005 
 Japan Human Ie 1 AB237138.1  2005 
Wu Z et al. 2003 Japan Human Ie 1 AY167593.1 2002 
 
Japan Human Ia 1 AY167594.1 2002 
Hijjawi N et al. 2010 Jordan Human Ib 8 N/A NS 
 
Jordan Human Id 7 N/A NS 
Hijjawi N et al. 2016 Jordan Human Ib 2 N/A NS 
Chalmers RM et al. 2008 Kenya Human Ia 1 EU161651.1 2007 
Jex AR & Gasser RB 2008 Kenya Human Ia 1 EU877238.1  2008 
 
Kenya Human Id 1 N/A NS 
Li W et al. 2011 Kenya Baboon Ib 2 JF681173.1  2011 
 Kenya Baboon If 2 JF681172.1  2011 
 
Kenya Baboon Ij 1 JF681174.1  2011 
Mbae C et al. 2015 Kenya Human Ia 5 N/A NS 
 Kenya Human Ib 20 KF974523.1, KF974525.1, 
KF974527.1  
2013 
 Kenya Human Id 32 KF984192.1  2013 
 Kenya Human Ie 23 KF974521.1, KF974522.1  2013 
 Kenya Human If 3 N/A NS 
Peng MM et al. 2001 Kenya Human Ie 2 AF402287.1, AF402288.1  2001 
 
Kenya Human Ia 1 AF403170.1  2001 
Sulaiman IM et al. 2001 Kenya Human Ia 1 AF402293.1  2001 
Unpublished (Gatei W) Kenya Human Ia 5 EU146126.1  2007 
 Kenya Human Id 7 EU146132.1  2007 
 Kenya Human Ie 1 EU146131.1  2007 
Sulaiman IM et al. 2005 Kuwait Human Ib 2 AY738187.1, AY738196.1  2004 
 Kuwait Human Id 1 AY738192.1  2004 
 Kuwait Human Ie 1 AY738184.1  2004 
Osman M et al. 2015 Lebanon Human Id 8 KM215759.1 - 
KM215766.1 
2014 
Osman M et al. 2016 Lebanon Human Ia 4 KU311887.1  2015 
 
Lebanon Human Ib 16 KU311884.1, KU311885.1, 
KU311888.1, KU311890.1, 
KU311892.1, KU311900.1, 
KU311908.1, KU311909.1  
2015 
Areeshi M et al. 2008 Madagascar Human Ia 3 N/A NS 
 Madagascar Human Id 4 N/A NS 
 Madagascar Human Ie 1 N/A NS 
Ghaffari S & Kalantari N Malawi Human Id 1 N/A NS 
Peng MM et al. 2003 Malawi Human Ia 4 AY382671.1  2003 
 Malawi Human Ib 5 AY382672.1 2003 
 Malawi Human Id 11 AY382669.1, AY382673.1  2003 
 Malawi Human Ie 6 AY382668.1  2003 
Unpublished (Ghaffari S et al.) Malawi Human Id 1 KF577772.1  2013 
Lim YA et al. 2011 Malaysia Human Ia 2 HQ631406.1, HQ631408.1  2010 
 Malaysia Human Ib 2 HQ631410.1, HQ836661.1  2010 
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 Malaysia Human Id 1 HQ836664.1  2010 
 Malaysia Human Ie 2 HQ631409.1, HQ836663.1  2010 
 Malaysia Human If 1 HQ836662.1  2010 
 Malaysia Human U 1 HQ631407.1  2010 
Insulander M et al. 2013 Mexico Human Ib 2 N/A NS 
Jex AR & Gasser RB 2008 Mexico Human Ia 1 EU877234.1  2008 
 
Mexico Human Ib 2 EU877241.1 2008 
Valenzuela O et al. 2014 Mexico Human Ia 5 KJ460366.1 - KJ460369.1, 
KJ460373.1  
2014 
 Mexico Human Ib 1 KJ460363.1  2014 
 Mexico Human Id 1 KJ460362.1  2014 
 Mexico Human Ie 3 KJ460364.1, KJ460365.1, 
KJ460371.1  
2014 
Wu Z et al. 2003 Nepal Human Ia 
 
AY167595.1 2002 
 
Nepal Human Ia 1 N/A NS 
Abeywardena H et al. 2012 New Zealand Cattle Ib 12 JQ837920.1, JQ837922.1, 
JQ837926.1 - JQ837929.1 
2012 
Chalmers RM et al. 2008 New Zealand Human Ig 1 EF214734.1  2006 
Akinbo FO et al. 2013 Nigeria Human Id 2 JX524490.1  2012 
Ayinmode AB et al. 2014 Nigeria Human Ia 3 JX644914.1, JX644916.1, 
JX644917.1 
2012 
 Nigeria Human Ib 1 JX644913.1  2012 
 Nigeria Human Ie 1 JX644915.1  2012 
Jex AR & Gasser RB 2008 Nigeria Human Ib 2 EU877242.1 2008 
Maikai BV et al. 2012 Nigeria Human Ia 2 JQ798143.1, JQ798144.1  2012 
Molloy SF et al. 2010 Nigeria Human Ia 10 N/A NS 
 Nigeria Human Ib 10 N/A NS 
 Nigeria Human Id 4 N/A NS 
 Nigeria Human Ie 3 N/A NS 
 Nigeria Human Ih 1 FJ971716.1  2009 
Chalmers RM et al. 2008 Pakistan Human Ia 3 EU161648.1, EU161649.1, 
EU161652.1  
2007 
Jex AR & Gasser RB 2008 Pakistan Human Ia 1 EU877237.1  2008 
 Pakistan Human Ib 1 N/A NS 
 Pakistan Human Id 3 EU877243.1, EU877244.1, 
EU877247.1 
2008 
 Pakistan Human Ie 4 N/A NS 
 Pakistan Human If 1 EU877249.1 2008 
Koinari M et al. 2013 Papua New 
Guinea 
Fish Id 1 N/A NS 
Koinari M et al. 2014 Papua New 
Guinea 
Goat Id 1 N/A NS 
Cama VA et al. 2007 Peru Human Ia 35 N/A NS 
 Peru Human Ib 39 EF035554.1  2006 
 Peru Human Id 40 N/A NS 
 Peru Human Ie 13 N/A NS 
Cama VA et al. 2008 Peru Human Ia 20 EU095258.1 - EU095263.1  2007 
 Peru Human Ib 23 N/A NS 
 Peru Human Id 12 EU095264.1, EU095265.1  2007 
 Peru Human Ie 19 N/A NS 
Li N et al. 2013 Peru Human Ia 2 JX088407.1, JX088408.1  2012 
 Peru Human Ib 1 JX088406.1  2012 
 Peru Human Id 2 JX088403.1, JX088404.1  2012 
 Peru Human Ie 1 JX088405.1  2012 
Sturbaum GD et al. 2003 Peru Human Ia 1 AF528755.1  2002 
 Peru Human Ib 1 AF528761.1  2002 
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 Peru Human Id 2 AF528756.1, AF528757.1  2002 
 Peru Human Ie 1 AF528759.1  2002 
Sturbaum GD et al. 2008 Peru Human Ib 1 EU052233.1  2007 
 
Peru Human Ia 1 EU052234.1  2007 
Insulander M et al. 2013 Philippines Human Ia 1 N/A NS 
Alves M et al. 2003 Portugal Human Ib 1 AY166807.1  2002 
 Portugal Human Ie 1 AY166808.1  2002 
 Portugal Human If 1 AY166810.1  2002 
Alves M et al. 2006 Portugal Human Ia 1 DQ280499.1  2005 
 Portugal Human Ib 10 N/A NS 
 Portugal Human Id 1 DQ280498.1  2005 
 Portugal Human Ie 2 N/A NS 
 Portugal Human If 1 N/A NS 
Insulander M et al. 2013 Portugal Human Ib 3 N/A NS 
Jex AR & Gasser RB 2008 Portugal Human Ib 1 N/A NS 
Peng MM et al. 2001 Portugal Human Ib 1 AF403174.1  2001 
Neagoe IM et al. 2014 Romania Human Ib 1 HG423391.1  2010 
Unpublished (Neagoe IM et al) Romania Human Ia 1 LT556067.1  2016 
 Romania Human Ib 2 LT556061.1, LT556068.1  2016 
 Romania Human Id 1 LT556069.1  2016 
Lobo ML et al. 2014 São Tomé  Human Ia 7 N/A NS 
 
São Tomé  Human Ie 7 N/A NS 
Jex AR & Gasser RB 2008 Saudi Arabia Human Ib 1 EU877240l 2008 
Unpublished (Areeshi MY et al.) Saudi Arabia Human Ie 1 AB369996.1 2007 
Unpublished (Al-Braikan FAA) Saudi Arabia Human Ib 1 AJ973150.1  2005 
Soba B & Logar J 2008 Slovenia Human Ia 1 AM937018.1  2008 
 
Slovenia Human Ib 1 AM988862.1  2008 
Unpublished (Beser J et al.) Somalia Human Ia 1 KU852724.1  2016 
Insulander M et al. 2013 Somalia  Human Ib 1 N/A NS 
Abu Samra N et al 2013 South Africa Human Ia 3 N/A NS 
 South Africa Human Ib 2 N/A NS 
 South Africa Human Id 5 N/A NS 
 South Africa Human Ie 4 N/A NS 
 South Africa Human If 5 N/A NS 
Abu Samra N et al. 2016 South Africa Human Ib 2 KU168244.1, KU168245.1 2015 
 
South Africa Human Ie 1 KU168246.1 2015 
Insulander M et al. 2013 South Africa Human If 1 JN867334.1  2011 
Leav BA et al. 2002 South Africa Human Ia 1 AF440634.1  2001 
 South Africa Human Ib 4 AF440626.1, AF440628.1, 
AF440637.1, AF440640.1  
2001 
 South Africa Human Id 5 AF440623.1 - AF440625.1, 
AF440632.1, AF440635.1  
2001 
 South Africa Human If 5 AF440629.1, AF440630.1, 
AF440633.1, AF440638.1, 
AF440639.1  
2001 
Insulander M et al. 2013 South Africa  Human Id 2 N/A NS 
Abal-Fabeiro JL et al 2013 Spain Human Ib 9 JQ349234.1 - JQ349242.1  2012 
 
Spain Human Id 1 JQ349243.1  2012 
Abal-Fabeiro JL et al 2014 Spain Human Ia 3 N/A NS 
 Spain Human Ib 336 N/A NS 
 Spain Human Id 27 N/A NS 
 Spain Human Ie 4 N/A NS 
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Chalmers RM et al. 2008 Spain Human Ib 14 N/A NS 
de Lucio A et al. 2016 Spain Human Ib 58 KT764962.1  2015 
 
Spain Human Ie 1 KT764963.1  2015 
Gherasim A et al. 2012 Spain Human Ib 1 N/A NS 
Insulander M et al. 2013 Spain Human Ib 3 N/A NS 
 
Spain Human Id 3 N/A NS 
Jex AR & Gasser RB 2008 Spain Human Ia 1 N/A NS 
 
Spain Human Ib 41 N/A NS 
Ramo A et al 2015 Spain Human Ia 6 KM222527.1  2014 
 
Spain Human Ib 35 KM222525.1, KM222526.1  2014 
Insulander M et al. 2013 Sweden Human Ia 1 N/A NS 
 
Sweden Human Ib 12 N/A NS 
Unpublished (Beser J et al.) Sweden Human Ik 1 KU727290.1  2016 
 
Sweden Human U 1 KU852719.1  2016 
O'Brien E et al. 2008 Switzerland Human Ib 2 N/A NS 
 
Switzerland Human Id 1 N/A NS 
Cheng YJ et al. 2014 Taiwan Human If 1 N/A NS 
Unpublished (Beser J et al.) Tanzania Human Ia 1 KU727289.1  2016 
 
Tanzania Human Id 1 KU852721.1  2016 
Koehler AV et al. 2014 Tasmania Human Ib 30 KJ506838.1, KJ506839.1 2014 
 Tasmania Human Id 29 KJ506844.1, KJ506846.1 2014 
 Tasmania Human Ie 1 KJ506842.1 2014 
 Tasmania Human If 1 KJ506843.1 2014 
Insulander M et al. 2013 Thailand Human Ib 9 N/A NS 
 
Thailand Human Id 1 N/A NS 
Unpublished (Beser J et al. 2015) Thailand Human Ii 2 KR296810.1, KR296811.1  2015 
Jex AR & Gasser RB 2008 The Netherlands Human Ib 1 N/A NS 
Roelfsema JH et al. 2016 The Netherlands Human Ia 23 N/A NS 
 The Netherlands Human Ib 218 N/A NS 
 The Netherlands Human Ie 3 N/A NS 
 The Netherlands Human If 1 N/A NS 
Wielinga PR et al. 2008 The Netherlands Human Ib 63 EF576982.1 - EF577044.1 2007 
 
The Netherlands Human Id 2 EF576980.1, EF576981.1  2007 
Chalmers RM et al. 2008 Tunisia Human Ib 2 N/A NS 
Unpublished (Essid R) Tunisia Human Ia 9 KU057075.1 - KU057083.1 2015 
Insulander M et al. 2013 Turkey Human Ib 2 N/A NS 
Chalmers RM et al. 2008 Turkey  Human Ib 1 N/A NS 
Jex AR & Gasser RB 2008 Turkey  Human Ib 1 N/A NS 
 
Turks and 
Caicos  
Human Id 1 EU877245.1 2008 
Akiyoshi DE et al. 2006 Uganda Human Ia 4 AY873783.1  2005 
 Uganda Human Ib 1 N/A NS 
 Uganda Human Id 2 AY873782.1, AY873784.1  2005 
 Uganda Human Ie 7 N/A NS 
 Uganda Human U 1 AY873781.1  2016 
Insulander M et al. 2013 Uganda Human Ie 1 N/A NS 
Jex AR & Gasser RB 2008 Uganda Human Ie 1 N/A NS 
Widmer & Lee 2010  Uganda Human Ia 3 HM365230.1, 
HM365231.1, HM365235.1 
2010 
 
Uganda Human Ie 3 HM365232.1 - 
HM365234.1 
2010 - 2012 
Xu P et al. 2004 Uganda Human Ia 1 XM_663000.1  2004 
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Bouzid M et al. 2010 United Kingdom Human Ib 4 GQ983356.1, GQ983358.1, 
GQ983360.1, GQ983362.1 
2009 
Chalmers RM et al. 2008 United Kingdom Human Ia 1 EU161650.1  2007 
 United Kingdom Human Ib 66 EU161653.1, EU161654.1  2007 
 United Kingdom Human If 1 EU161655.1  2007 
 United Kingdom Human Ig 1 EF214735.1  2006 
Chalmers RM et al. 2013 United Kingdom Human Ia 1 JX043493.1  2012 
 
United Kingdom Human Ib 2 JX294571.1, JX294572.1  2012 
Connelly L et al. 2013 United Kingdom Sheep Ib 10 KC679684.1 - KC679693.1 2013 
 
United Kingdom Sheep U 1 KC679695.1 2013 
Davies AP et al. 2009 United Kingdom Human Ib 1 FJ031237.1  2008 
Ghaffari S & Kalantari N, 2014 United Kingdom Human Ib 13 N/A NS 
Ghaffari S et al. 2014 United Kingdom Cattle Ib 1 KF537685.1 2013 
Giles M et al. 2009 United Kingdom Sheep Ib 1 EU186152.1  2007 
Hadfield SJ et al. 2011 United Kingdom Human Ia 1 HQ149032.1  2010 
 United Kingdom Human Ib 2 HQ149031.1, HQ149033.1  2010 
 United Kingdom Human Id 1 HQ149034.1  2010 
 United Kingdom Human Ie 1 HQ149035.1  2010 
 United Kingdom Human If 1 HQ149036.1  2010 
Hadfield SJ et al. 2015 United Kingdom Human Ia 1 KM012047.1  2014 
 
United Kingdom Human Ib 2 KM012048.1, KM085027.1  2014 
Jex AR & Gasser RB 2008 United Kingdom Human Ia 1 EU877236.1  2008 
 United Kingdom Human Ib 2 EU877239.1 2008 
 United Kingdom Human Id 1 EU877246.1 2008 
O'Brien E et al. 2008 United Kingdom Human Ib 3 N/A NS 
Pangasa A et al. 2010 United Kingdom Human Ia 3 GU214343.1, GU214345.1, 
GU214346.1  
2009 
 United Kingdom Human Ib 3 GU214347.1 - GU214349.1  2009 
 United Kingdom Human Id 4 GU214350.1 - GU214353.1  2009 
 United Kingdom Human Ie 1 GU214354.1  2009 
Unpublished (Elwin K et al) United Kingdom Human Ib 3 JQ413446.1, KF660596.1, 
KF660597.1  
2012 & 
2013  
United Kingdom Human Id 1 KF539855.1  2013 
Unpublished (Ghaffari S et al) United Kingdom Human Ib 1 KF577771 2013 
Unpublished (Leoni F et al) United Kingdom Human Ie 1 EF495194.1 2007 
Widmer & Lee 2010  United Kingdom Human Ib 5 HM365224.1 - 
HM365228.1 
2010 
 United Kingdom Human Ie 1 HM365222.1 2010 
 United Kingdom Human If 1 HM365223.1 2010 
Feltus DC et al. 2006 United States Human Ib 1 N/A NS 
Feng Y et al. 2011 United States Rhesus 
monkey 
Ii 1 HM234173.1  2010 
Feng Y et al. 2014 United States Human Ia 18 KF682372.1, KF682373.1  2013 
 United States Human Id 8 KF682371.1  2013 
 United States Human Ig 1 KF682374.1  2013 
Jex AR & Gasser RB 2008 United States Human Ib 2 N/A NS 
Strong WB et al. 2000 United States Human Ia 5 AF164502.1 - AF164505.1, 
AF224462.1 
1999 
 United States Human Ib 6 AF164498.1 - AF164500.1, 
AF178690.1, AF224463.1, 
AF224464.1  
1999 
 United States Human Id 1 AF164497.1  1999 
Sturbaum GD et al. 2003 United States Human Ib 1 AF528762.1  2002 
Sulaiman IM et al. 2001 United States Human Ie 1 AF402289.1  2001 
 
United States Human Ia 2 AF403161.1, AF403162.1  2001 
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Unpublished (Beser J et al.) United States Human Ia 1 KU852725.1  2016 
Unpublished (Fan X et al) United States Human Ib 1 JN571736.1 2011 
Widmer & Lee 2010  United States Human Ib 1 HM370430.1 2010 
 
United States Human Ie 1 HM370431.1 2010 
Insulander M et al. 2013 Venezuela Human Ib 5 N/A NS 
Alyousefi NA et al. 2013 Yemen Human Ie 1 JX032693.1  2012 
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Appendix VII 
 
Geographical disparities of C. hominis Ia-subtype GP60 allelic diversity 
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Appendix VIII 
 
Geographical disparities of C. hominis Ib-subtype GP60 allelic diversity 
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Appendix IX 
 
Geographical disparities of C. hominis Id-subtype GP60 allelic diversity 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
221 | P a g e  
 
Appendix X 
 
Geographical disparities of C. hominis Ie-subtype GP60 allelic diversity 
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Appendix XI 
 
Geographical disparities of C. hominis If-subtype GP60 allelic diversity 
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Appendix XII 
 
Normal curves showing percentiles and standard deviations (±1-3 SD) for phylogeographic estimations 
(Gst-Nst) of geographically-defined C. hominis GP60 allele groups 
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Appendix XIII 
 
Allelic diversity of Ia-type C. hominis GP60 alleles 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix Figure XI. Phylogenetic clustering and geographic distribution of Ia-type GP60 alleles  
25 unique alleles were identified from SNP-based comparisons of Ia GP60 consensus sequence alignments (DnaSP v 5.10.1; Librado & Rozas, 2009). 
Maximum likelihood phylogenetic reconstruction of ClustalW aligned gapless consensus sequences (A) revealed distinct clustering of isolates into 
predominantly two alleles, type A (57.0%) and type B (19.5%), with the remaining isolates comprising ‘other’ alleles at substantially lower total 
frequencies (0.8-3.1%) (Tamura-Nei Model, MEGA v 7.0). Geographic composition of these three subtype classes revealed inter-allelic differences, with 
allele A predominating in Central Asia and Sub-Saharan Africa, and allele B predominating in North and South America, and less conventional alleles 
dominating in North African samples (B). Relative sizes of individual pie figures are accurate proportional representations of total isolates analysed.  
Regional differences of allelic composition were additionally assessed, revealing coexistence of both alleles A and B in most defined geographic regions 
(62.5%), and differential proportions for intra-regional compositions of all allele types (C).  
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Appendix XIV 
 
Allelic diversity of Ib-type C. hominis GP60 alleles 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix Figure XII. Phylogenetic clustering and geographic distribution of Ib-type GP60 alleles  
17 unique alleles were identified from SNP-based comparisons of Ib GP60 consensus sequence alignments (DnaSP v 5.10.1; Librado & Rozas, 2009). 
Maximum likelihood phylogenetic reconstruction of ClustalW aligned gapless consensus sequences (A) revealed distinct clustering of isolates into 
predominantly two alleles, type A (58.5%) and type B (20.8%), with the remaining isolates comprising ‘other’ alleles at substantially lower total 
frequencies (0.8-6.2%) (Tamura-Nei Model, MEGA v 7.0). Geographic composition of these three subtype classes revealed inter-allelic differences, with 
allele A predominating in Europe, and allele B predominating in Central Asia and North America, and less conventional alleles dominating in Australasian 
and East Asian samples (B). Relative sizes of individual pie figures are accurate proportional representations of total isolates analysed.  Regional 
differences of allelic composition were additionally assessed, revealing coexistence of both alleles A and B in all but two of the defined geographic regions 
(75.0%), and differential proportions for intra-regional compositions of all allele types (C).  
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Appendix XV 
 
Allelic diversity of Id-type C. hominis GP60 alleles 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix Figure XIII. Phylogenetic clustering and geographic distribution of Id-type GP60 alleles  
26 unique alleles were identified from SNP-based comparisons of Id GP60 consensus sequence alignments (DnaSP v 5.10.1; Librado & Rozas, 2009). 
Maximum likelihood phylogenetic reconstruction of ClustalW aligned gapless consensus sequences (A) revealed distinct clustering of isolates into 
predominantly two alleles, type A (53.8%) and type B (18.7%), with the remaining isolates comprising ‘other’ alleles at substantially lower total 
frequencies (1.1-2.2%) (Tamura-Nei Model, MEGA v 7.0). Geographic composition of these three subtype classes revealed inter-allelic differences, with 
allele A predominating in Sub-Saharan Africa and South America, and allele B predominating in Central Asia, and less conventional alleles dominating in 
Australasian, Central Asian and Sub-Saharan African samples (B). Relative sizes of individual pie figures are accurate proportional representations of total 
isolates analysed.  Regional differences of allelic composition were additionally assessed, revealing coexistence of both alleles A and B in only half of the 
geographic regions compared (50.0%), and homogenous B-type allele populations in North Africa and South America (C).  
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Appendix XVI 
 
Allelic diversity of Ie-type C. hominis GP60 alleles 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
Appendix Figure XIV. Phylogenetic clustering and geographic distribution of Ie-type GP60 alleles  
10 unique alleles were identified from SNP-based comparisons of Ie GP60 consensus sequence alignments (DnaSP v 5.10.1; Librado & Rozas, 2009). 
Maximum likelihood phylogenetic reconstruction of ClustalW aligned gapless consensus sequences (A) revealed distinct clustering of isolates into 
predominantly two alleles, type A (73.1%) and type B (11.5%), with the remaining isolates comprising ‘other’ alleles at substantially lower frequencies 
(1.9% each) (Tamura-Nei Model, MEGA v 7.0). Geographic composition of these three subtype classes revealed inter-allelic differences, with allele A 
predominating in Central Asia and Sub-Saharan Africa, and allele B predominating in Eastern Asia, and less conventional alleles dominating in Australasian 
and Central Asian samples (B). Relative sizes of individual pie figures are accurate proportional representations of total isolates analysed.  Regional 
differences of allelic composition were additionally assessed, revealing coexistence of both alleles A and B in less than half of the geographic regions 
compared (37.5%), and homogenous A-type allele populations in Europe (C).  
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Appendix XVII 
 
Allelic diversity of If-type C. hominis GP60 alleles 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix Figure XV. Phylogenetic clustering and geographic distribution of If-type GP60 alleles  
8 unique alleles were identified from SNP-based comparisons of If GP60 consensus sequence alignments (DnaSP v 5.10.1; Librado & Rozas, 2009). 
Maximum likelihood phylogenetic reconstruction of ClustalW aligned gapless consensus sequences (A) revealed distinct clustering of isolates into 
predominantly two alleles, type A (38.5%) and type B (34.6%), with the remaining isolates comprising ‘other’ alleles at substantially lower frequencies 
(3.8-7.7%) (Tamura-Nei Model, MEGA v 7.0). Geographic composition of these three subtype classes revealed inter-allelic differences, with allele A 
predominating in Central Asia, and allele B predominating in Europe and Sub-Saharan Africa, and less conventional alleles dominating in Australasian 
samples (B). Relative sizes of individual pie figures are accurate proportional representations of total isolates analysed.  Regional differences of allelic 
composition were additionally assessed, revealing coexistence of both alleles A and B in only a single geographic region (16.7%), and homogenous A-type 
allele populations in Central Asia and North Africa, versus homogenous B-type allele populations in Europe (C).  
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Appendix XVIII 
 
Nst and Gst values for pairwise geographic comparisons of GP60 allele populations 
 
Subtype Ia 
Population 1 Population 2 Gst Nst Gst-Nst 
AU CA 0.07532 0.12196 -0.04664 
AU EA 0.12207 0.06417 0.05790 
AU EU 0.03389 0.04706 -0.01317 
AU NAF 0.01856 0.19236 -0.17380 
AU NAM 0.06196 0.00719 0.05477 
AU SAM 0.08184 0.04026 0.04158 
AU SSA 0.12339 0.13125 -0.00786 
CA EA 0.22744 0.40590 -0.17846 
CA EU 0.01149 0.00314 0.00835 
CA NAF 0.14070 0.14400 -0.00330 
CA NAM 0.12823 0.18388 -0.05565 
CA SAM 0.23920 0.37688 -0.13768 
CA SSA 0.00588 0.00110 0.00478 
EA EU 0.14776 0.23310 -0.08534 
EA NAF 0.13099 0.32626 -0.19527 
EA NAM 0.01907 0.05246 -0.03339 
EA SAM 0.00143 0.00026 0.00117 
EA SSA 0.42980 0.41649 0.01331 
EU NAF 0.06843 0.12636 -0.05793 
EU NAM 0.03849 0.05921 -0.02072 
EU SAM 0.11111 0.21070 -0.09959 
EU SSA 0.05575 0.00696 0.04879 
NAF NAM 0.09633 0.23226 -0.13593 
NAF SAM 0.09155 0.32223 -0.23068 
NAF SSA 0.25488 0.12681 0.12807 
NAM SAM 0.01463 0.05576 -0.04113 
NAM SSA 0.23860 0.20225 0.03635 
SAM SSA 0.35643 0.39054 -0.03411 
Subtype Ib 
Population 1 Population 2 Gst Nst Gst-Nst 
AU CA 0.17206 0.43119 -0.25913 
AU EA 0.20880 0.47464 -0.26584 
AU EU 0.14715 0.06233 0.08482 
AU NAF 0.00696 0.00312 0.00384 
AU NAM 0.04336 0.04879 -0.00543 
AU SAM 0.10175 0.05100 0.05075 
AU SSA 0.01869 0.00194 0.01675 
CA EA 0.60440 0.82373 -0.21933 
CA EU 0.49233 0.85166 -0.35933 
CA NAF 0.29579 0.55550 -0.25971 
CA NAM 0.13103 0.33374 -0.20271 
CA SAM 0.63971 0.84836 -0.20865 
CA SSA 0.24082 0.44655 -0.20573 
EA EU 0.51415 0.79896 -0.28481 
EA NAF 0.35624 0.60677 -0.25053 
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EA NAM 0.41395 0.58553 -0.17158 
EA SAM 0.66108 0.79592 -0.13484 
EA SSA 0.38206 0.52252 -0.14046 
EU NAF 0.04288 0.09613 -0.05325 
EU NAM 0.16948 0.33912 -0.16964 
EU SAM 0.00500 0.05797 -0.05297 
EU SSA 0.06733 0.12151 -0.05418 
NAF NAM 0.02941 0.00324 0.02617 
NAF SAM 0.03369 0.07489 -0.04120 
NAF SSA 0.02380 0.00703 0.01677 
NAM SAM 0.20032 0.32407 -0.12375 
NAM SSA 0.02517 0.00470 0.02047 
SAM SSA 0.06530 0.10429 -0.03899 
Subtype Id 
Population 1 Population 2 Gst Nst Gst-Nst 
AU CA 0.00232 0.11206 -0.10974 
AU EA 0.15940 0.13943 0.01997 
AU EU 0.06399 0.10500 -0.04101 
AU NAF 0.19155 0.14456 0.04699 
AU NAM 0.03526 0.08057 -0.04531 
AU SAM 0.28227 0.14456 0.13771 
AU SSA 0.10448 0.09820 0.00628 
CA EA 0.21927 0.24485 -0.02558 
CA EU 0.13647 0.13111 0.00536 
CA NAF 0.22603 0.27063 -0.04460 
CA NAM 0.06812 0.00597 0.06215 
CA SAM 0.34279 0.27063 0.07216 
CA SSA 0.19745 0.16135 0.03610 
EA EU 0.01284 0.00084 0.01200 
EA NAF 0.00725 0.00000 0.00725 
EA NAM -0.03194 0.00038 -0.03232 
EA SAM 0.00189 0.00000 0.00189 
EA SSA 0.01244 0.00242 0.01002 
EU NAF 0.06539 0.00151 0.06388 
EU NAM -0.00228 -0.04007 0.03779 
EU SAM 0.08064 0.00151 0.07913 
EU SSA 0.01122 0.00212 0.00910 
NAF NAM 0.00297 0.00000 0.00297 
NAF SSA 0.05753 0.00000 0.05753 
NAM SAM 0.03045 0.00217 0.02828 
NAM SSA 0.03086 0.00000 0.03086 
SAM SSA 0.05410 0.00268 0.05142 
Subtype Ie 
Population 1 Population 2 Gst Nst Gst-Nst 
AU CA 0.12817 0.14325 -0.01508 
AU EA -0.01248 -0.07848 0.06600 
AU EU 0.29825 0.29938 -0.00113 
AU NAF 0.09416 0.24013 -0.14597 
AU NAM -0.02094 -0.10747 0.08653 
AU SAM 0.15439 0.08768 0.06671 
   
231 | P a g e  
 
AU SSA 0.19421 0.26645 -0.07224 
CA EA 0.06145 0.08478 -0.02333 
CA EU 0.03566 -0.00065 0.03631 
CA NAF -0.00854 0.00022 -0.00876 
CA NAM 0.00256 0.00063 0.00193 
CA SAM -0.01295 -0.03032 0.01737 
CA SSA -0.00993 0.00013 -0.01006 
EA EU 0.1878 0.33333 -0.14553 
EA NAF 0.03625 0.21101 -0.17476 
EA NAM -0.08808 -0.30000 0.21192 
EA SAM 0.07182 0.00044 0.07138 
EA SSA 0.10024 0.25834 -0.15810 
EU NAF 0.00415 0.00000 0.00415 
EU NAM 0.01370 0.00000 0.01370 
EU SAM 0.00000 0.00000 0.00000 
EU SSA 0.00149 0.00000 0.00149 
NAF NAM -0.07348 0.00055 -0.07403 
NAF SAM -0.04803 0.00055 -0.04858 
NAF SSA -0.03226 0.00032 -0.03258 
NAM SAM -0.04348 -0.20023 0.15675 
NAM SSA -0.02227 0.00035 -0.02262 
SAM SSA -0.03544 0.00035 -0.03579 
Subtype If 
Population 1 Population 2 Gst Nst Gst-Nst 
AU CA 0.18019 0.17297 0.00722 
AU EU 0.19656 0.41986 -0.22330 
AU SSA 0.08901 0.12385 -0.03484 
CA EU 1.00000 1.00000 0.00000 
CA SSA 0.64339 0.39551 0.24788 
EU SSA 0.00000 0.00000 0.00000 
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Appendix XIX 
 
Characterization of genomic differences between C. hominis Ia and Ib whole genome sequences: 
Chromosome 1 
 
 
 
Appendix XX 
 
Characterization of genomic differences between C. hominis Ia and Ib whole genome sequences: 
Chromosome 2 
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Appendix XXI 
 
Characterization of genomic differences between C. hominis Ia and Ib whole genome sequences: 
Chromosome 3 
 
 
Appendix XXII 
 
Characterization of genomic differences between C. hominis Ia and Ib whole genome sequences: 
Chromosome 4 
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Appendix XXIII 
 
Characterization of genomic differences between C. hominis Ia and Ib whole genome sequences: 
Chromosome 5 
 
 
Appendix XXIV 
 
Characterization of genomic differences between C. hominis Ia and Ib whole genome sequences: 
Chromosome 6 
 
   
235 | P a g e  
 
Appendix XXV 
 
Characterization of genomic differences between C. hominis Ia and Ib whole genome sequences: 
Chromosome 7 
 
Appendix XXVI 
 
Characterization of genomic differences between C. hominis Ia and Ib whole genome sequences: 
Chromosome 8 
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Appendix XXVII 
 
Sequence alignment of 208 bp In Situ PCR target across variable C. parvum GP60 subtypes and C. 
meleagridis (Screenshots MEGA v 7.0, Kumar et al. 2016) 
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